
==== Front
Signal Transduct Target Ther
Signal Transduct Target Ther
Signal Transduction and Targeted Therapy
2095-9907
2059-3635
Nature Publishing Group UK London

1946
10.1038/s41392-024-01946-6
Review Article
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
Ma Ziqi ziqi.ma@med.uni-heidelberg.de

12
http://orcid.org/0000-0001-8450-5281
Zuo Tao 34
Frey Norbert Norbert.frey@med.uni-heidelberg.de

12
Rangrez Ashraf Yusuf ashrafyusuf.rangrez@med.uni-heidelberg.de

12
1 https://ror.org/013czdx64 grid.5253.1 0000 0001 0328 4908 Department of Cardiology, Angiology and Pneumology, University Hospital Heidelberg, Heidelberg, Germany
2 https://ror.org/031t5w623 grid.452396.f 0000 0004 5937 5237 DZHK (German Centre for Cardiovascular Research), partner site Heidelberg/Mannheim, Heidelberg, Germany
3 https://ror.org/03m01yf64 grid.454828.7 0000 0004 0638 8050 Key Laboratory of Human Microbiome and Chronic Diseases (Sun Yat-sen University), Ministry of Education, Guangzhou, China
4 https://ror.org/005pe1772 grid.488525.6 Guangdong Institute of Gastroenterology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
23 9 2024
23 9 2024
2024
9 2375 3 2024
3 7 2024
1 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The human microbiome is a complex and dynamic system that plays important roles in human health and disease. However, there remain limitations and theoretical gaps in our current understanding of the intricate relationship between microbes and humans. In this narrative review, we integrate the knowledge and insights from various fields, including anatomy, physiology, immunology, histology, genetics, and evolution, to propose a systematic framework. It introduces key concepts such as the ‘innate and adaptive genomes’, which enhance genetic and evolutionary comprehension of the human genome. The ‘germ-free syndrome’ challenges the traditional ‘microbes as pathogens’ view, advocating for the necessity of microbes for health. The ‘slave tissue’ concept underscores the symbiotic intricacies between human tissues and their microbial counterparts, highlighting the dynamic health implications of microbial interactions. ‘Acquired microbial immunity’ positions the microbiome as an adjunct to human immune systems, providing a rationale for probiotic therapies and prudent antibiotic use. The ‘homeostatic reprogramming hypothesis’ integrates the microbiome into the internal environment theory, potentially explaining the change in homeostatic indicators post-industrialization. The ‘cell-microbe co-ecology model’ elucidates the symbiotic regulation affecting cellular balance, while the ‘meta-host model’ broadens the host definition to include symbiotic microbes. The ‘health-illness conversion model’ encapsulates the innate and adaptive genomes’ interplay and dysbiosis patterns. The aim here is to provide a more focused and coherent understanding of microbiome and highlight future research avenues that could lead to a more effective and efficient healthcare system.

Subject terms

Microbiology
Cell biology
https://doi.org/10.13039/501100001659 Deutsche Forschungsgemeinschaft (German Research Foundation) RA 2717/4-1 1289/17-1 Frey Norbert Rangrez Ashraf Yusuf https://doi.org/10.13039/501100004543 China Scholarship Council (CSC) issue-copyright-statement© West China Hospital, Sichuan University 2024
==== Body
pmcIntroduction

The 2022 publication of the complete human genome sequence closed gaps from the Human Genome Project starting 20 years ago,1–6 and the recent “pangenome” draft further advanced our understanding of human genetic diversity.7–9 In symbiosis with the human body, the microbiome - a collective of microbes such as bacteria, fungi, archaea, viruses and their respective genomes, maintains a continuous crosstalk with the human genome. Exploring their interplay may elucidate a broader spectrum of individual phenotypic variations, considering that genomic differences between individuals account for only 0.1% of the total genome.10

Microorganisms were first discovered and reported by Antoni van Leeuwenhoek in the 17th century using microscope.11 Advancements in modern techniques such as high-throughput sequencing, multi-OMICS, and artificial intelligence have greatly facilitated our understanding of the value of human microbiomes in health and disease. Notably, the Human Microbiome Project (HMP) and Integrative Human Microbiome Project (iHMP),12–15 European MetaHIT project (Metagenomics of the Human Intestinal Tract),16–20 American Gut Project (AGP),21 Dutch Microbiome Project (DMP)22 are prominent studies in this field. In the current landscape, microbial dysbiosis has gained significant recognition as a hallmark of both human health and the ageing process.23–25

To date, the overall understanding of the microbiome in the human body has been summarized in extensive classical and elegant reviews.26–43 Also, some conceptual terms have significantly enhanced our understanding of the human-microbe relationship. For example, concepts such as “holobiont”, “superorganism”, and “meta-organism” have expanded the definition of human.44–46 The “hologenome” frames the human genome and the genetic content of microbiomes as a single entity.47 The characterization of microbial physiological functions led us to consider them as another “organ”.48 Hypotheses like the “Hygiene Hypothesis”, the “Old Friends Hypothesis”, and the “Microflora Hypothesis” also prompted a reassessment of their immunomodulatory role.49–51 Despite their insightful contributions, the fragmented nature and limitations (will be discussed in the main text) of these hypotheses or theories have impeded a unified understanding of the microbiome.

To establish a systematic understanding of the role of the microbiome in human health and disease, this review first delves into the anatomical distribution and characteristics of the microbiome within the human body, elucidating its regulatory mechanisms on physiological functions. Among them, we introduce the concept of “acquired microbe immunity,” which synthesizes the microbiome’s “colonization resistance” and “immune modulation” functions. By further examining the physiological traits of germ-free animals, the complete knockout of microbial genomes, we termed “germ-free syndrome”. The abnormalities resulting from the loss of the microbiome further prompt us to explore the integrity of the human genome parts through the lens of genetics and evolution. Herein, the “adaptive genome” refers to the external and dynamic microbiome, while the “innate genome” denotes the inherent genetic blueprint that humans are born with. The introduction of the “adaptive genome” concept allows us to extend the notion of a single host to that of a “meta-host”, thereby gaining a comprehensive understanding of disease heterogeneity or the success rate of organ transplantation resulting from host-microbiome interactions. To address the complex interplay of physiological dependence and conflict with microbes, the hypothesis of “slave tissue” was introduced, viewing the microbe as an exogenous tissue under the control of human master tissues such as nerve, connective, epithelial and muscle tissues. Recognizing that homeostasis theory is fundamental to understanding health and disease, we further discuss the hypothesis of “homeostasis reprogramming” based on the theoretical foundation of the adaptive genome and slave tissue. Utilizing the “cell-microbe co-ecology model,” we describe the phenomenon of co-homeostasis between microbes and human cells. Lastly, to deepen our understanding of how microbes contribute to disease, a “health-disease conversion model” was proposed, outlining the common patterns of dysbiosis. To conclude, the above envisioned coherent and systematic conceptual framework is expected to bolster the effectiveness and efficiency of the healthcare system.

Human microbial distribution, development, personalization, and stabilization

The human body is inhabited by diverse microorganisms including bacteria, fungi, archaea and viruses (bacteriophages). Throughout long human history, microorganisms have co-evolved with us,52–61 exhibiting periodic variations that align with the different stages of a person’s life.37 These microbes are mainly found in the mucosal and superficial layers of organs and can interact with the environment. Of the known bacterial distributions, the gastrointestinal tract is the most densely populated (29%), followed by the oral cavity (26%) and skin (21%), while the respiratory tract (14%) and urogenital tract (9%) have lower densities62 (Fig. 1). Microbial communities also show density gradients within specific organs, such as higher densities in the upper respiratory tract than in the lower respiratory tract, and lower densities in the stomach, duodenum, and jejunum than in the ileum and colon.62Fig. 1 Human microbial-related characteristics. The distribution data of the microbiome were obtained from the Human Microbiome Project,62,657 supplemented by modified data from Ron Sender et al.658,659

Emerging insights in traditionally sterile human sites

Anatomical sites traditionally considered sterile in human anatomy are now being challenged by the emergence or potential existence of resident microbiota, albeit with some controversy. The environment on diseased blood vessels is non-sterile, containing bacteria and viruses, with the sequencing of arterial atherosclerosis providing compelling evidence.63 Alison Clifford et al. extensively discussed the presence of normal vascular microbiota, but the evidence is largely from non-viable samples.64 Using strict exclusion criteria, aseptic sampling, repeated measures, and negative controls to eliminate potential contamination, László Hidi et al. analyzed microbiomes in femoral arteries from brain-dead donors, mainly those with hemorrhagic or ischemic strokes.65 They identified Proteobacteria, Firmicutes, and Actinobacteria as the predominant phyla, with Staphylococcus, Pseudomonas, Corynebacterium, Bacillus, Acinetobacter, and Propionibacterium being prevalent genera.65 Additionally, they observed a notable correlation between blood type and microbiota diversity.65 Although limitations such as the small sample size (14 participants) and the older age range of donors (40–60 years) reduce the power of this study and the lack of characterization of microbial function,65 it however provides valuable insights into the possible presence of the microbiome in the normal human vasculature and potential research directions for unraveling vasculature-based diseases. Interestingly however, despite previous findings of approximately 1% of the human body’s bacterial presence in blood samples from the Human Microbiome Project, an analysis of 9770 samples from healthy individuals revealed the absence of similar microbial communities in the bloodstream.62,66 Notably, 82% of the sampled population exhibited no microbial sequences, emphasizing the sterile nature of the blood in healthy individuals.66 A diverse microbiome is also found on the human ocular surface, with Pseudomonas, Bradyrhizobium, Propionibacterium, Acinetobacter, and Corynebacterium being the most abundant genera.67–70 Similarly, the brain has long been considered a sterile organ because of its blood-brain barrier and immunity.71 However, surprising findings from the microscopic examination of multiple brain regions post-mortem in healthy individuals, presented at a neuroscience conference, have revealed the existence of microbiota in the brain.72 Nevertheless, convincing evidence awaits confirmation using animal models and independent human material.73 Certain organs responsible for the secretion of body fluids also contain microbiota. For example, although sampling difficulties exist, a study on healthy humans confirmed the presence of microbial community in the gallbladder which may retrograde entry of gastrointestinal microbiota.74 In women aged 18–90, a diverse range of bacteria, predominantly belonging to Proteobacteria, have been identified in mammary tissue.75 The question of whether a normal fetus is colonized by microbes in the prenatal environment (“in utero colonization” hypotheses), challenging the assumption of uterine and placental sterility (“sterile womb” hypotheses), remains controversial.76–81 A recent comprehensive discussion suggests that the detected microbes may be due to contamination, emphasizing the lack of reliable evidence for the presence of microbial colonization.82

Colonization and development of common microbiomes

Although microbial sampling can't cover every anatomical niche or the complete microbiome, including bacteria, viruses, and fungi, throughout an individual’s entire lifespan, microbiome composition is influenced by various factors like host and environmental factors (which will be discussed in the section on adaptive genome), substantial progress has been made in recent decades in sequencing the microbiomes of the gut, oral cavity, skin, vagina, and lung. Overall, microbiota development initiates at birth, with the primary succession phase characterized by rapid microbial changes that decelerate into a more stable “climax community” by adolescence.83 This community, while relatively stable, can still experience fluctuations in adulthood.37 Disturbances such as antibiotics or infections may prompt secondary succession, potentially leading to a new microbial state.84 Finally, in old age, the microbiota undergoes final succession, typically resulting in a community with reduced diversity.37 Below, we will provide a brief overview of the microbiota throughout the lifespan by integrating current knowledge. While much of the information has been comprehensively reviewed,37,85,86 we include some of the latest research findings.

Digestive tract microbiome

In the early stages, newborns acquire pioneer microorganisms from their mother’s vaginal tract, skin and possibly through fecal exposure during the birth process. The gut bacteria are initially dominated by Bifidobacterium spp. and gradually shifts to a mixed community of Bifidobacterium, Clostridium and Bacteroides spp. by the end of the first year.87 This shift is accompanied by a greater diversity of genera within the Firmicutes, including Clostridia, Faecalibacterium, Ruminococcus and Veillonella, while the abundance of Bifidobacterium spp. decreases.15 At approximately 3 years of age, the gut microbiota stabilizes and is dominated by Firmicutes and Bacteroidetes.88 However, the majority of the studies to date are largely based on easily accessible fecal samples, and endoscopic examinations are also limited by single-site sampling in certain areas.80 To study the distribution of microbiota across multiple regions of the human intestinal tract under undisturbed and uncontaminated conditions, in 2023, Dari Shalon et al. developed an ingestible capsule device capable of sampling four specific sites from the small intestine to the ascending colon suggesting that specific microbial phyla may be enriched in specific intestinal segments compared to fecal samples.89,90 A more detailed and rigorous identification was conducted by Jun-Jun She et al. who sampled seven surface organs of deceased individuals within 1.5 h postmortem.91 In their study, Helicobacter species were found to be enriched in the esophagus and can also be found in the stomach, where it likely contributes to the fatty acid metabolism alongside Lactobacillus.91 Prevotella, which accumulates in the duodenum, is potentially involved in the degradation of carbohydrates and amino acid synthesis.91 Enterococcus and Bacteroides are enriched in the ileum, where they may play a role in amino acid synthesis and the enterohepatic circulation of bile acids.91 Lastly, the right colon is characterized by an enrichment of Klebsiella, Enterococcus and Lactobacillus, which are likely engaged in fermentation processes and the production of short-chain fatty acids, while the left colon shows an enrichment of Parabacteroides, Bifidobacterium and Dorea, indicating their involvement in intestinal motility and bile acid metabolism.91 Of note, the biogeographical map also emphasizes the presence of bacterial translocation along the upper and lower gastrointestinal tract due to luminal flow conditions, as well as significant differences between mucosal and luminal samples.91 In general, the microbial diversity in the esophagus and stomach is markedly lower compared to the small intestine and colon.91

Oral microbiome

The oral bacterial community is initially dominated by the genera Streptococcus, Gemella, Granulicatella, and Veillonella at birth, followed by an increase in Lactobacillus and Fusobacterium.92 Staphylococcus reaches its peak around 3 months of age before declining, making way for an increase in Gemella, Granulicatella, Haemophilus, and Rothia species.93 With the emergence of teeth, the oral microbiota transitions to include a greater abundance of Fusobacteriota, Synergistetes, Tenericutes, Saccharibacteria (TM7), and SR1 phyla as individuals progress into adulthood.94–96 Interestingly, re-analysis of raw 16S rRNA sequences of over 2000 saliva samples from 47 different studies identified 68 consistent core bacterial taxa.97 Streptococcus oralis subspecies dentisani is recognized as a potentially beneficial organism for oral health and is highly abundant across different oral niches in healthy humans.97 The Neisseria genus, dominant in the salivary microbiome, is associated with lipid metabolism pathways, suggesting a key role in regulating oral lipid-related metabolic processes.97 Lautropia, in conjunction with Neisseria, has been found to increase the abundance of certain metabolic pathways in Chinese samples, particularly those involved in lipid metabolism.97 In contrast, the Prevotella genus, which is less abundant in Western populations, may be linked to a reduction in specific metabolic pathways when compared to Chinese samples.97 The Veillonella genus, which is more abundant in Western populations, is linked to the ‘Flavone and flavonol biosynthesis’ pathway, whereas the Atopobium genus is observed to be less prevalent in the same demographic.97

Skin microbiome

The skin bacterial community initially has a high presence of maternal vaginal Lactobacillus spp. at birth.83 By around weeks 4–5, the infant skin microbiota starts resembling that of adults but becomes more specific to different body areas during adolescence.98 Common genera include Staphylococcus and Corynebacterium, with Pseudomonas, Enterobacter, Enterococcus, Proteus, and Klebsiella at specific sites like the armpit or forearm.99 The skin bacteria can primarily be categorized into three major classes: sebaceous or oily including the face, chest, and back; moist such as the bend of the elbow, back of the knee, and groin; and dry like the volar forearm and palm. Sebaceous skin regions are notably enriched with Propionibacterium acnes and exhibit a variety of metabolic pathways that are pivotal to lipid metabolism and energy production, including glycolysis, ATP and GTP generation, and NADH dehydrogenase I.100,101 In contrast, dry skin regions are characterized by a distinct microbial composition that includes species such as Corynebacterium and Staphylococcus epidermidis, with a significant enrichment in citrate cycle modules that are likely adapted to the drier conditions of these areas.100,102 Moist skin regions are predominantly inhabited by fungi, particularly Malassezia globosa and Malassezia restricta, which thrive in the higher-humidity environment.100,103 The toenail region, which is unique compared to other skin types, houses a specific microbial community that is distinguished by its energy production components, including the conversion of oxaloacetate to fructose-6-phosphate, and the presence of ATPase and ATP synthase.100 Additionally, the skin’s microbiome as a whole serves as a reservoir for antibiotic resistance genes, displaying considerable variability among individuals and resistance types, with certain classes like MATE efflux pumps being highly host-specific.100,103

Vaginal microbiome

Dominated by a single Lactobacillus species, the human vaginal microbiome is intriguingly different from that of other species, including primates.104 Currently, with a lack of reliable data on the neonatal vaginal microbiota, the developmental trajectory of the human vaginal microbiome remains incompletely understood. Before puberty, the vaginal microbiome exhibits high diversity, including streptococci, enterococci and anaerobes, possibly due to the thinning of vaginal epithelial cells and minimal glycogen deposition resulting from lower estrogen levels, which may not provide sufficient nutrition for Lactobacilli.105 However, in premenopausal women, the vaginal microbiome is dominated by one or a few Lactobacillus species, such as L. crispatus, L. iners, L. jensenii or L. gasseri, leading to reduced microbial diversity.106 This dominance is accompanied by an increase in oestrogen levels.106 During the menopause, declining estrogen levels result in decreased glycogen accumulation and reduced abundance of Lactobacilli, facilitating colonization by anaerobic bacteria associated with bacterial vaginosis and an increase in microbial diversity.107–109 Although approximately 25% of North American women have vaginal microbiomes that are not dominated by Lactobacilli, but instead consist of a mixture of anaerobic and aerobic bacteria, such as Gardnerella, Prevotella, Atopobium, Sneathia, Megasphaera and Peptoniphilus.110 L. iners, L. crispatus and G. vaginalis are the three most common bacterial species in the vaginal microbiota of nearly all ethnic groups of women studied to date.111–116 A recent notable study called “Isala”, conducted in Belgium, involved self-sampling (using citizen science methods) of 3,345 women.117 In this cohort of healthy individuals, L. crispatus was the most common taxonomic unit (43.2%), followed by L. iners (27.7%) and G. vaginalis (9.8%).118

Respiratory microbiome

Encompassing the nasal cavity, sinuses, pharynx and supraglottic portion of the larynx, the upper respiratory tract has different microbial compositions in different regions.119 In particular, the nasal cavity and nasopharynx are dominated by Moraxella, Staphylococcus, Corynebacterium, Haemophilus and Streptococcus species, whereas the oropharynx hosts Prevotella, Veillonella, Streptococcus, Leptotrichia, Rothia, Neisseria and Haemophilus species.120 In neonates, the lower respiratory tract microbial community is dominated by either Staphylococcus or Ureaplasma species during the first weeks of life, correlating with mode of delivery; vaginal births enrich for Ureaplasma, whereas cesarean births enrich for Staphylococcus.121 In the first 2 postnatal months, lung microbiome diversifies to include oral commensals such as Streptococcus, Prevotella, Porphyromonas and Veillonella.121 However, the lower respiratory tract, comprising the trachea and lungs, maintain a low biomass that is essential for efficient gas exchange, supported by a rapid clearance system including immune actions such as mucociliary clearance and phagocytic activity of macrophages, as well as mechanisms like pulmonary surfactant and cough reflex.122,123

Personalization and relative stability

The abundance and composition of microbial communities in different anatomical ecological niches can be influenced and disturbed by multiple host and external factors, resulting in highly personalized variations.124 However, they also exhibit relative stability and a certain degree of resilience.125–127 In a recent contribution from the iHMP, Zhou et al. reported on the dynamics of microbiomes at three body sites—oral, nasal, and skin—and in fecal samples from 86 individuals monitored longitudinally over six years.128 Their findings highlight the variable stability of the human microbiome across different individuals and anatomical sites, with fecal and oral microbiomes showing greater stability than those from the skin and nasal microbes.128 Moreover, microbiome characterized by high individual specificity are more stable over time, reflecting an enhanced regulation by the host.128 Microbes closely associated with human development can also serve as means to predict chronological age, with the skin microbiome offering the most accurate age predictions (mean error ± standard deviation of 3.8 ± 0.45 years), outperforming both the oral microbiome (4.5 ± 0.14 years) and the gut microbiome (11.5 ± 0.12 years).129 In summary, in reviewing the past deciphering efforts, we are progressing along the path of identifying common microbiota, then core microbiota, and finally individualized microbiota. At the same time, the accompanying exploration of microbiota functionality and perturbation mechanisms is approaching the possibility of regulation.

Physiology and regulatory role of commensal microbes

Digestion and microbiome-related products

Microbiome-related products encompass a range of substances, including microbiota-derived metabolites (MDM), microbiota-derived components (MDC), and microbiota-secreted proteins (MSP).130 Nestled in the complex ecosystem of the digestive tract, a thriving microbial community produces an extensive repertoire of metabolic enzymes (biogenic enzymes, glycosidases, and proteases), thereby enhancing the digestive and metabolic capabilities of the human body.15,16 For example, humans lack specific and efficient nitrate reductases131 which is essential to convert dietary nitrate into nitrite and Nitric oxide (NO) through the nitrate-nitrite-NO pathway.132 The oral cavity harbors nitrate-reducing bacteria, such as Veillonella and Actinomyces.133 The nitrate reductase Nar in oral bacteria is encoded by genes narX, narG, narJ, narH, narY, narI, and narW.134 Additionally, certain bacteria like Rothia possess nitrite reductase encoded by genes nirK and nirS, which further reduce nitrite to NO.135 NO has long been recognized as an endothelium-derived relaxing factor, functioning as a vasodilator and modulating vascular tone, blood pressure, and hemodynamics.136,137

Involved in the synthesis of vitamin K and most water-soluble B vitamins, these microorganisms actively contribute to the production of prothrombin and osteocalcin, thus influencing blood coagulation and bone metabolism.26 They also serve as essential cofactors and coenzymes that are central to various cellular metabolic pathways.138 Beyond their enzymatic contributions, gut-dwelling microbes orchestrate the assimilation and conversion of carbohydrates, proteins, and amino acids, yielding a range of essential products.139,140 These include short-chain fatty acids (SCFAs) as well as branched-chain amino acids (BCAAs), secondary bile acids (BAs), polyamines, lipids and an enigmatic realm known as “dark matter”.26,138 These remarkable entities have emerged as key participants in human tissue development, neural function, immune response (Fig. 2), metabolism, and behavioral regulation, revealing their profound impact on human well-being.141 It’s important to note that the digestive tract serves as the primary gateway for the body to actively absorb nutrients and substances from the external environment. As a result, the oral and gastrointestinal microbiomes play an integral role in digestion. Whereas, microbes in other sites of the body are primarily involved in physiological regulation through mechanisms such as colonization resistance, immune modulation and maternal transmission.Fig. 2 Acquired microbial immunity. The human immune consists of innate and acquired immunity, which is mainly carried out by T and B cells. The main strategies of adaptive immunity are active and passive immunization. In active immunity, natural immunity can be acquired by direct infection with the pathogen, while vaccination with the antigen is the artificial way. Passive immunization is mainly achieved by natural means, such as breastfeeding, or artificial means, such as immunoglobulin injections. Commensal microbiota described here can provide another form of acquired defence and regulating power against pathogens (commensal microbiota immunity). Correspondingly, maternal human milk oligosaccharides (HMOs), acquired through maternal reproductive transmission and exposure, can enhance the colonization of beneficial microbes under natural conditions. Under artificial conditions, fecal microbiota transplantation (FMT),660–664 probiotics,665–669 prebiotics,670 synbiotics671,672 and postbiotics673–676 can be used to acquire this immunity. Commensal microbiota immunity strengthens cellular barriers and regulates immune cells through metabolites such as short-chain fatty acids. They train and educate the immune system as a competitor while providing colonization resistance against foreign and established pathogenic microbes. The decline of commensal microbiota immunity increases the risk of skin and food allergies,677 asthma,548 type 1 diabetes (T1D),678 pathogenic overgrowth (such as Clostridium difficile),667,679–687 and susceptibility to inflammatory bowel disease (IBD)555,688–695 and other potential diseases696,697

Metabolic regulation

Short-chain fatty acid

Anaerobic bacteria ferment non-digestible substrates such as non-starch polysaccharides, resistant starch, and oligosaccharides, resulting in the production of SCFAs (mainly including acetate, propionate, and butyrate).142 The majority of these SCFAs are rapidly and almost completely absorbed by colon cells.143 Acetate enters the liver through the portal vein and is released into the peripheral tissues for cholesterol metabolism and fatty acid synthesis.144 Propionate is involved in gluconeogenesis regulation, inhibition of cholesterol synthesis, and interactions with intestinal fatty acid receptors to regulate satiety.145–148 Butyrate controls intestinal hormones, reduces appetite and food intake.149 Importantly, butyrate metabolism serves as a source of energy for 60–70% of the colon, maintaining a hypoxic state in the gut through β-oxidation, reducing intestinal inflammation and preserving mucosal integrity.150,151 Furthermore, butyrate has been shown to have beneficial effects in inhibiting colon cancer cell proliferation, differentiation, invasion, and inducing apoptosis.152–154

Secondary bile acids

The gut microbiota actively participates in the conversion of primary bile acids to secondary bile acids and plays a crucial role in the enterohepatic circulation of bile acids.155 It exerts regulatory control over glucose homeostasis, lipid metabolism, insulin signaling, and inflammation through the FXR and TGR5 receptors.156 Abnormalities in bile acid metabolism have been implicated in several diseases, including irritable bowel syndrome (IBS), colorectal cancer, neuroinflammation, and non-alcoholic fatty liver disease.155–157

Arg-Lys-His

The novel tripeptide Arg-Lys-His (RKH), synthesized by Akkermansia muciniphila (AKK), binds to TLR4 receptors and inhibits TLR4-mediated signaling pathways. This reduces sepsis-induced inflammatory cell activation and excessive cytokine release which protects against sepsis-related mortality and organ damage.158

Indole-3-propionic acid (IPA)

IPA was found to be decreased in a mouse model of autism spectrum disorder (ASD) leading to deficits in social interaction and cognitive memory.159 Mechanistically, IPA restores inhibitory synaptic transmission in the hippocampal region by activating the ERK1 signaling pathway, which is encoded by the MAPK3 gene located within the 16p11.2 chromosomal region.159

Homovanillic acid (HVA)

Bifidobacterium longum (B. longum) produces HVA, a metabolite that modulates synaptic integrity by inhibiting excessive autophagy.160 This mechanism reduces the degradation of microtubule-associated protein 1 light chain 3 (LC3) and the protein SQSTM1/p62, safeguarding the synaptic vesicle membrane of hippocampal neurons and contributing to depression alleviation.160 Roseburia intestinalis (R. intestinalis), athough not a HVA producer, facilitates the growth of B. longum, indirectly enhancing HVA synthesis.160

Also, the induction of specific Helper T cell 17 (Th17) expression by skin commensal microbiota is associated with transcriptional programs relevant to skin-neuronal interactions and repair.161 Following skin injury, Th17 cells upregulate IL-17A, which binds to IL-17A receptors upregulated on damaged nerves, promoting axonal growth and local nerve regeneration.161 Disruption of the pulmonary microbiota significantly influences susceptibility to autoimmune diseases of the central nervous system.162 Augmenting microbial populations capable of producing lipopolysaccharide (LPS) can enhance endogenous immune factors in brain microglial cells, thus modulating neuroimmune responses in the brain.162

Epigenetic modulation

Epigenetic changes represent reversible modifications in gene expression regulation and heritable traits that occur without permanent changes to the DNA sequence, and can even be transmitted to offspring through sexual reproduction.163–166 It has duly been established that the human microbiota can extensively influence the expression of the human genome through mechanisms such as DNA methylation, histone modification, non-coding RNA and chromatin remodeling, leading to a broad range of physiological impacts.167 Early-life epigenetic crosstalk significantly impacts the development of adult tissues.168

DNA methylation

DNA methylation at CpG islands can recruit methyl-CpG-binding proteins, which alter chromatin conformation, leading to chromatin condensation that prevents the binding of transcription factors and RNA polymerase, thus inhibiting the expression of specific genes.169 Metabolites produced by microbial communities can serve as substrates and/or co-factors in these reactions/interactions. For example, folate can metabolically generate S-adenosylmethionine (SAM), which becomes a substrate for DNA and histone methylation.170 Microbiota can adjust DNA methylation in mice intestinal epithelial cells, affecting the expression of 824 upregulated and 358 downregulated genes.168 TET2/3 enzymes are key in this process, facilitating the conversion of 5-methylcytosine to 5-hydroxymethylcytosine, which promotes demethylation and the activation of genes essential for intestinal homeostasis.168

Histone modification

Histones are the fundamental proteins that make up chromatin, tightly binding with DNA to form nucleosome structures, which then coil and fold into complex chromatin.171 Modifications of histones, like acetylation and methylation, regulate the condensation of chromatin, thus regulating gene expression.172 For example, microbiota-derived butyrate can inhibit the activity of histone deacetylases (HDACs), leading to increased acetylation of histone H3 at the Foxp3 gene locus.173 This acetylation enhances the expression of the Foxp3 gene, facilitating the differentiation of colonic regulatory T cells (Treg).173 Gut microbiota can also regulates intestinal epithelial gene expression by suppressing Hepatocyte Nuclear Factor 4 Alpha (HNF4A) through reduced DNA binding and altered histone modifications such as Histone 3 Lysine 4 monomethylation (H3K4me1) and Histone 3 Lysine 27 acetylation (H3K27ac), which could be linked to the pathogenesis of Inflammatory Bowel Disease (IBD).174

Non-coding RNA

Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), circular RNAs (circRNAs) and long non-coding RNAs (lncRNAs), regulate host gene expression through various mechanisms.175 MiRNAs modulate protein synthesis within host cells by binding to complementary sequences on messenger RNAs (mRNAs), leading to mRNA degradation or translational repression, while circRNAs function as “sponges” for miRNAs, sequestering them to modulate their activity.176 Microbiota can influences the expression of the miR-181 in white adipose tissue of mice through the production of tryptophan-derived metabolites, such as indole and indole-3-carboxylic acid (I3CA).177 This mechanism leads to a decrease in miR-181 expression within white adipocytes, which in turn stimulates increased energy expenditure and enhanced insulin sensitivity, counteracting the development of diet-induced obesity and insulin resistance.177 LncRNAs regulate genes through multiple mechanisms: they can organize protein complexes on DNA, direct proteins to gene sites, and change the epigenetic marks that control gene activity.178 They also interact with transcription factors, influence mRNA splicing and produce regulatory RNAs like miRNAs.178 Significant differences in lncRNA expression occur when germ-free mice are re-colonized with distinct microbial types, such as complex mouse microbiota, E. coli or E. coli expressing bile salt hydrolase (EC-BSH), with only a few lncRNAs showing overlap and most being type-specific.179

Immunomodulation

Commensal microorganisms play a fundamental role in the education and maintenance of immune homeostasis. In the past few decades, there has been a notable increase in the incidence of allergic diseases, such as asthma, atopic dermatitis, and food allergies, as well as autoimmune diseases like type 1 diabetes (T1D) in industrialized countries.49,180,181 Interestingly, individuals who migrate from countries with low incidence rates of these conditions to those with higher rates, and do so before a certain age threshold, tend to adopt the disease prevalence of their host country. For instance, research indicates that children who move to countries with higher incidences of allergic asthma before the age of 5 are more likely to develop asthma at rates similar to those of the host country’s population.182 Similarly, the risk of type 1 diabetes has been observed to increase in migrants who move before adolescence, with studies suggesting a critical age threshold around 15 years for the development of multiple sclerosis.183–186 In 1989, David Strachan proposed the novel concept that infections could serve as a preventative measure against the development of allergic diseases.187 Building on this idea, in 2000, he formally introduced the term “hygiene hypothesis” to describe the observed correlation between a lower incidence of infectious diseases in early life and the rising prevalence of allergic conditions,188 which exerted a profound influence on public health.189,190 Subsequently, Rook et al. as well as Noverr and Huffnagle, further emphasized the “Old Friends Hypothesis” or “Microflora Hypothesis,” highlighting the importance of microorganisms in achieving immune homeostasis in the human body.191,192 It is recognized that the immune system development of the individual involves critical developmental periods.193 Early exposure to a diverse range of microbes is essential for the proper development of the immune system, with the activation of immune regulatory pathways, particularly through Toll-like receptors (TLRs), fostering a balanced immune response. This process is thought to promote the generation of regulatory T cells (Treg), which produce anti-inflammatory cytokines like IL-10 and TGF-β, thus suppressing excessive immune reactions and potentially reducing the risk of developing allergic and autoimmune diseases. The protective effects of commensals are also suggested to involve antigenic competition and the modulation of inflammatory responses, possibly through mechanisms like TLR desensitization.193

Colonization resistance

Microbial communities that inhabit human mucosal surfaces or skin are capable of preventing the colonization of pathogens and overgrowth of indigenous pathogens, known as “colonization resistance” (Fig. 2).194,195 This phenomenon was first discovered by Bohnhoff and Miller in 1967 when they observed increased susceptibility of mice to Salmonella infection following treatment with streptomycin.196 This antibiotic-related susceptibility explains the widespread harm caused by antibiotic abuse in recent years,197,198 as commensal microbial colonization appears to provide the body with an additional defense mechanism. They compete with pathogens through various mechanisms for the specific nutritional and physicochemical environment of the human body, ultimately leaving newcomers unable to secure adequate nutrition and space for survival and reproduction.199

The way microbes protect their own territory may indirectly protect the human body. For example, S. salivarius TOVE-R strain is effective against virulent streptococci like S. mutans, S. sobrinus and S. pyogenes, which are associated with tooth decay, pharyngitis, and periodontitis.200 Its bacteriocin (a type of heterogenous peptide) inhibits S. pyogenes and S. pneumoniae200 and can also modulates immune responses by inhibiting inflammatory pathways activated by these pathogens.201 Coagulase-negative staphylococci (CoNS), which are typically present in the skin and nasal cavity, secrete bacteriocins that reduce the colonization of pathogenic S. aureus.202 The commensal bacterium S. epidermidis, through the secretion of serine protease Esp, can degrade and inhibit the biofilm of S. aureus, reducing its virulence.203 Torres Salazar et al. have elucidated that S. epidermidis can also produces a novel, rapidly degrading broad-spectrum antibacterial agent termed epifadin, which demonstrates efficacy in mitigating nasal colonization by S. aureus.204 Analyzing 2229 bacterial genomes from the Human Microbiome Project, sourced from diverse body sites such as skin, gastrointestinal tract, urogenital tract, mouth, and trachea, researchers identified gene clusters encoding for lanthipeptides and lasso peptides.205 These clusters direct the synthesis of peptides that, through unique post-translational modifications, give rise to novel compounds exhibiting antimicrobial activity.205

In addition to bacteriocin and enzyme secretion, common metabolites such as SCFAs can inhibit the growth of pathogenic Escherichia coli,206 Clostridium difficile,207 and Salmonella208 in the gut. Moreover, secondary bile acids have been shown to inhibit many Gram-positive bacteria, including C. difficile.209

Nevertheless, microbes can also develop resistance to being colonized by other microbes through direct physical interactions. Contact-dependent inhibition systems have been discovered in microorganisms such as E. coli and Pseudomonas aeruginosa, which can inhibit neighboring microbes by targeting their receptor proteins.210,211 Many Gram-negative bacteria, such as P. aeruginosa and Burkholderia spp., can use type VI secretion systems (T6SS), a multi-protein complex that punctures nearby microbes and injects toxic proteins.212–215 Interestingly, microbes that occupy niches also participate in the niche modification. A commonly cited example is Lactobacilli, a resident of the vaginal microbiota, which lowers the pH of the vagina, thereby reducing the colonization of pathogenic bacteria that can thrive in neutral environment.110,216,217 The mechanisms of microbial colonization resistance may shift depending on the environment where they are situated. In germ-free or antibiotic-treated mice, e.g. Klebsiella oxytoca inhibits the growth of S. Typhimurium by producing toxins such as tilimycin.218 Whereas, in mice with a complex microbiota, K. oxytoca competes with S. Typhimurium for survival resources by utilizing specific carbohydrates like dulcitol.218

In general, if the exposed areas of the human body are inevitably colonized by external microbes, perhaps the best strategy would be to use controlled microbes as the first line of defense in external immunity, thus minimizing the disruption of internal immunity. Salvarsan, the first antibiotic in 1910, heralded a medical revolution.219 The subsequent discovery of penicillin in 1928 propelled us into the golden age of antibiotics, pivotal in saving lives and advancing civilization.220 However, the widespread utilization of antimicrobial drugs has resulted in a rising incidence of infections caused by antimicrobial resistance (AMR) globally, leaving us in a quandary with diminishing treatment alternatives.221 In 2019 alone, an estimated 4.95 million deaths were linked to bacterial AMR, with 1.27 million deaths directly attributable to it.197 By exploiting the immunomodulatory properties of microorganisms and implementing colonization resistance strategies, it is hoped that dependence on antimicrobial drugs will be reduced and a promising path will be opened in the present predicament.

Regulation and transmission of parental microbiota

The maternal gut microbiota produces SCFAs that can enter the embryo through the mother bloodstream.222 SCFAs act on the GPR41 receptor in the sympathetic nervous system of the fetus and GPR43 receptor, which is highly expressed in intestinal epithelial cells and pancreatic beta cells, promoting the development of prenatal metabolic system in neurons, enteroendocrine cells and beta cells.222 This reduces the risk of offspring developing metabolic syndrome.222 The normal development of the fetal brain and nervous system in mice is also influenced by maternal microbiota and its metabolites.223 Treatment with antibiotics or germ-free pregnancy in mice can lead to defective growth of embryonic hypothalamic axon and a decrease in tactile sensitivity in adulthood.223 Although research in humans is limited, a recent follow-up study of 860 children found an association between the maternal gut microbiota during pregnancy and neurodevelopment in the first year after birth.224 In addition, the presence of Clostridia in the maternal gut microbiota is associated with high fine motor skills in children.224 Microbial colonization also drives innate immune development in offspring, increasing certain innate lymphocytes and monocytes while causing widespread changes in the gene expression profile of the intestinal epithelial mucosa, better preparation for colonization by postnatal microbes and prevention of microbial invasion.225 In conclusion, maternal microbiota during pregnancy may participate in the regulation of fetal endocrine, neural and immune development through multiple mechanisms. However, vaginal and fecal contact, as well as skin-to-skin contact and later breastfeeding, provide more than half of the initial microbial colonization for infants.226 While the transmissibility of different microbial species can vary depending on the mode and place of delivery, species such as Bifidobacterium have demonstrated consistent vertical transmission regardless of the delivery environment.227 In addition to supporting the development of vital organs228 and providing defense against harmful bacteria in the infant’s gut,229,230 maternal milk provides probiotics231 and human milk oligosaccharides (HMOs) that facilitate the metabolism and colonization of beneficial bacteria like Bifidobacterium.232 Given the current limitations of commercial formulas in fully replicating human milk,233,234 it is critical to prioritize breastfeeding as the primary feeding method.235–238 Fathers are also a consistent source of infant strains and their cumulative contribution equals that of mothers after one year.239 Recent research suggests that dysbiosis in the gut microbiota of male mice prior to conception can affect testicular function and sperm quality, as well as lead to compromised placental function in female mice, thereby increasing the risk of offspring with low birth weight, severe growth restriction and early mortality.240 These findings underscore the potential value of microbiota in guiding reproductive health.

Germ-free syndrome

David, also known as the “Bubble Boy”, was born in 1971 with severe combined immune deficiency syndrome (SCID) and lived his entire life in a sterile isolation unit.241 Unfortunately, he died at the age of 12 years due to severe infection.241 Although it was rarest of the cases, due to the lack of advanced technologies available today, incomprehensive health evaluations, particularly the lack of anatomical data, prevent us from fully understanding this unique germ-free human individual. More importantly, individuals with underlying diseases are also not an ideal subject for research. Since 1940, the germ-free (GF) animal model has gradually become a cornerstone of microbiological research, meticulously cultivated in sterile environments through cesarean section, where pups are extracted from sterile mothers and reared by surrogates—or by artificial rearing, which nurtures cesarean-born pups with formula milk in an aseptic setting, ensuring their lifelong freedom from microorganisms.242–245 The progressive commercialization of GF mice/rat in laboratories has elucidated the phenotypes of these animals, shedding light on the intricate interplay between the microbiome and the health of organisms.

Systemic somatic growth and development

At the age of 8 weeks, GF mice exhibited a 14.5% reduction in weight and were 4% shorter in stature compared to their conventionally raised (CONV-R) peers.246 The disparity in weight was not a result of increased adiposity, as both groups demonstrated equivalent adipose tissue and serum leptin levels.246 After weaning, GF mice consumed food at a rate comparable to their body weight as CONV-R mice did, yet differences in nutrient absorption and utilization efficiency may account for growth discrepancies.246 Despite elevated early levels of growth hormone in GF mice, this did not enhance insulin-like growth factor–1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP-3) levels, indicating growth hormone resistance.246 Most organs and tissues, including the heart, liver, spleen, thymus, thyroid, skin and intestine, are reduced in mass or size.243

Cardiovascular system

The cardiac output is approximately 30% lower in GF rats compared to conventional controls, accompanied by a mild phenomenon of hemoconcentration which result in reduced blood supply to peripheral organs.247,248 Under normal oxygen conditions, the transcriptomic changes in the hearts of GF mice revealed 117 differentially expressed genes, with 73 genes upregulated and 44 genes downregulated.249 These changes implicate key biological processes such as cardiac function, cell proliferation, transcriptional regulation, and immune response.249 For instance, the upregulation of Amd1 may foster cell proliferation, while the downregulation of Cacna1d could affect the electrophysiological properties of the heart.249 These alterations might have short-term beneficial impacts on cardiac health but could also pose long-term risks for disease development. In contrast, under conditions of intermittent hypoxia and hypercapnia (IHH), which simulate obstructive sleep apnea syndrome, CONV-R mice exhibited 192 changes in gene expression, predominantly related to cardiac cell death and cardiac hypertrophy.249 Genes such as Bcl2l1, Cryab, and Gsn showed regulatory changes that could influence the heart’s response to stress.249 Whereas, GF mice displayed 161 gene expression changes, more closely associated with regulators of cardiac hypertrophy, including the downregulation of genes like Ace, Ankrd1, and Aplnr, and the upregulation of genes such as Cdkn1a, Fhl2, Rgs2, and Stat3.249 During fasting, GF mice showed a significant decrease in heart weight, linked to a notable alteration in the pathways of cardiac metabolism.250 With the lack of microbiota, there is a reduction in the generation of hepatic ketone bodies, causing the hearts of GF mice to shift their dependence towards glucose as the principal energy substrate to maintain performance.250 The absence of the microbiota also adversely impacts vascular integrity, with these impacts being sexually dimorphic.247 Regardless of sex, GF mice exhibit reduced vascular contractility; however, male mice display increased vascular stiffness and inward hypertrophic remodeling, indicative of chronic blood flow reduction, while female mice exhibit outward hypertrophic remodeling, potentially associated with vascular aging.247

Respiratory system

GF mice displayed a 24% reduction in both nasal paranasal sinus mucosa and epithelial layer thickness, coupled with a 45% increase in collagen content and a 50% decrease in goblet cell count.251 Additionally, the nasal-associated lymphoid tissue (NALT) area in GF mice was reduced by 30%, indicating a compromised local immune response.251 Their lungs are characterized by a reduced number of alveoli, an enlargement in alveolar dimensions, and a decrease in mucus secretion.252,253 In room air, GF and CONV-R mice exhibit similar lung development and function, along with comparable pulmonary vascularization in both normoxia and hyperoxia; however, GF mice demonstrate reduced hyperoxia-induced lung injury and improved lung function compared to CONV-R mice.254 This is because under hyperoxia, the pulmonary microbiota shifts favoring oxygen-resistant species such as S. aureus, with this alteration preceding and correlating with the severity of lung inflammation.255

Digestive system

In terms of intestinal morphology, GF mice exhibit a reduction in both the total mass of the intestine and the overall surface area of the small intestine.256 The villi of the small intestine are slender and uniform, with shorter villi in the ileum and longer villi in the duodenum.257 The rate of cell renewal in the crypts of the small intestine is slower.258,259 A prominent feature of GF rats is the enlargement of their cecum, a condition that results from the accumulation of mucopolysaccharides, digestive enzymes, and water within the intestinal lumen.260 During periods of fasting, the cecum of GF rats expands considerably, and the majority of the proteins and carbohydrates within its contents originate from within the body, indicating that the small intestine’s ability to effectively break down and assimilate these materials is compromised.261 Regarding intestinal motility, the intrinsic primary afferent neurons (IPANs) in the enteric nervous system of GF mice demonstrate reduced baseline excitability, as indicated by an enhanced slow afterhyperpolarization (sAHP), leading to an extended refractory period following the initial neuronal firing.262,263 This disruption potentially affects the rhythmicity and coordination of gut movements, resulting in irregularities such as abnormal transit rates—either slowed or accelerated—and irregular peristalsis.262 Furthermore, GF mice showed a diminished response to the IKCa channel blocker TRAM-34, a drug that typically modulates gut motility.262 Their increase in muscular tissue in the cecum, characterized by elongated and hypertrophied muscle cells, which also leads to an extended transit time through the intestines.264 Physiologically, there is a decrease in osmolarity within the small intestine, while the oxygen tension and electrical potential are elevated.257 Functionally, GF mice showed enhanced absorption of vitamins and minerals, with alterations in the uptake of other ingested substances.265 There is also a change in the enzymatic content of the feces, with increased levels of trypsin, chymotrypsin, and invertase.266 The feces of GF mice have a higher content of mucin (mucoproteins and mucopolysaccharides), and there is a reduction in fatty acids within the intestinal content, with a predominance of excreted unsaturated fats.257 While the inability to synthesize certain vitamins, GF mice/rats require additional dietary supplementation of vitamins like K and B.267–269 However, these mice also experience an impact on fluid balance, evidenced by an increased intake of water.265

Kidney function

The detrimental aspects of kidney health in GF mice are characterized by a significant increase in the expression levels of purine-metabolizing enzymes, such as xanthine dehydrogenase (XDH), which leads to higher urinary excretion of purine metabolites.270 Particularly, the production of 2,8-dihydroxyadenine (2,8-DHA), a nephrotoxic byproduct, is elevated, exacerbating adenine-induced kidney damage.270 Moreover, the fecal purine metabolite profile in GF mice is substantially altered, with higher levels of guanosine, inosine, xanthine, and urate, and lower levels of guanosine monophosphate (GMP), adenosine monophosphate (AMP), guanine, adenosine, adenine and hypoxanthine compared to mice with a normal microbiota.270 These alterations in purine metabolism and the presence of toxic metabolites contribute to the increased vulnerability of GF mice to kidney injury.

Internal metabolism

The thyroid gland of GF mice, which is responsible for iodine uptake and storage, showed a reduced ability to concentrate inorganic iodine and a decrease in basal metabolic rate.271 During the light phase, when resting and fasting, GF mice have a lower respiratory exchange ratio, signifying a reliance on fat oxidation for energy.272 Low liver glycogen levels at the end of the light phase may suggest a more rapid depletion of hepatic glycogen in these mice.272 Conversely, during the dark phase, when they are active and consuming food, their metabolism favors glucose as the main energy source.272 The liver’s circadian gene expression is significantly altered, with a notable reduction in sex-based differences, which correlates with shifts in sex hormone levels and growth hormone secretion patterns.273 The diminished levels of ghrelin in these mice are rectified by exogenous administration, which normalizes gene expression and metabolism, underscoring the microbiota’s role in hormonal and metabolic regulation.273 Additionally, GF mice showed impaired liver regeneration and diminished conversion of cholesterol and bile acids, suggesting a reduced capacity for metabolizing these lipids into necessary compounds or excretory products.274 The microbiota’s influence on liver regeneration may primarily mediated through the regulation of bile acid and short-chain fatty acid metabolism, the activation of immune cells and cytokines including IL-6 and TNF-α, and the modulation of immune responses via metabolic byproducts such as LPS.275

Immune system

GF mice have a range of immune defects such as reduced in size and cellular content of thymus, an important immune organ, decreased circulating immune cell numbers (T cells, B cells and white blood cells) and antibodies.243,276,277 These animals showed significant underdevelopment of the gut-associated lymphoid tissue (GALT), including reduced volume and cellularity of the Payer’s patches and mesenteric lymph nodes.278 Additionally, they have a decreased number of CD8+ T cells within the intestinal epithelial lymphocytes (IELs),279 and a proportional decrease in CD4+ T cells, with notable differences in the quantity and distribution of Th17 cells.280 At the molecular level, there is a decrease in the expression of antimicrobial peptides in Paneth cells,281 a reduction in secretory IgA produced by B cells,282 and lowered expression of MHC II molecules and TLR 9 in intestinal epithelial cells, along with a decrease in IL-25 levels, which may affect microbial recognition and immune response.283,284 GF mice also have a reduced resistance to various pathogens, demonstrating decreased immune resistance and increased mortality upon infection.285 Moreover, immune abnormalities may also lead to Sjögren-Like Lacrimal Keratoconjunctivitis.286

Neurological and behavioral alterations

GF mice display higher blood-brain barrier (BBB) permeability from embryonic day E16.5 through E18.5, a condition that persists into adulthood.287 In these mice, the expression of key tight junction proteins, occludin and claudin-5, is lower, leading to a weakened BBB that allows more substances to enter the brain from the bloodstream which can affect brain development.287 Throughout their development, GF mice demonstrate pronounced differences in brain structure, maturation and behavioral performance.288 Compared with GF mice, CONV-R mice showed greater development in gray and white matter volume, fractional anisotropy and myelination, leading to enhanced spatial learning and memory, along with reduced anxiety and improved social novelty recognition.288 Notable disparities in the brain architecture of GF mice were observed, particularly impacting the amygdala and hippocampus.289 The amygdala showed a pronounced enlargement, with both aspiny interneurons and pyramidal neurons exhibiting dendritic hypertrophy.289 These neurons were characterized by an elevated count of dendritic spines, featuring an array of slender, stubby, and mushroom-shaped profiles.289 In stark contrast, the ventral hippocampus of GF mice presented with pyramidal neurons that were not only shorter but also displayed reduced branching, alongside a diminished presence of stubby and mushroom spines.289 Moreover, while the dentate granule cells in GF mice exhibited a decreased complexity in branching, the overall spine density was found to be consistent with that of conventionally colonized counterparts.289 These extensive modifications may potentially contributing to the observed stress responsivity, anxiety-like behaviors and deficits in social cognition in GF mice.290 Although GF mice showed reduced social activity and elevated cortisol levels after social interactions, colonization with Fecalibacterium improves social deficits and normalizes cortisol levels after social interaction.291 From the notable reductions in nerve fiber diameter and an increase in hypermyelination, peripheral nerves and dorsal root ganglia demonstrated a significant delay in the development leading to skeletal muscle atrophy and impaired development as well as maturation of neuromuscular junctions, highlighting the crucial role of the microbiota in the proper growth and functionality of the somatic peripheral nervous system.292 In particular, the axons of intestinal wall nerves undergo significant degeneration with advancing age.293 Transplanting microbiota from CONV-R into GF mice alters the neural anatomy of the enteric nervous system and improves intestinal transit, facilitated by microbiota-regulated 5-HT release.294 The establishment of the mucosal glial cell network is a postnatal process, where they form a population that is continuously renewed and essential for the preservation of gut homeostasis.295 The gut microbiota plays a pivotal role in not only guiding the development of this network but also in the ongoing regulation and sustenance of these mucosal cells.295

Reproductive system

Typically, GF mice showed irregular estrous cycles, particularly due to the prolongation of the luteal or metestrus phases, which leads to a reduced frequency of the entire cycle.296 This irregularity may be associated with fluctuations in the levels of sex hormones. Moreover, GF mice generally have a lower reproductive capacity, which may manifest as lower mating rates, implantation rates, and litter sizes.296 Male mice showed delayed lumen formation in the seminiferous tubules and increased Blood-Testis Barrier (BTB) permeability at postnatal day 16, which correlated with reduced expression of intercellular adhesion molecules such as occludin, ZO-2 and E-cadherin.297 Additionally, male mice had lower serum levels of gonadotropins (LH and FSH) compared to CONV-R mice, and their testicular testosterone levels were also lower than those peers.297 In terms of sperm vitality, male mice may have lower sperm motility compared to CONV-R mice, potentially impacting fertilization ability and reproductive success.296 Notably, when GF mice are accidentally exposed to certain bacteria, such as B. distasonis and C. perfringens, their reproductive capacity significantly improves which is evidenced by the normalization of estrous cycles, increased mating and implantation rates, and enhanced sperm motility.296 Exposure to C. butyricum, capable of producing high levels of butyrate, restored the integrity of the BTB and normalized the levels of cell adhesion proteins in GF male mice.297

Skeletal system

GF mice showed increased bone mass and altered bone matrix properties, characterized by reduced bone resorption, enhanced trabecular microarchitecture, elevated tissue strength, and increased bone mineral density, along with decreased whole-bone strength compared to CONV-R mice.298 The elevated bone mass evident in increased bone mineral density and cortical thickness, is primarily due to reduced activation of the NOD1 and NOD2 signaling pathways.299 The reduction leads to decreased expression of inflammatory cytokines like TNFα and the osteoclastogenic factor RANKL, resulting in fewer osteoclasts and consequently less bone resorption.299 Additionally, the collagen structure of the bones in GF mice is altered, yet they do not exhibit reduced fracture toughness.298 These changes are accompanied by sexual dimorphisms, particularly in bone tissue metabolism, with male GF mice showing an enhanced signature of amino acid metabolism, while female GF mice display an increased signature of lipid metabolism.298 Male rats born germ-free exhibit a significant acceleration in bone growth and changes in bone marrow cellular content following the reconstitution of the gut microbiota. Specifically, after the introduction of gut microbiota, these GF rats rapidly increased the bone mass of both cortical and trabecular bones, enhanced the bone tissue mineral density and improved the proliferation and hypertrophy of growth plate chondrocytes, leading to an increase in tibial length.300 In addition, there was an increase in the number of small-sized adipocytes and a decrease in the number of megakaryocytes in the bone marrow, indicating that the microbiota not only affects bone mass but may also regulate the bone marrow environment.300 The increase in short-chain fatty acids, particularly butyrate, may boost liver production of IGF-1, thus promoting bone growth through increased circulating IGF-1 levels.300

Musculature

Various types of skeletal muscles in GF mice, including the tibialis anterior (TA), gastrocnemius, soleus, extensor digitorum longus (EDL) and quadriceps, exhibited significant abnormal phenotypes.301 Overall, these phenotypes encompassed reduced muscle mass, muscle fiber atrophy, mitochondrial dysfunction, and impaired neuromuscular junction (NMJ) function.301 Specifically, muscle atrophy was associated with upregulated expression of muscle growth inhibitory genes Atrogin-1 and Murf-1, while the decrease in muscle quality and strength correlated with downregulated expression of IGF-1.301 Also, depletion of the microbiota results in elevated levels of the FXR antagonist TbMCA, which suppresses the FXR-FGF15 pathway and lowers FGF15, finally reduces ERK signaling necessary for muscle protein synthesis.302 The expression of muscle-specific transcription factors MyoD and Myogenin was diminished, affecting the differentiation and regenerative capacity of muscle cells.301 Mitochondrial dysfunction was reflected in the reduced mitochondrial DNA content and SDH activity, linked to decreased expression of mitochondrial biogenesis-related genes such as Pgc1α and Tfam.301 NMJ impairment was related to reduced expression of Rapsyn and Lrp4, alongside lowered serum choline levels, affecting the synthesis and neurotransmission of acetylcholine.301 Additionally, amino acid metabolism changes in the muscles of GF mice were observed, with increased levels of glycine and alanine, potentially connected to increased expression of the Alt gene.301 Decreased expression of glycolytic genes like Pfk, Pk, Ldh and Pdh impacted energy production.301 Increased glycogen accumulation in the quadriceps may indicate impaired glycogen metabolism.301 These integrated genetic and metabolic changes led to poor performance in muscle strength tests for GF mice.301 Interestingly, transplanting the gut microbiota from pigs into GF mice replicated the muscle phenotype of the donor pigs, including higher body fat mass, a greater proportion of slow-contracting fibers, reduced fiber size, lower percentage of fast IIb fibers and enhanced fat production in the gastrocnemius muscle.303

Adipose tissues

GF mice have a lower percentage of body fat, despite the increased food intake304 and the elimination of sex-based differences in adiposity.305 They also show a reduction in adipocyte size marked by an increased quantity of smaller adipocytes coupled with a diminished presence of larger ones.306 The inguinal subcutaneous adipose tissue (ingSAT) and perigonadal visceral adipose tissue (pgVAT) regions exhibit browning features.306 Within the white adipose tissue, there is an observable infiltration of eosinophils and M2-type macrophages, which are implicated in the browning process of the adipose tissue.306 A reduction in lactate levels alongside an elevation in (D)-3-hydroxybutyrate levels within their brown adipose tissue (BAT) suggests an upregulated fatty acid oxidation pathway.305 It is known that they show resistance to diet-induced obesity through following mechanisms: increased levels of the fasting-induced adipose factor (Fiaf), which activates peroxisome proliferator-activated receptor gamma coactivator 1-alpha (Pgc-1α) to enhance fatty acid oxidation, and heightened AMPK activity, which is crucial for energy balance and metabolism.307 They may compensate for the impaired storage and utilization of glucose in skeletal muscle by increasing the lipolysis in adipose tissue and promoting the browning of adipose tissue, thereby meeting their energy demands.308 However, this compensatory mechanism might also limit their immediate fuel supply during exercise, leading to a decrease in exercise capacity.308 In addition, the levels of very-low-density lipoprotein (VLDL) are decreased while high-density lipoprotein (HDL) levels remain unaffected.305

Skin

GF mice display reduced stratum corneum complexity, elevated transepidermal water loss and delayed healing post-injury, indicative of a compromised skin barrier.309 Decreased corneodesmosomes and downregulated genes crucial for keratinization and barrier integrity are observed.309 Notably, the aryl hydrocarbon receptor signaling pathway, key for skin homeostasis, shows reduced activity.309 Skin bacteria can enhance the production of inflammatory cytokine IL-1β, which in turn activates the IL-1 receptor and myeloid differentiation primary response 88 (MyD88) signaling pathway within keratinocytes.310 This activation is diminished in GF mice, which may partially explaining their reduced capacity for skin regeneration.310

Longevity and death

Due to lack of potential infection by pathogens, GF mice have an extended average lifespan of 88.9 weeks, outliving CONV-R mice, which average 75.9 weeks.311 But under a restricted diet, equivalent to 80% of their usual intake, CONV-R mice significantly boost their lifespan to 117.5 weeks, while GF mice only increase to 109.6 weeks, showing that dietary restriction powerfully extends life, particularly in CONV-R mice.311 The deaths of GF mice are typically associated with gastrointestinal dysfunction, including intestinal atonia, an abnormally enlarged cecum (with the average weight of the cecum being approximately 15 times that of CONV-R mice at the time of death), intestinal volvulus, liver abnormalities, and degeneration of the kidneys.312 In contrast, the causes of death in conventional mice are more diverse, encompassing respiratory infections such as pneumonia, circulatory failure, intestinal volvulus, intestinal spasms, inflammations of the genital tract, peritonitis, and ear infections.312

Altogether, these findings demonstrate that the humans and other animals without microbiota are abnormal with severe deformities. Thus, to better characterize the functional dependence of animals on microbiota, the collective set of abnormal symptoms can be referred as “germ-free syndrome”. While we do not inhabit a sterile world,313 the progressive loss of microbes during infancy and adulthood, along with the cumulative effects across generations, may gradually propel humanity towards a state resembling germ-free syndrome.314–318 In this context, germ free, or more precisely, the absence of core microbiota, assumes clinical significance as it signifies a shift in the paradigm of microbial influence on disease—from focusing on the presence of pathogenic microbes to contemplating the consequences of a lack of essential microbiome. However, caution should be exercised when extrapolating rodent germ-free syndrome to humans, as the degree of dependence on microbiota may vary.319

To adapt or not to adapt, that is a question

The relationship between the host and microbes has been a longstanding topic of interest among biologists. Examples that best illustrates their close relationship are that mitochondria and chloroplasts are cellular organelles that evolved through endosymbiosis,320 with each playing a key role in cellular energy metabolism and photosynthesis, respectively.321,322 Mitochondria, which are thought to have originated from an ancient Alphaproteobacteria, emerged around 1.5 to 2 billion years ago.323 Chloroplasts, on the other hand, originated from cyanobacteria and are estimated to have been incorporated into their host cells around 1 billion years ago.324 Recently, the nitrogen-fixing cyanobacterium UCYN-A has been proposed as an organelle called the nitroplast in Braarudosphaera bigelowii, attracting significant interest.325

In addition to endosymbionts,326 looking back through history, the term ‘symbiosis’ was first coined by Adolf Meyer-Abich in 1943 to describe the state in which more complex organisms live in association with simpler ones.327 In 1991, Lynn Margulis introduced the term ‘holobiont’ to describe a single organism and the collection of all the microorganisms within it, which highlighted symbiosis as a source of evolutionary innovation.328 However, “superorganism“45,46 and “meta-organism”329–335 have risen to prominence in contemporary literature and media, reflecting an extension with their original definitions. To be specific, introduced by William Morton Wheeler in 1911, ‘superorganism’ was primarily used to describe social insect colonies such as ants, bees, and termites, which exhibit a high degree of organization and integration. Within these colonies, individual members have clear divisions of labor and work collaboratively towards the survival and reproduction of the group, functioning as if the entire colony were a single organism.336 While Graham Bell in 1998 posits “metaorganism” as a singular multicellular organism like Volvox, serving as a good model for the study of the origins of multicellularity.46 After that, at the genetic level, the concept of ‘hologenome’, the combination of host genome and microbiome, was subsequently introduced by Richard Jefferson in 2007, emphasizing microbes as an essential component of organismal function.337 Rosenberg and Zilber-Rosenberg further developed the theory of hologenome evolution in 2007/2008, stating that the holobiont and hologenome are independent units of evolutionary selection.338–341 To resolve possible controversies, Bordenstein and Theis proposed ten principles to better understanding the hologenome and holobionts.44 Overall, they did not regard the organism as an independent organism but emphasizes holobiont and hologenome is the fundamental biological and evolutionary unit and all animals and plants exist as holobionts, these entities exhibit unique anatomical, metabolic, and immunological traits that contribute to their development and evolutionary processes.340 Their genetic information can transmissible across generations, collectively shaping the distinctive characteristics of the holobiont.340 Genetic variation within the hologenome stems not only from the host genome but also from the microbiome .340 The latter, with its capacity to adapt more swiftly to environmental changes, plays an essential role in the adaptability and evolution of the holobiont.340 For example, coral, a small and simple marine invertebrate contribute to the formation of coral reefs through their collective calcium carbonate secretions, not only possesses its own genome but also forms a holobiont genome with various microorganisms, such as Symbiodinium.338 The corals provide essential shelter and inorganic nutrients to Symbiodinium, while Symbiodinium supplies the corals with energy-rich organic matter through photosynthesis, meeting up to 95% of the corals’ energy needs.342 These microscopic algae have undergone a series of adaptive evolutions in the process of adapting to their symbiosis with corals including photosynthesis, ion transport, synthesis and modification of amino acids and glycoproteins, as well as responses to environmental stress.342 The holobiont genome enables corals to rapidly adapt to environmental changes more swiftly than it could rely solely on its own genetic mutations.343–345 In the melon and grape plants subjected to grafting experiments, a detailed analysis of the composition of the root endospheric microbial communities revealed a distinct pattern of deterministic assembly.346 To be more specific, the rootstock played a predominant role in recruiting the microbial community which means that the composition of microbial communities was influenced in a non-random manner by the genetic characteristics of the host plants.346 Vampire bat, one of the only three species of obligate blood-feeding mammals, whose genomes and microbiomes have co-evolved to meet the unique challenges posed by a hematophagous diet.347 The bats’ genomes show adaptive changes for this lifestyle, including morphological adaptations such as sharp incisors and canines, sensory adaptations with the positive selection of the PRKD1 gene for locating blood vessels, digestive adaptations like the loss of sweet taste receptor genes and a significant reduction in the number of bitter taste receptor genes, and their immune systems have evolved to combat common blood-borne pathogens.348 Their microbiome have also undergone positive selection for genes that collaborate with energy production (involved in metabolic pathways such as the reverse Krebs cycle, enabling the derivation of energy from blood components), carbohydrate metabolism (enabling the breakdown and utilization of scarce carbohydrates found in blood), vitamin synthesis (including genes for biosynthesis of essential vitamins, such as carotenoids, which aid in immune function), fat storage (with key genes like glycerol kinase critical for the formation of triacylglycerol and fat storage, managing energy reserves), immune protection (enriched with protective bacteria like Amycolatopsis mediterranei, known for producing antiviral compounds, and genes from bacteria such as Borrelia and Bartonella, adapted for transmission by sanguivorous species), and metabolism of iron and urea (including genes for iron storage like ferritin light and heavy chains, and microbial genes like urease subunit alpha for urea degradation, addressing the challenges of high protein intake and nitrogen waste management).348 As a classic example of homogenome vertical inheritance, Buchnera aphidicola is an obligate intracellular symbiotic bacterium that forms a specialized mutualistic relationship with aphids, characterized by a streamlined genome that retains only the essential genes required for synthesizing amino acids vital to its aphid host, while lacking genes for cell surface components and cellular defense mechanisms, indicative of its adaptation to the stable environment within the host’s bacteriocytes.349,350 This symbiotic bacterium reproduces within the aphid’s specialized cells and is maternally transmitted to offspring, ensuring the continuation of the symbiotic relationship across generations.351 The interdependence between Buchnera and the aphid is manifested at the genomic level, with neither being capable of independent survival without the other.352

Currently, the evidence supporting the coevolution of hominids and microbes is gaining strength. Tracing the evolutionary threads of key gut bacteria such as Bacteroidaceae and Bifidobacteriaceae, revealing that these lineages have cospeciated with humans, chimpanzees, bonobos, and gorillas over an extensive period spanning 15 million years.54 This profound coevolutionary synchrony has led to a harmonized diversification across the nuclear, mitochondrial, and gut bacterial genomes, indicating they have a deep-seated and intimate relationship. Research by Suzuki et al. further supports this, showing codiversification between human populations and their gut microbiota across Europe, Asia, and Africa.53 It highlights the emergence of microbial strains with population specificity, potentially due to a shared evolutionary history, and species that have adapted to host dependency with traits like reduced genomes and sensitivities to oxygen and temperature.53 Moreover, the earliest fossil records indicate that the origins of enterococci can be traced back to the time of animal terrestrialization, approximately 425 to 500 million years ago.353 The diversification of enterococci has paralleled that of their hosts, particularly following the rapid emergence of new species after the Permian-Triassic extinction event.353 Despite constituting less than 0.1% of the human gut microbiome, enterococci have become prominent multidrug-resistant, hospital-adapted pathogens.353 This adaptability is largely attributed to the hardened cell wall they developed during the early terrestrialization process, along with their resistance to desiccation, starvation, and disinfectants, traits that have been crucial for their persistence in the modern hospital environment.353

Undoubtedly, the concept of “holobiont” and the “hologenome theory” offer profound insights into the understanding of the aforementioned phenomena. Although these concepts redefine the composition of individual unit, they do not fundamentally rewrite the theory of natural selection proposed by Charles Darwin and Alfred Russel Wallace.44,354 That is, natural selection remains the primary mechanism driving evolutionary change, the inheritance and variation of advantageous traits in the struggle for existence, leading to the gradual adaptation of species and the emergence of new ones.44,354 However, holobiont and hologenome extend the classical theories by incorporating the genetic contributions of the microbiome into the considerations of biological evolution and adaptive change, thereby offering a supplement for the modern evolutionary synthesis.355 As a simple understanding, natural selection can operates at multiple levels, including genes, individuals, populations, species, ecological communities, and holobiont entities, collectively shaping the diversity and evolution of life.356 In our limited comprehension, the concepts of holobiont and hologenome currently have areas that require refinement especially when apply these concepts to humans. Firstly, when considering the life cycle, these theories struggle to adequately explain the sequence of appearance between the host genome and the microbiome. For humans, the normal embryonic development occurs in the absence of live microbes within their own body—previous discussions have touched upon the fact that if there is an impact, it is more likely due to contamination. Microbes colonize during and after birth, and the assertion that all organisms are holobiont and homogenome may lead to the paradox that unborn baby are not considered biological entities. From a genetic perspective, the inheritance of microbes is not high-fidelity. Vertical transmission (through the birth canal of the mother) or horizontal transmission (acquired from the surrounding environment) are essentially forms of contact transmission, which cannot even be considered inheritance, accompanied by a certain degree of randomness. The example of Buchnera aphidicola is one of the exceptions that can be explained by the existence of hologenome inheritance, but it does not imply that other modes do not exist. The diversity of life constantly reminds us that when interpreting biological phenomena, we should allow for the existence of multiple patterns. Although we prefer to use a single pattern to explain all phenomena, this may limit our further thinking. When considering the driving phenomena behind the co-evolution of multicellular organisms with their microbes, it appears that the underlying potential causes have not been well pointed out, and currently, more attention is given to a general phenomenon. More research is needed to verify whether the evolution of microbes is towards a direction more beneficial to the host or towards a direction more beneficial to the microbes themselves. Determining who leads whom is crucial. We may consider that the host’s proactivity is the most likely driving force behind the happening of homogenome, a notion that is also evident from the discussed examples, just as the ecological environment of the Earth largely dominates the diversity of life, and the host can also be the natural selective force for microbes. In terms of application, the hologenome theory may not be a host-centered theory. Therefore, there is a lack of refinement in the framework of their interrelationship with the host’s interests at the core.

To better delineate the evolutionary boundaries between the human genome and the microbiome, we can distinguish their characteristics using the terms “innate genome” and “adaptive genome.” The innate genome, humans are born with, forms the foundation of our biological identity, comprises a complete set of human nucleic acid sequences that can be inherited across generations following “Mendelian inheritance” and develops into organ systems, performing physiological functions in an organized manner. Conversely, the microbiome is acquired, regulated, and subject to dynamic changes, resulting in extensive biological crosstalk with the innate genome, ultimately affecting health and disease development (Fig. 3). They serve as an adaptive genomic repertoire for humans to adapt to general external environment.357–359 However, the notion of the microbiome as a “second genome” to humans maybe inappropriate.360 The terms “first” and “second” imply a sequential relationship within the same entity, whereas humans and their associated microbes are distinct species with their own evolutionary trajectories. The innate and adaptive genomes, together with the concepts of histological, immunological, host and homeostatic regulation proposed in this paper form a systematic framework to help us better understand the human-microbiome relationship and its interactions at all levels. Next we further discuss how the microbiome acts as an adaptive genome.Fig. 3 The meaning of adaptive genome. Human sperm and egg form the innate human genome. Microbes, through various selections, become the adaptive genome. Adaptive genomes may adapt to host selection and regulation, the dynamics of established microbial communities (which may promote, inhibit or remain neutral),698–700 exposure to different diets and drugs, and fluctuations in the external environment. DASH: Dietary Approaches to Stop Hypertension

Adaptation to the selection, control and regulation of the host

Immunological and neurological regulation

The immune system plays a crucial role in regulating the microbial community by utilizing both innate and adaptive immunity, and mucosal and systemic immunity. The central nervous system and the peripheral nervous system are indispensable components in the coordination of immunity. The brain engages in intimate communication with the immune system through its extensive neural networks and chemical messengers. Specifically, neurons in the central amygdala and the paraventricular nucleus of the hypothalamus express corticotropin-releasing hormone (CRH).361 The axons of these CRH neurons extend to the spinal cord and sympathetic nervous system, ultimately connecting with the splenic nerve to interact with immune cells in the spleen.361 Within the spleen, norepinephrine stimulates T cells to produce acetylcholine, a neurotransmitter that further acts on B cells, particularly through the α9 subtype of nicotinic acetylcholine receptors (nAChRs), promoting their activation and differentiation into plasma B cells.361 These plasma B cells are responsible for antibody production in circulation, a crucial component of the adaptive immune response.362 Indeed, the nervous system also can detects inflammatory cytokines like IL-1β, TNF-α, and IL-6 via sensory nerve terminals, relaying signals through the vagus nerve to the nucleus tractus solitarius in the brainstem initiating a neuro-immune feedback loop that regulates body inflammatory responses.363

The recognition and regulation of commensal microbes are carried out by CD4+ effector T cells and innate lymphocytes.364 T cell receptors (TCR) recognize widely conserved, highly expressed bacterial surface antigens.364 Th17 is induced by commensal microbes to express cytokines IL-17 and IL-22, which maintain a non-inflammatory state, while pathogenic bacteria induce Th17 cells to express IFN-γ and TNF, leading to an inflammatory state.365 Mucosal immunity produces secretory immunoglobulin A (sIgA), which limites commensal microbes to specific microbial niches in the body, thereby preventing pathogen isolation and spread.366–368 IgA deficiency has been associated with an overgrowth of Candida albicans in the intestinal tract and increase systemic immune dysregulation.369–371 However, when microbes invade the epithelium, they bind to FcαRI (CD89) on pro-inflammatory cells and cause a local inflammatory response.372 SIgA also has the ability to modulate microbial gene transcription, promoting the growth of beneficial bacteria while inhibiting the growth of harmful microbes.373 A recent interesting study has found that in the aged pituitary, growth hormone-secreting cells can independently produce IgA without the need for B cells, a process that is positively regulated by the diversity of the gut microbiota.374 It is speculated that this might serve as a compensation for the aging immune system, although the low level of IgA signals in pituitary cells has limited further understanding of this issue.374

Antimicrobial peptides (AMPs) or host defense peptide (HDPs), possesses antimicrobial activity in response to infection375,376 The secretion of IL-18 by enteric neurons is necessary for the expression of AMPs in goblet cells.377 Specifically deleting IL-18 in enteric neurons leads to a decline in the mice’s resistance to Salmonella typhimurium infection, manifested by greater weight loss and increased bacterial abundance in the cecum, liver, and spleen.377 In fact, AMPs exert their effects with distinct specificity with not merely functionally overlapping.375 For instance, Paneth cells secrete Peptide YY, an antifungal peptide that is released into and retained within the intestinal mucus layer.378 This peptide selectively inhibits the invasive and pathogenic hyphae of Candida albicans while having minimal impact on the yeast form that coexists with the human body.378 The evolution of certain AMP gene families could be an adaptive phenomenon.379–381 Fruit fly mutant analysis has detailed the distinct roles of antimicrobial peptides DptA and DptB, with DptA combating the pathogen Providencia rettgeri and DptB targeting the Acetobacter.382 The presence of these genes in Dipteran insects is closely tied to the microbes in their environment, with gene loss or pseudogenization occurring in the absence of these specific microbes.382 Interestingly, human AMPs (e.g. LL-37, a member of the cathelicidin family) were found to synergize with the Sh-Lantibiotics, secreted by the skin commensal S. epidermidis and S. hominis, to efficiently and selectively kill the S. aureus.383 So decreased secretion of AMPs such as defensins, lectins, lysozyme, ribonucleases, and cecum toxins can leads to increased susceptibility to certain pathogens.384,385 Therefore, in this section, it may be more accurate to understand AMPs as microbial regulatory peptides (MRPs) as they do not remove all microorganisms, but rather play more of a regulatory role.

Host sources

Sources of oxygen, carbon, nitrogen, electron transport chain receptors, and trace metals from the host form a nutritional ecological niche that regulates the selection and abundance of microorganisms. The colonization of facultative anaerobic bacteria gradually transforms the aerobic environment of the early intestine into an anaerobic environment, which favors the survival of obligate anaerobic bacteria.41 Obligate anaerobic bacteria further increase the oxygen consumption of IECs by producing metabolic products such as SCFAs, inducing the expression of hypoxia-inducible factor 1 (HIF-1)-related genes, affecting the metabolism of IECs, enhancing the tight junctions of IECs and promoting the production of mucus and antimicrobial peptides, thus shaping the microbiota group.41,386,387 In pigs, Yang et al. indicated that a 2.3 kb deletion in the ABO blood group gene, which occurred millions of years ago, led to a decrease in the concentration of N-acetylglucosamine (GalNAc) carbon sources in the intestine, directly affecting the nutritional metabolism of the family Erysipelotrichaceae and reducing its abundance.388 In contrast, in humans, it is Faecalibacterium prausnitzii and Collinsella aerofaciens that are capable of utilizing GalNAc.389 Bacteroides acidifaciens and Akkermansia muciniphila can utilize host-derived mucin as the nitrogen source.390 The latter is considered a potentially beneficial probiotic that can effectively regulate the host immunity and metabolism.391 It is worth noting that electron transport chain receptors from the host also flexibly regulate the microbiota. The epithelial cell NADPH oxidase 1 (Nox1) produces hydrogen peroxide (H2O2), preventing anaerobic bacteria from surviving in the inner layer of the mucus and crypts.392 Trace metals play critical roles as structural and cofactor elements in approximately one-third of proteins; however, excessive accumulation can lead to metal toxicity.393 Essentially, the body can suppress microbial replication, transcription, metabolism and survival by limiting or sequestering metals (such as iron, zinc, manganese, and copper) in the mucosal barrier and circulation.393,394 Immune cells can also employ a metal intoxication strategy by using zinc and copper to fight microbes in lysosomes.393 This “nutritional immunity” has recently been elegantly reviewed and may be exploited for the development of novel antimicrobial therapies.393

Extracellular vesicles

Host-derived extracellular vesicles (EVs) are a type of vesicle secreted by cells into the extracellular space.395 The nucleic acids carried by EVs, including miRNAs, circRNAs, and IncRNAs, have been shown to regulate microbiota.396 miRNAs in EVs can enter bacteria and regulate microbial gene transcription. For instance, miR142a-3p secreted by IECs can bind to targets in the commensal bacterium Lactobacillus reuteri, promoting its growth.397 Secretion of factors like IL-11 in response to the microbiota can influence the expression of host cellular circRNAs, subsequently modulating the levels of corresponding miRNAs.398 Interestingly, this host response affects the capability of cancer cells to metastasize.399 Moreover, the IncRNA expression profiles of germ-free mice differed significantly from those of conventionally raised mice and can be used in distinguishing between colonized E. coli strains or fecal-derived microorganisms.179

Hormones and metabolites

Hormones and metabolites circulating in the host body also affect the regulation of microbiota. Lyte and Ernst pioneered the field of microbial endocrinology, noting the impact of stress-activated neuroendocrine hormones on bacterial growth.400 Their work laid the foundation for subsequent discoveries that microbes possess hormone receptors, suggesting a role in intercellular messaging.401 Specifically, the gut microbiota of castrated male mice was more similar to that of female mice, suggesting that androgens may play a role in regulating the microbiota.402 Estrogen can reduce the abundance of Proteobacteria by activating estrogen receptor beta (ERβ) and increasing α-diversity of the gut microbiota.403 Ovariectomy (OVX) leads to increased levels of LPS in the serum, elevates the ratio of Firmicutes to Bacteroidetes.404 The decline in sex steroid levels, commonly experienced during menopause, enhances intestinal permeability and initiates inflammatory responses in the small intestine and bone marrow. This process stimulates the production of osteoclastogenic cytokines such as TNFα, RANKL and IL-17.405 Consequently, these cytokines promote osteoclast formation and activity, leading to bone loss, which may underlie the development of osteoporosis in postmenopausal women.405 Catecholamines can directly regulate bacterial gene expression, alter biofilm formation by Staphylococcus aureus, and downregulate the resistance of Salmonella to AMPs.406–408 Host metabolites, such as serum lactate, can be utilized by Veillonella atypica to produce propionate, which provides more energy to meet the body’s metabolic demands during exercise.409

Pregnancy

During normal pregnancy, women experience significant changes in their hormonal, immune, and metabolic profiles, which are reminiscent of the characteristics of metabolic syndrome.410 Research has indicated that the gut microbiota of pregnant women undergoes substantial alterations throughout gestation, particularly in the third trimester, where there is a notable increase in microbial diversity and a rise in the relative abundance of certain bacterial groups such as Proteobacteria and Actinobacteria.411 These shifts in microbial composition are closely associated with the host’s state.

From a macroscopic perspective, during human evolution, various modes have been developed to regulate the commensal relationship with the microbiome. Variations in regulatory patterns caused by host factors such as gender dimorphism,412–414 age (developmental stage),415 genetics (ethnic origins, genetic mutations),416,417 behavior (sleep, stress, exercise),418–420 and disease status (infection, activity, organ failure)421,422 may affect the variability of adaptive genomic profiles among individuals.

Adaptation to variations in diet

Food serves as a fundamental requirement for sustaining human growth, reproduction and health.423 The sources, variety, and quality of the food we consume have a profound impact on the composition, diversity and richness of our microbiome.424–426 Differences in the gut microbiota across regions and countries may be attributed to dietary practices.427 Microorganisms can rapidly and reproducibly respond to ingested nutrients, exhibiting a simultaneous and consistent convergence in the changes observed between humans and other mammals.334,428,429 Studies have suggested that dietary protein (e.g. animal protein, whey protein isolate, and pea protein isolate) can enhance microbial diversity, whereas a high-fat diet (HFD) can significantly reduce the abundance of gut Lactobacilli and increase the proportion of Clostridium, Bacteroides and Desulfovibrio (producing propionate and acetate).424 The genus Desulfovibrio can also produce significant amount of leucine when exposed to HFD, which activates the mTORC1 signaling pathway in myeloid progenitors, fostering the differentiation and proliferation of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs).430 This mechanism is integral to the “gut-bone marrow-tumor” axis, facilitating the progression of cancers including breast cancer and melanoma.431 Digestible carbohydrates, such as starch and sugars (glucose, fructose, sucrose and lactose), can increase the abundance of Bifidobacterium and decrease the abundance of Prevotella, whereas, artificial sweeteners show the opposite trend.424,432 Polyphenols, found in various fruits, vegetables, seeds, and beverages (e.g., beer, wine, juice, coffee, tea, and chocolate), and in small amounts in grains and legumes, can significantly reduce the number of pathogenic bacteria, such as Staphylococcus aureus and Salmonella enterica, while enhancing the abundance of beneficial microorganisms.424 Of all the nutrients, the effect of dietary fiber on microbes has been the most widely and intensively studied due to their wide-ranging benefits for human immunity and metabolism.433 Dietary fibers may influence the gut microbiota by: (1) providing direct nutrient substrates, such as resistant starch, which is utilized by Ruminococcus bromii in the colon;434 (2) activating microbial enzyme systems, such as Bifidobacterium, which uses its enzymatic capabilities to effectively metabolize galactooligosaccharides, thereby increasing its presence and activity in the intestinal tract;435 (3) regulating environmental pH, where the production of butyrate from fiber fermentation lowers intestinal pH and inhibits the growth of non-adaptive bacterial species;436 and (4) facilitating cross-feeding, where primary decomposers such as R. bromii breaks down resistant starch into short-chain fatty acids, which are subsequently utilized by secondary decomposers such as Faecalibacterium prausnitzii.437 A recent comprehensive assessment supports specific dietary fibers selectively enhance the abundance of certain gut bacteria—carrageenan increases Phascolarctobacterium, Prevotella, and Treponema; xylan boosts Butyricimonas; arabinogalactan augments Bacteroides; and β-glucan promotes Lactobacillus.438 Conversely, the abundance of Clostridium perfringens and Bacteroides fragilis is reduced by a range of fibers, including arabinoxylan, apple pectin, xylan, arabinogalactan, xanthan gum, guar gum, carrageenan, glucomannan, and β-glucan.438 In particular, Cynthia et al. reviewed over 1500 human fiber intervention studies, integrating 16 S rRNA amplicon data from 2368 gut microbiome samples from 488 participants.439 The above robust dataset offers strong clinical evidence, enabling a comprehensive assessment of human microbiome’s response to various types of dietary fiber.439 The interplay between diet and the gut microbiome contributes to the fluctuation of serum metabolites, which in turn correlates with the alteration of specific clinical indices. For example, systolic blood pressure is specifically decreased by the consumption of vegetable oil, which enhances the abundance of the Blautia and concurrently lowers the serum levels of 1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1).440 In addition, fruit consumption exerts a similar blood-pressure-lowering effect by elevating the serum levels of threonate, a metabolite enhanced by Blautia.440 Overall, different dietary patterns, such as Western diet,441 Mediterranean diet,442–445 veganism,446 Nordic diet,447 Dietary Approaches to Stop Hypertension (DASH) diet,448 Carnivore diet,449 Ketogenic diet,450 plant-based diet,451 intermittent fasting,452 and traditional Asian diets,453 provide various combinations of nutrients, thereby changing the composition and richness as well as function of surviving microbes. Harnessing dietary interventions to modulate the microbiota represents a promising avenue for optimizing human metabolism.426,454

Adaptation to environmental conditions

In contrast to genetics, environmental factors are better able to explain the variations observed between microbial communities.455,456 Due to geographical isolation and the impact of human migration, H. pylori populations in different regions exhibit varying levels of genetic diversity.457–459 For instance, the hpEurope population demonstrates a higher degree of genetic variability as a consequence of multiple historical waves of human migration.457,458 Analysis of 13,000 publicly available metagenomic samples using artificial intelligence has revealed a close relationship between microbial genes and their habitat.460 Systematic summary has been reported indicating striking differences of the gut, oral cavity, respiratory tract, skin and urinary tract microbiome across different populations worldwide.461 Within 3224 Chinese individuals, researchers found that geographical factors are the most significant external influences on the composition of the gut microbiome, with the similarity of the microbiomes among individuals being inversely proportional to their geographic distance.440 Interestingly, gut microbes share approximately 48.6% similarity in the cohabitation scenario.456 Furthermore, airway microbiome can serves as a mediator in the influence of environmental pollution factors on respiratory system health.462 With the transition of humans from a primitive hunting and farming lifestyle to an urban lifestyle, there has been a decline in microbiome diversity. Specifically, the gut microbiomes of primitive civilizations were characterized by high abundance of Prevotella, Aspergillus, Spirochetes and Clostridium, whereas those of urban dwellers typically contain Bacteroides, Bifidobacteria and Firmicutes.461 Western urban populations appear to have lost microorganisms such as dense intestinal spirochetes, possibly due to multiple factors, including changes in dietary habits and modern drug treatments, as this microorganism is still retained in other primates (excluding the effects of climate change).461 Of all the microbiomes, the skin, which is exposed to the natural environment, appears to be the most affected. For example, in rural areas, they were more exposed to soil and environmental microbial sources, while in urban areas, participants worked indoors and had less access to these sources.463 These environmental differences may explain the differences in the abundance of Trabulsiella and Propionibacterium in the participants’ skin.463 A systematic review reported that greenspace exposure was associated with increased microbial diversity as well as alterations in the overall composition of the microbiota in the gut and skin.464 Specifically, there were increases in the relative abundance of beneficial bacteria (e.g., Ruminococcaceae) and decreases in the relative abundance of harmful bacteria (e.g., Streptococcus and Escherichia/Shigella).464 However, regionalized differences also pose challenges in establishing uniform microbial-related predictors and models.465 The space environment, which includes microgravity and radiation, could profoundly influence on the physiology, genetics and community composition of microorganisms. During short-term spaceflight, the skin microbiome exhibits a temporary increase in viral populations, including Uroviricota, Cressdnaviricota and Phoxiviricota.466 In the oral microbiome, there is an observed increase in bacterial groups associated with periodontal disease and dental caries, such as Fusobacteriota, with notable species like Fusobacterium hwasookii, Fusobacterium nucleatum and Leptotrichia hofstadii.466 Spaceflight also enriches microbial genes related to phage activity, toxin-antitoxin systems and stress responses across multiple body sites, indicating adaptive changes of microbes to the stressors of the space environment.466 Although most of these changes are transient, such as Corynebacterium species, showed a temporary decrease in transcriptional activity,466 some bacterial groups in the skin microbiome, like Acinetobacter spp. demonstrated a persistent reduction.466

Adaptation to various medications

Medication can alter the intestinal microenvironment, influencing microbial growth or undergoing direct microbial metabolism, ultimately modifying the composition and function of the microbiota.467,468 Antimicrobial resistance is a common survival mechanism in both pathogens and commensal bacteria.469 Initially, six-month antibiotic treatments for tuberculosis disrupt the gut microbiome, allowing drug-resistant pathogens to dominate.470 However, commensals soon overtake them through competitive adaptation.470 Additionally, non-antibiotics like antidepressants can increase mutation rates and speed up the horizontal transfer of resistance genes by activating bacterial defense mechanisms.471 With the expansion of research, our understanding of the effects of drugs on microorganisms has extended to more medications.472 Proton pump inhibitors (PPIs), a type of medication used to treat digestive disorders, can reduce the acidity of gastric fluid and increase the number of oral microorganisms that migrate to the intestine.473,474 Metformin, a traditional medication for lowering glucose, can increase the abundance of mucin-degrading bacteria Akkermansia muciniphila and butyrate-producing bacteria.475 In addition, data from 2173 individuals in the European Heart and Metabolic Disease cohort showed that 28 drugs significantly affected the microbial characteristics, demonstrating a combination, cumulative and dose-dependent effect.476 The synergistic effect of multiple drugs can redirect the host microbiota to a more favorable state, and an increase in the number of antibiotic courses is associated with an increase in the abundance of harmful microorganisms.476 Microorganisms can chemically modify oral medications to produce different functional and pharmacological properties. For example, 5-aminosalicylic acid (used to treat ulcerative colitis) relies on colonic bacteria to cleave azo bonds and release active drugs in the colon;477 and digoxin (used to treat heart disease) can be inactivated by Eggerthella lenta.478 Similarly, Gardnerella vaginalis, the dominant bacterium in the vagina, can predict poor outcomes for tenofovir (a pre-exposure prophylactic drug for HIV infection), whereas Lactobacilli can increase its efficacy threefold.479 The β-glucuronidase of commensal bacteria can convert irinotecan (a prodrug for colon cancer treatment) into a toxic form, killing intestinal epithelial cells and causing severe diarrhea.480 In a study by Zimmermann et al. of the 271 oral medications tested, two-thirds could be metabolized by various strains of intestinal bacteria, and each strain could metabolize 11-95 drugs.481 Recently, a team established a drug metabolism model based on the genomes of 7,302 microorganisms to explore personalized prediction and analysis.482 In addition to activating, inactivating, and exhibiting toxic effects on various medications, microorganisms have also received widespread attention for improving clinical responses to immune therapy for cancer treatment.483–485 Further studies of the interplay between the adaptive genome and the innate genome’s drug response, absorption, distribution, metabolism, and excretion show potential in predicting disease treatment efficacy and improving individual drug efficacy levels, leading to Precision-Comprehensive Drug Microbiology.

Adaptation to established microbial communities

The human microbiota community is a complex ecological network. Established microbial communities influence newcomers positively, neutrally, or negatively.486 In vitro co-cultures of fecal microbiota show that 51.67% of these relationships are neutral.487 Commensalism, which make up 21.67% of interactions, occur when one organism benefits from another without harm, or both benefit from each other.488 This often occurs through cross-feeding between microbes, such as when Acetobacter pomorum obtains lactic acid from Lactobacillus plantarum and in turn produces amino acids essential for the growth of Lactobacillus plantarum.489 In addition, bacteria can cooperate to form biofilms-aggregations that enhance protection and competitive advantage by conferring antibiotic resistance to their members.490 Interestingly, a recent discovery involves an oral Saccharibacteria isolate (TM7x) that protects its host bacterium, Schaalia odontolytica (XH001), from predation by the lytic bacteriophage LC001.491 Antagonistic relationships account for 18.33%, where one organism inhibits another without harming itself.492 Some bacteria can secrete antibiotics or other inhibitory substances to suppress competitors and maintain resource dominance.493 Competitive interactions, which account for 5%, involve two species competing for the same resources and adversely affecting each other.494 For example, in vitro cultures of Intestinimonas butyriciproducens and Shigella flexneri showed inhibited growth when in close proximity.487 Exploitative relationships, which account for 3.33%, are similar to predatory relationships in which one organism uses another as a resource.495 A classic example is bacteriophages, which are often described as obligate predators of bacterial hosts, achieving reproduction through mechanisms such as generalized transduction, specialized transduction, and lateral transduction.496 However, Shkoporov et al. suggested that at the population level, phage-bacteria interactions may facilitate long-term coexistence.496 In the face of constant phage threats, bacteria are forced to continuously produce genotypic and phenotypic variants, reducing the sensitive subpopulation through lysis and allowing the spread of resistant mutants, thus increasing intraspecies diversity.496 It is crucial to emphasize that higher-order interactions within microbial communities are key drivers explaining the characteristics of microbial consortia.497 Quantifying the genetic adaptability of E. coli in different communities (from two to four species) suggests that these higher-order interactions significantly affect microbial gene expression and function.497 Even in simple microbial communities, the dynamics of interactions are complex and essential for understanding microbial functional mechanisms. In fact, the specific microbes and the nature of their co-occurrence relationships can vary significantly between organs and are influenced by a range of factors including pH levels, immune responses and the presence of specific nutrients or other environmental conditions within each organ’s microenvironment. For example, the oral cavity and the large intestine are characterized by a higher incidence of co-exclusive relationships among microbes, while other organs show a more pronounced presence of co-occurrence relationships.91 Unraveling adaptive mechanisms is crucial for predicting the regulation of community dynamics and enhancing the success and stability of microbial transplants. However, this endeavor presents significant challenges. In this context, the study of keystone taxa - first introduced by Paine as species that play a critical role in the stability of their ecosystems may be a good strategy.498,499

Host or Meta host

The introduction of the adaptive genome in above context can led to reconsideration of our understanding of the host, transitioning from a ‘host’ (innate genome) to a ‘meta-host’. As a meta-host, it offers a unique ecological niche for other organisms, thereby affecting the host’s susceptibility to infections, the pathogenicity of the infecting agents, and the severity of diseases (Fig. 4).500 Specifically, Miller et al. found that, compared to traditional mice, which are not typically suitable hosts for nematodes and tapeworms, were able to develop seemingly healthy and reproductive adults in germ-free guinea pigs when infected with Nippostrongylus muffs, Nematospiroides dubius and Hymenolepis nana.501 The study also indicated that the destruction of commensal microorganisms led to increased susceptibility to Salmonella infection in mice treated with antibiotics (streptomycin) after infection with a lower titer.196 In contrast, Entamoeba histolytica is known to be pathogenic in the intestinal tract of traditional guinea pigs, but not in germ-free mice. When E. coli was added to the inoculum, intestinal damage occurred, which was not caused by E. coli alone.502,503 Patients with nontuberculous mycobacterial lung disease (NTM-LD) exhibit a significant perturbation in gut microbiota, particularly marked by a decrease in Prevotella copri, which is strongly correlated with both the occurrence and severity of NTM-LD.504 This is accompanied by a reduction in TLR2 activation activity and a discernible immunosuppressive effect within the lungs.504 Angela Wahl and colleagues developed a germ-free humanized mouse model that demonstrates the human microbiota significantly enhances the infection and pathogenicity of Epstein-Barr virus (EBV) and human immunodeficiency virus (HIV).505 The presence of a normal microbiota in conventional humanized mice (CV-BLT) promotes more frequent EBV-induced tumorigenesis and higher levels of HIV replication in the gut and systemic circulation.505 In young South African women, it has been discovered that the diversity of the cervicovaginal bacterial community is also closely associated with the risk of HIV infection.506 Specifically, communities with high diversity dominated by anaerobic bacteria other than Lactobacillus have been found to increase the risk of HIV infection by more than four times.506 Certain bacterial groups, such as Lactobacillus crispatus, are correlated with a reduced risk of infection, while others like Prevotella and Sneathia are associated with an increased risk by increasing the number of activated CD4 + T cells in the reproductive tract, which are the target cells for HIV infection.506 Another highly regarded example is the significant changes observed in the composition of the gut, lower respiratory, vaginal, and oral microbiota in individuals infected with coronavirus SARS-CoV-2.507–511 These changes manifest as a striking enrichment of pathogenic microorganisms and a concomitant reduction in beneficial counterparts, and are closely associated with levels of biomarkers of inflammation and tissue damage suggesting a potential interplay between the microbial community and disease severity.512 The immune response and physiological milieu of infected individuals may induce these compositional changes, thereby compromising the host’s antiviral capacity.513,514 The diminished biosynthesis of immunoregulatory metabolites, such as butyrate and L-isoleucine further impairs the body’s ability to counteract viral invasion515–517 and the increased infectivity of microbial agents exacerbates the clinical prognosis.518 While comprehensive investigations are warranted to unravel the complex effects of the microbial community on viral susceptibility and transmissibility, these findings necessitate a reevaluation of our defensive and therapeutic strategies in anticipation of future infectious diseases. Such efforts hold the promise of mitigating the disastrous consequences of rampant viral outbreaks on the world’s population.519 Meta-Host model also show potential in the interpretation of organ transplantation heterogeneous outcomes. While the classic understanding points to genetic mismatches as the main cause of graft rejection, the unique microbiota of each individual might also play a crucial role. It can be evidenced by the extended survival of skin transplants in mice associated with the presence of Alistipes, suggesting that specific microbes could impact the host’s physiological responses.520 Sequencing of 1370 fecal samples from 415 liver transplant recipients and 672 kidney transplant recipients also indicated that ecological shifts in the human microbiota are associated with increased mortality rates following transplantation.521 This underscores the potential therapeutic potential of targeted microbiota manipulation, such as with probiotics or microbiota transfers, to improve transplant success rates.Fig. 4 Original host (conventional host model) and Meta-host (ecological host model). The meta-host is used to describe conventional host that exhibit marked differences in colonization, susceptibility and pathogenicity to microorganisms following microbial accession. This phenomenon is the result of the dynamic integration of the adaptive genome with the innate genome and corresponds to the human ecological perspective

Do we manage a slave tissue?

The captivating role microorganisms play in human physiology has sparked the prevalence of the ‘organ’ theory. In 1992, Bocci proposed that the gut microbiota is an overlooked organ that is critical for immune stimulation in humans.522 Subsequently, in 2006, O’Hara et al. further elaborated on this theory, calling for a deeper understanding of this hidden organ to unlock secrets related to human health as well as various infectious, inflammatory and tumor diseases.523 Since then, the gut microbiota has been popularized as an “organ” in academic and popular media. In 2013, Burcelin et al. pointed out that bacteria are also found in common tissues such as the liver and adipose tissue.524 The interaction between host tissues and microorganisms may provide new opportunities for disease diagnosis, immune regulation and nutritional applications, although their review did not consider it as an independent tissue rather named “tissue microbiota hypothesis”.524 To further emphasize that host regulation is fundamental to the normal functioning of microbial organs, Byndloss and Bäumler proposed the “Germ-organ theory” in 2018 to describe how host dysregulation (such as epithelial dysfunction) can lead to the occurrence of non-infectious diseases (such as an increase in Proteus mirabilis).525 While the ‘organ theory’ deepens our appreciation for the significance of microorganisms, it has simultaneously sparked scientific debate. For example, Fucarino et al. contended against such perspectives, primarily because they adhered to the traditional definition of organs as structures composed of tissues with similar or varying embryonic origins within the human body, a criterion that microorganisms evidently do not meet.526 They proposed that the term “mucosal microbiota layer” of hollow organs more precisely encapsulates the role of microorganisms, as exemplified by the gut and respiratory tract ecosystems.526 However, this designation does not encompass the skin microbiota also falls short of offering a comprehensive systemic view on genetic and hereditary aspects.

In fact, the traditional definition can be appropriately adjusted based on the motivation behind the traditional terminology. Medical classification of cells, tissues (a group of cells), organs (a group of tissues), systems (multiple organs) and organisms (multiple systems) is helpful for scientists to focus on different levels of research. Owing to limited detection techniques, we initially did not have a clear understanding of the interaction of microorganisms in human physiology and pathology, and it is not surprising that we did not consider them as part of human tissues and organs. Overall, the ‘organ theory’ has stimulated greater research interest and clearly given microbial communities the attention it deserved. To better manage microbes in our bodies, several issues related to our understanding of body composition need to be addressed. Firstly, in our understanding, human microbiota are more like a component of the tissues that make up organs, rather than being stand-alone organs themselves. For example, in the gut, certain microbes play a critical role in the complete performance of digestive functions which can be consider as part of gut organ. The incomplete gastrointestinal function exhibited as we discussed in germ-free syndrome also corroborates this point. That is to say, a gut devoid of microorganisms cannot be considered a complete intestine and is unable to perform the full range of functions associated with a healthy gut. Similarly, the skin is an organ whose complete defensive function is facilitated by a covering layer of microbial tissue. Second, on specific classifications, the composition and functions of microbial communities vary greatly at different anatomical sites. Designating each distinct microbial community as a separate organ would unduly complicate the existing human organ classification system. Classifying microbial communities according to their specific anatomical locations is more consistent with traditional methods of tissue classification, such as the further categorization of epithelial tissues into overlying epithelium and glandular epithelium. Microbial tissues can be similarly categorized by corresponding anatomical locations, such as skin microbiota, gut microbiota, etc. Hence, regarding microbes as distinct organs isn’t pragmatic. The final conundrum is that the traditional tissues are generally solid rather than fluid or dynamically mobile. Our previous discussions on how the microbiome adapts to and is regulated by host conditions provide a rationale for the emergence of the concept of “slave tissues”. As a hypothesis, the multicellular organisms may exhibit a form of “slavery” towards microorganisms, maintaining a constant struggle that has driven long-term evolution. This concept, borrowed from sociology, can partially elucidate the variations in microbes across different developmental stages of an individual’s life cycle. It also aids in explaining the acquired immunity and the models of host health and disease conversions. Most importantly, it expands the concept of histology to include an external, dynamic tissue, thereby resolving a nomenclature dilemma about microbiome in histology. Conversely, if microbes were to form an organ - implying significant proliferation - they could have fatal consequences for the human body. Overall, these tissues have developed from adaptive genomes and possess physiological functions closely tied to the four master tissues (epithelial, connective, muscular, and nervous) (Fig. 5). Loss of control (microbial dysbiosis) of microbial tissue may lead to malignant cycles of cardiovascular,527–531 respiratory,532–534 digestive,535 nervous,536–540 endocrine and metabolism,541–543 oral,544,545 skin,102,103,546 autoimmune,547–549 urogenital,550 mental disease,551 and even cancers,552–554 although the causality of related diseases so far is not always clear (Some of these diseases will be discussed in next sections). The formidable organizational structure of the human body’s composition is profoundly systematic. This is precisely why, even when confronted with a great number of dispersed microorganisms resembling the human body, they still maintain a dominant position. Hence, it is prudent to regard microorganisms as a subservient or controlled component of the system. The “slave” perspective also makes hygiene practices (brushing teeth, washing face, bathing, disinfecting) more understandable and acceptable. Their development, the ‘biofilm’ and ‘quorum sensing’ abilities can damage our health.555,556 Therefore, we still need to control their location, limiting unrestricted growth and widespread communication, avoiding serious damage to other tissues (Fig. 5).Fig. 5 Slave tissue hypothesis. Microbial tissue is the additional fundamental tissue of the human body, a slave tissue alongside nervous, epithelial, connective and muscular tissues.701,702 The maternal microbiota exerts a regulatory influence on fetal growth and development and can partially transfer seed microbiota to the newborn through microbial exposure. Microbes that colonize in body site (including but not limited to the gastrointestinal tract, respiratory tract, reproductive tract, skin and urinary tract) play a vital role in digestion, immunity, neural regulation and metabolic crosstalk throughout human growth and ageing, and ultimately participate in the degradation of the body upon death.37,415,703,704 The human microbiota has undergone co-speciation, co-evolution, co-adaptation, and co-diversification with humans over a long period of time.53 Throughout the life cycle, factors such as mode of delivery, genetics, gender, diet, medication, environment and behavior (e.g. exercise) can potentially contribute to differential microbial tissue formation705–707

Attempts to classify microbial tissues with greater precision have ventured into new territory. The notion is that these so-called “slave tissues” can be systematically categorized through an ecological framework of classification. For example, in 2011, the MetaHIT team proposed the concept of ‘enterotypes’, dividing the gut microbiota into three types.557 They are robust classifications which are not influenced by nationality or region and characterized by a unique composition and metabolic signature of the microbial community: Enterotype 1, characterized by Bacteroides and efficient in fermenting carbohydrates and proteins; Enterotype 2, marked by Prevotella and its mucin-degrading capabilities, often in synergy with Desulfovibrio; and Enterotype 3, defined by Ruminococcus and Akkermansia, specializing in mucin binding and sugar transport.557 In subsequent research, the authors emphasize that enterotypes are not strictly separated categories but rather exhibit a tendency for clustering within a continuous spectrum of gut microbial community composition. They also provided a standardized procedure and guidelines for enterotype analysis to enhance the accuracy and comparability of research findings across studies.558 Different research teams, however, employing a variety of experimental approaches, algorithms, and analytical techniques, classified the gut microbiota into diverse categories.559,560 Recently, Senying Lai et al. conducted an extensive analysis of 3363 fungal sequencing samples from 16 cohorts across Europe, North America, and Asia, further delineating the four fungal enterotypes of the human gut (mycobiome).561 The Sacc_type enterotype, dominated by Saccharomyces cerevisiae, is more prevalent among younger individuals and correlates with a better intestinal barrier.561 In contrast, the Can_type enterotype, characterized by the abundance of Candida albicans, is enriched in the elderly and associated with an increased risk of various diseases and a compromised intestinal barrier.561 The Asp_type enterotype, led by Aspergillus species, shows a correlation with certain bacterial enterotypes, while the Asc_type enterotype is driven by either unclassified Ascomycota or Saccharomycetales.561 With advancements in capsule sampling and microbial visualization techniques, we may anticipate a shift towards more efficient classification that isn’t solely reliant on fecal samples.89,90,562 In an analysis of the oral microbiome of 1500 Spanish adolescents revealed two predominant oral microbial community patterns, termed “stomatotypes”.563 The first pattern is dominated by the genera Neisseria and Haemophilus, designated as the Neisseria-Haemophilus stomatotype (Stomatotype 1), while the second is characterized by the dominance of Prevotella and Veillonella, known as the Prevotella-Veillonella stomatotype (Stomatotype 2).563 They hypothesized that these stomatotypes may represent two potential optimal equilibria of the oral microbiome on a global scale, prevalent across various geographical regions, lifestyles, and age groups.563 Another example is vaginal Community State Types (CSTs), a classification system used to describe the composition of vaginal microbial communities in women of reproductive age.110 Specifically, CST I is characterized by the dominance of a single species of Lactobacillus, in particular L. crispatus.564 CST II is similarly characterized by Lactobacillus dominance, primarily L. gasseri.116 CST III is dominated by L. iners, although its association with vaginal health remains unclear.116 CST IV lacks Lactobacillus dominance and includes other facultative and obligate anaerobic bacteria such as Gardnerella, Prevotella, Atopobium, Sneathia, Megasphaera and Peptoniphilus.116 This microbial composition is associated with bacterial vaginosis (BV) and may increase the risk of several adverse health outcomes.116 Finally, CST V is dominated by L. jensenii.110 In summary, the detailed classifications of microbial types will empower researchers to discern various microbial community states, enhancing our comprehension of their relationship with human health. This advancement in turn will unlock significant clinical implications, including disease vulnerability, diagnostic accuracy, and the efficacy of medical interventions.

From homeostasis to homeostatic reprogramming

In our previous discussions, we concluded the discourse on the hypothesis of the existence of foreign, salve-like tissues within the human body. Next, it is essential to re-examine the foundational theory of physiological medicine—homeostasis, as without homeostasis, there is no health. The internal environment, comprising extracellular fluids such as interstitial fluid, plasma, and lymphatic fluid, represents the environment in which the cell lives.565 In the 19th century, French physiologist Claude Bernard introduced the concept of “interior milieu,” emphasizing its stable and autonomous nature as a prerequisite for life. This property enables an organism to compensate for variations in the external environment.565 In 1929, the American physician Walter B. Cannon proposed the concept of “homeostasis”, highlighting the dynamic stability and regulation of the internal environment.566 Currently, it is widely acknowledged that the internal environment maintains the dynamic stability of chemical composition (water, inorganic salts, and organic compounds) and physico-chemical properties (osmotic pressure, pH, temperature) in a coordinated manner across tissues, organs, and systems through neural, metabolic, and immune regulation.567,568 Maintenance of the internal environment’s stability is critical for cellular metabolism and physiological functions of the body, and its disruption can result in diseases.569 The theoretical basis of the internal environment and homeostasis has made medical interventions possible. The hypotheses of adaptive genomes, slave tissue and germ-free syndrome, presents us with the opportunity to further expand the framework of homeostasis. Here, we introduce the concept of ‘Homeostatic reprogramming’ to describe a phenomenon in which the adaptive genome coordinates with the innate genome to deviate the scope and outcome of neuroendocrine and immune regulation from the original trajectory (Fig. 6a). In other words, the statement of maintaining homeostasis may not be accurate. A classic example of reprogramming is the possibility that ‘healthy’ body temperature is the result of a combined microbiota-host regulation. Intermittent changes in the external environment can induce changes in the resting metabolic rate, serum thyroid hormones and core body temperature in mice, while dynamic gut microbiota and their metabolites can provide the host with metabolic plasticity to regulate temperature fluctuations.570 Supporting this notion, antibiotic clearance of bacteria has been shown to damage body’s thermogenic capacity.570 Recently, it has been shown that changes in the gut microbiota can predict the temperature course of hospitalized patients with sepsis, and that GF or antibiotic-treated mice have lower basal body temperatures than those harboring natural microbiota.571 When exposed to cold, animals can produce heat and maintain body temperature by activating brown adipose tissue (BAT) and browning of white adipose tissue (WAT).572 The absence of certain microbiota inhibits the increase in uncoupling protein 1 (UCP1) expression in BAT and reduces the degree of fat browning.572 These findings suggest that the presence of an adaptive genome may lead to reprogramming of body temperature, and that animals lacking microbiota may experience impaired thermoregulation. Of greater concern is that this may partly explain the curious phenomenon of a 1.6% average decrease in human body temperature since the 1860s, the use of antibiotics, improvements in hygiene and an increase in processed foods, accompanied by a decrease in microbiota diversity and abundance.573,574 Uric acid (UA), as another example, is the end product of purine metabolism in the human body, and excessive accumulation can lead to metabolic imbalances. Recent findings have revealed widespread purine degradation and anaerobic uric acid metabolism within the gut microbiota.575,576 This microbial process appears to compensate for the host’s deficiency in UA-degrading enzymes, possibly stemming from a “thrifty gene” that gradually became inactive during human evolution to enhance adaptation to periods of hunger and cold by stimulating gluconeogenesis, increasing fat storage, and reducing fat oxidation.577 In rodent models lacking UA-degrading enzymes, depletion of gut bacteria results in severe hyperuricemia, while colonization with UA-consuming intestinal bacteria reduces UA levels.575 In retrospective patient studies, the use of antibiotics targeting anaerobic bacteria were associated with an increased risk of subsequent gout.575 Overall, the loss of UA-consuming microbes could partly account for the rising prevalence of hyperuricemia in modern times.578 Commensal microbes are also involved in the regulation of blood glucose homeostasis. Intestinal intrinsic enteric-associated neurons (iEANs), operating independently of central neural regulation, autonomously oversee functions such as intestinal motility and secretion.579 A subset of iEANs, characterized by CART+ neurons regulated by the gut microbiota, traverses from the intestines, establishing neural circuits with the liver and pancreas through the sympathetic nervous network.579 Activation of these neurons induces a decrease in insulin levels, a rise in blood glucose, and reduced food intake in mice.579 Microbial changes induced by non-nutritive sweeteners can causally lead to individualized alterations in blood glucose responses.580 GF mice exhibited lowered blood pressure levels, while population analyses of oral and gut microbial profiles indicated substantial correlations with blood pressure.581 The microbial regulation of blood pressure mechanisms has recently undergone comprehensive review.582 It is worth noting that changes in the microbiota that occur at each stage of development, from infancy to adolescence, adulthood, and old age, may show different perturbations. The presence of homeostatic reprogramming phenomena may require the correction of some relevant indicators used to assess an “individual microbial coefficient” due to potential individual variations. For a long time, our understanding of the holistic impact of microbial dysbiosis on human homeostatic equilibrium was limited. In light of this, we propose here a conceptual model (cell-microbe homoecology and co-homeostasis) elucidating why “microbial dysbiosis” influences “cellular homeostasis” (Fig. 6b). Building upon this model, commensal microbiota emerges as a additional regulatory force in maintaining homeostasis, in addition to the well-established roles of the nervous, immune, and metabolic systems. This foundational understanding lays groundwork for the establishment of a model to investigate the transformation between health and disease in the following discussion.Fig. 6 The conceptual model of homeostatic reprogramming mediated by commensal microbes. a The concept of ‘Homeostatic reprogramming’ is used to describe a phenomenon in which the adaptive genome (commensal microbiota) coordinates with the innate genome (human cell/tissues) to deviate the scope and regulation outcome from the original trajectory including body temperature, uric acid levels, glucose level, blood pressure, etc. The interplay between human life stages - from youth to old age - and microbial development - from increasing to decreasing diversity - overall results in different regulatory forces. b The conceptual model of cell-microbe co-ecology and co-homeostasis. Plasma, tissue fluid and lymphatic fluid form the internal environment of the human body’s cell life. This internal environment is regulated by the neural, immune, and metabolic systems to maintain a dynamic homeostasis of physical and chemical properties such as temperature, pH, and osmotic pressure. The internal factors of cell differentiation, proliferation, ageing, damage, and apoptosis can affect this homeostasis. Human tissues are involved in shaping a physico-chemical and nutritional environment where external microorganisms can colonize, replicate, experience loss and die. On the one hand, human cells, and microorganisms in the digestive tract work together to metabolize nutrients from food. Microbes not only affect nutrient absorption, but also produce metabolites, vitamins, and potential “dark matter”, which can enter the internal environment and affect its homeostasis. The imbalance of the internal environment also leads directly to the disruption of the microenvironment they form. The diversity, relative abundance, and products of beneficial, harmful, and neutral microorganisms (composition) are important indicators for assessing the environmental balance. On the other hand, microorganisms also participate in shaping the microenvironment by providing a barrier to respond to external environmental changes. This overall change regulates the susceptibility of the internal environment to external perturbations, acting another regulatory force for homeostasis

Physiological dependence and internal competition, Health and disease

Moderate exposure of the human body to commensal microbiota is essential for maintaining the development and physiological functions of nervous, immune, and metabolic systems. The absence of commensal microbiota poses a potential risk to human health. However, to maintain healthy homeostasis, the body must continually counteract the potential damage caused by the dominant microbiota. While our preceding discourse included examples like Staphylococcus aureus and Candida albicans as conditional pathogens, it is imperative to recognize that, in a rigorous sense, all human microbes exhibit conditional pathogenicity. Essentially, real “mutualism” may not exist.

Controllable microbial community

Excessive proliferation of the microbiota at specific anatomical sites, such as small intestinal bacterial overgrowth (SIBO), can cause symptoms such as nausea, bloating, vomiting and abdominal pain, which may be caused by abnormalities in the structure or motility of the intestinal tract.583 In specific cases, the intervention of antibiotics also indirectly promotes the growth of specific microorganisms. For example, meropenem treatment reduced Clostridiaceae and promoted colonization and expansion of Bacillus polymorphus (BT) in the intestinal mucus layer.584

Intact microbial barrier

An intact barrier function is also a strategy to prevent microbiota translocation and its impact on distant tissues or organs.585 The Microbiota and their components can enter the circulation and cause chronic inflammation, endotoxemia and multiple organ failure to varying degrees.586–588 In mice with TET2 gene deficiency, microbial signals are key drivers of pre-leukemic myeloproliferation (PMP), inducing intestinal barrier dysfunction and systemic inflammation, particularly by increasing the production of interleukin-6 (IL-6).589 This development of PMP can be effectively reversed or prevented through antibiotic treatment and germ-free conditions.589 Additionally, mutations in the CRB1 gene compromise the barrier functions of retinal and colonic epithelial cells, leading to a disruption of critical intercellular junctions.590 Such impairment allows specific gut bacteria to translocate across the intestinal epithelial barrier, enter the bloodstream and eventually reach the retina, where they trigger a localized inflammatory response.590 This activation of immune cells causes retinal cell damage, culminating in retinal degeneration, and emphasizes the importance of an intact intestinal barrier in averting both systemic and localized pathological consequences.590 Other disease conditions, particularly diabetes and obesity, have been also associated with the isolation of bacteria from patients’ adipose tissue.591,592 In addition, the major structure of the outer membrane of gram-negative rods, LPS, has been shown to be involved in the mechanisms of cardiometabolic disease, obesity and insulin resistance, cognitive dysfunction, depression, ageing and many other diseases.593–596

Resist damage from microbial genetic mutations

It is important to note that commensal microbiota exhibit “adaptive” properties to the humans across lifecycle stages. Different strains of microbiota colonizing the same host show different pathogenic characteristics. For example, the Enterococcus gallinarum strain in the intestinal lumen can be controlled by the host immune system, whereas the strain residing in the intestinal mucosal wall niche can translocate to the mesenteric lymph nodes and liver, causing inflammation that may be associated with specific gene mutations, changes in gene expression programs, and even the remodeling of cell wall structures.597 This similar divergent evolutionary pattern was also observed in Lactobacillus reuteri, suggesting that recognition of microbiota pathogenicity should be specific at the strain level.597

Reducing exposure to harmful metabolites

Although the human body can benefit from a variety of microbial products (as discussed above), harmful microbial products can also induce or exacerbate disease. Specifically, dietary substances such as choline, phosphatidylcholine (lecithin) and carnitine can be metabolized by the gut microbiota to trimethylamine (TMA). Physiological concentrations of TMA can damage tight junctions and increase permeability of the blood-brain barrier (BBB).598 TMA is converted to oxidized trimethylamine (TMAO) by flavin-containing monooxygenase 3 (Fmo3) in the liver, which can promote macrophage accumulation in the vascular wall, inhibit cholesterol recycling, increase platelet aggregation activity, activate the endoplasmic reticulum, and activate endoplasmic reticulum stress and cell apoptosis pathways in vascular smooth muscle cells; TMAO is closely associated with the onset and progression of several cardiovascular diseases, including atherosclerosis, heart failure and abdominal aortic aneurysm.599–601 However, research has unveiled the intriguing potential of TMAO to augment the therapeutic efficacy of immunotherapy, particularly for the treatment of triple-negative breast cancer and pancreatic cancer.602,603 These findings underscore the importance of context-specific considerations when assessing the beneficial or deleterious impact of microbial products.602,603 Although GF mice display anxiety-like behaviors (see discusstion in the section on the germ-free syndrome), certain gut bacteria strains, such as Bacteroides ovatus, metabolize dietary tyrosine into p-coumaric acid via the enzyme tyrosine ammonia lyase (encoded by BACOVA_01194).604 The p-coumaric acid is then converted to 4-vinylphenol (4VP) by phenolic acid decarboxylase, and subsequently reduced to 4-ethylphenol (4EP) by vinyl phenol reductase.604 The host’s sulfotransferase SULT1A1 sulfates 4EP to produce 4-ethylphenyl sulfate (4EPS).604 Upon entering the brain, 4EPS induces changes in the activity and functional connectivity of specific brain regions, impairs the maturation of oligodendrocytes and reduces their interaction with neurons, can also leading to the manifestation of anxiety-like behaviors in the mice.604 In female patients with polycystic ovary syndrome, an increase in the gut microbiota Bacteroides vulgatus is associated with the characteristic manifestations of the syndrome, including excessive androgen levels, ovulatory dysfunction, and polycystic ovary morphology.605 On one hand, B. vulgatus, through its metabolic activities—particularly via the action of bile salt hydrolase enzymes—reduces the levels of glycodeoxycholic acid (GDCA) and tauroursodeoxycholic acid (TUDCA) in the gut. These bile acids are potent agonists of the farnesoid X receptor (FXR), and their decrease leads to weakened FXR signaling, which may in turn suppress the production of IL-22, a cytokine crucial for gut barrier and immune function, associated with the development of PCOS.605 On the other hand, agmatine produced by B. vulgatus from dietary arginine through the action of arginine decarboxylase acts as an endogenous agonist of FXR.606 The activation of FXR in intestinal L cells inhibits the expression of the proglucagon gene, which encodes the precursor of glucagon-like peptide-1 (GLP-1), decreased secretion of GLP-1 in response to glucose contributing to insulin resistance in PCOS.607 Similarly, Imidazole propionate (ImP) is a microbial metabolite produced from histidine that may regulate host inflammation to promote insulin resistance and is significantly elevated in the serum of diabetic patients.608,609 Three branched-chain amino acids (BCAAs), leucine, isoleucine and valine, synthesized by Prevotella copri and Bacteroides vulgatus, also increase the risk of diabetes.610 porA and fldH genes of the gut microbiota mediate the conversion of dietary phenylalanine to phenylacetic acid and phenylpropionic acid, respectively.611 The former can be synthesized into phenylacetylglutamine (PAGln), which enhances platelet activation and thrombogenic potential.611 In addition to metabolic molecules, microbial peptides can disrupt the body. For example, E. coli secretes ClpB, a melanocyte-stimulating hormone (α-MSH) analogue that can cause anxiety, anorexia and eating disorders.612 Similarly, the genus Bacteroides produces a myosin heavy chain 6 (MYH6) mimetic peptide, β-galactosidase, which can induce T-cell attack on the heart, causing fatal inflammatory cardiomyopathy.613 Recent research has identified several novel enzymes in the gut microbiota that have similar functions to those found in the host (Microbial-host-isozyme).614 Among these, the bacterial isoenzyme of the key diabetes target, dipeptidyl peptidase-4 (DPP4), can reduce the activity of endogenous GLP-1 in a mouse model of impaired intestinal barrier function which negatively affects glucose homeostasis.614 Notably, microorganisms can secrete exopolysaccharides (EPS) that cloak the LPS on their surface, which are typically recognized by the human immune system.615 By doing so, they diminish the activation of the hypothalamic acute stress response mediated by TLR4-TRPV1+ sensory neurons in the lungs, effectively sidestepping the body’s defense mechanisms against infection.615

In summary, in the long-term co-evolution with microbes, both humans and microbes have developed various adaptive mechanisms that influence each other. Understanding human dependence and internal competition with commensal microbes is key to understanding the transition between health and disease, homeostasis and dysregulation (Fig. 7). It is known that co-inhabitants can share 12% gut and 32% oral microbiota strains, so as a special point, certain non-communicable diseases such as cardiovascular diseases, diabetes, and inflammatory bowel diseases maybe predicted transmitted within human communities via human microbiota as intermediaries, becoming atypical infectious diseases.616,617 This gives rise to another concept: the social microbiome, which encapsulates the intricate interplay of microbial communities across a host’s social fabric, shaping the landscape of health and disease.618Fig. 7 The model of the interplay between the human innate and adaptive genome in health and disease transformation. The human innate and adaptive genomes form a holistic functional phenotype but are also in constant competition. The regulation of the nervous, immune, metabolic, and commensal microbiota constitutes the four major features and regulatory forces of human health and disease states. These forces interact with each other, and microbial dysbiosis can lead to the disruption of other forces and vice versa. The innate genome requires (a) the necessary exposure to commensal microbiota and a controllable microbial community, (b) an intact microbial barrier, (c) the ability to resist damage from microbial genetic mutations, and (d) the ability to utilize beneficial products of the adaptive genome and metabolize harmful ones to maintain a healthy steady state (with the innate genome in the dominant position). Conversely, (e) inadequate exposure to appropriate microbiota (which can lead to germ-free syndrome in extreme cases) or microbial overgrowth, (f) microbes or their components (e.g. LPS) entering the circulation through an incomplete barrier and causing harm to other tissues and organs, (g) microbial genetic mutations causing additional damage, and (h) a decrease in beneficial microbial products and an increase in harmful ones can lead humans towards disease progression (with the adaptive genome dominant). LPS Lipopolysaccharides, TMA Trimethylamine, TMAO Trimethylamine N-oxide, PAGln Phenylacetylglutamine, ClpB a melanocyte-stimulating hormone (α-MSH) analogue, BCAAs Branched-chain amino acids, SCFAs Short-chain fatty acids, RKH Arginyl-lysyl-histidine

Conclusion

The fusion of human sperm and egg creates our innate genome, while the microbiome, with its random and non-heritable nature, evolves as an adaptive genome. This adaptive genome is dynamic and personalized, constantly adapting to our physiology, pathology, environment, diet and microbial interactions. The innate genome and adaptive microbiomes are intertwined, resulting in the reprogramming of the organism’s homeostasis. Loss of interaction with the adaptive genome is likely to result in germ-free syndromes (hypotheses based on germ-free animals). From a histological perspective, the human microbiota can be viewed as ‘slave tissues’ managed by the epithelial, connective, muscular and nervous tissues that have evolved from the inherent genome. The incorporation of slave tissue allows for an extension of the body’s immune capabilities, providing an additional form of defence and immune modulation. When interacting with the external environment, understanding the host and its microbiome as a unified entity, or ‘meta-host’, may partially explain the heterogeneity in disease susceptibility, pathogenicity, severity and varying success rates of organ transplantation. When examining the internal relationship between the human body and its microbiota, it’s understood that human tissues reap the potential benefits provided by the microbiome, while at the same time using various mechanisms to regulate and minimize the potential harms or costs associated with it. The homeostasis and dysbiosis of microorganisms with the human neural, metabolic and immune systems are the causal driving force behind health and disease outcomes.

Within the theoretical framework discussed above and diagrammatically presented in Fig. 8, the “germ-free syndrome” highlights the need to shift from the traditional view of “microbes as pathogens” to the understanding that “a lack of microbes can also be detrimental to health”. The “Innate and adaptive genome” improves our understanding at the genetic and evolutionary level of the complete human genome, detailing the essential characteristics of the adaptive genome. The concept of “slave tissue” integrates ecological and human tissue perspectives, illustrating the intricate relationship between multicellular organisms and their associated microbiome. It elucidates how human master tissues can both reap benefits and endure adversities due to the presence of microbes. This concept redirects focus towards the alterations in ‘slave tissue’ as the disease progresses, emphasizing the dynamic interplay between host and microbe in health and disease. The “Acquired microbial immunity” unifies the roles of colonization resistance and immune regulation, considering the microbiome as a source of supplementary power to human defences. This concept provides a theoretical foundation for combating antibiotic misuse and for utilizing microecological therapies in the treatment of allergic and inflammatory diseases. The “Homeostasis reprogramming hypothesis” complements the foundations of modern medicine, represented by the “internal environment theory”, by bridging the conceptual gap left by the neglect of the microbiome’s role. This may in part explain the trend observed since the industrialization of a decline in some of the body’s homeostatic indicators, such as basal body temperature and changes in blood glucose levels, in association with the body’s microbial diversity. The “Cell-microbe co-ecology model” demonstrate the close association between “microbial regulation” and “cell homeostasis,” offering a necessary understanding of why microbial dysregulation can impact homeostatic balance in humans. The “meta-host model” extends the definition of host. It suggests that symbiotic microorganisms act as co-hosts within the human ecological environment. The “Health-illness conversion model” elucidates the dual relationship between the innate and adaptive genomes as a whole and their internal competition. It summarizes four patterns of microbial dysregulation within the human body.Fig. 8 A systematic framework for understanding human microbes and the history of the development of some of these concepts. The systematic framework consists of eight fundamental concepts/models: “innate genome and adaptive genome”, “slave tissue”, “acquired microbial immunity”, “cell-microbe co-ecology and co-homeostasis model”, “meta-host model”, “health and illness transformation model” and “germ-free syndrome”

Future perspectives

The recent release of the global burden report highlights the daunting challenges we face in various public health crises, including obesity and malnutrition,619 cardiovascular diseases,620 gastrointestinal disorders,621 diabetes,622 antimicrobial resistance197 and cancers.623 The outbreak of the novel coronavirus has further compelled us to reflect on how we can enhance our prevention and treatment strategies for potential future infectious disease outbreaks.624 Microbiome, as the human adative genome, present a promising avenue for potential breakthroughs in this regard. Although progress has been made, the secrets of the relationship between humans and microbes have not been fully unlocked. More research is needed in the future to glimpse what lies beneath the tip of the iceberg. Some of the directions include but are not limited to the following:

Protecting the diversity of human and environmental microbiomes,625 avoiding the gradual loss of adaptive genomic elements, and establishing and maintaining microbiome banks are possible strategies that depend on interdisciplinary and international collaborations. These proactive measures have the potential to provide substantial benefits to diverse organisms, including augmented crop yields and bolstered resilience of plants in the face of climate change626,627 and shows potential in protecting endangered animal species.628

Further deciphering the interaction mechanisms between the microbiota and other organs and tissues is essential. Currently, microbiota research on the following:

The effects of other tissue developmental stages are insufficient;

Viruses,496,629–636 fungi,637,638 archaea639–642 have received less attention than bacteria;

Non-gut microbiomes are understudied;

Communication mechanisms between microbiomes from different body sites, such as interaction between the gut and the lung/skin/oral, are not well understood;

Tumor tissues disrupt body homeostasis, allowing microbes to colonize the tumor environment through damaged tissues and bloodstream.643–645 These microbes promote tumor development by inducing mutations, affecting gene regulation, promoting inflammation, evading the immune system, and enhancing metastasis.646 Their interaction offers an additional opportunity for targeted cancer interventions;647

Specific populations, such as rare disease patients, surgical patients, and transplant recipients, have not been well considered.

The causal relationship between microbes and diseases is still not well revealed.

The clinical applications of microbiomes mainly include diseases diagnosis (biomarkers), classification (severity), treatment (gene editing), and prognosis assessment.

Adaptive genomic elements and their effects on diet and drug responses must not be overlooked, as they have significant impacts on human physiology and therapy. Further characterization is required.

The utilization of “acquired microbial immunity” could offer additional therapeutic options for allergies, autoimmune diseases, and enteric infections, but potential risks should be carefully assessed with consideration of host conditions.

Standardized clinical guidelines are prerequisites for clinical translation. “Microbial clinical specialists” and “microbial clinical department” are potential forms for future implementation.

The field of microbiome engineering is advancing with precision and complexity, employing a range of genetic strategies to manipulate the microbial ecosystem for therapeutic benefit.648 Engineered bacteria, such as E. coli Nissle 1917 strain, SYNB1020, effectively converts ammonia in the gut to L-arginine, ameliorating hyperammonemia and boosting survival rates in mice.649 By meticulously tuning key elements of gene expression, researchers have successfully achieved efficient biosynthesis of important compounds such as β-carotene and violacein in Saccharomyces boulardii.650 In an innovative approach to addressing C. difficile infections, researchers have developed a recombinant bacteriophage that expresses CRISPR RNAs to guide the native Cas3 protein in targeting and degrading the pathogen’s chromosomal DNA, leading to the bacterial destruction.651 Programmable exogenous phage-delivered CRISPR/Cas9 delivery demonstrates the feasibility of strain-specific gene knockout and chromosomal deletion in complex microbial communities.652 For example, utilizing engineered M13 bacteriophages as vectors to specifically deliver the CRISPR-Cas9 system to E. coli within the mouse gut, enabling precise genetic editing at targeted loci despite the need to address challenges such as low bacteriophage viability and bacterial evasion of editing.652 Additionally, synthetic genetic elements developed through computational design enable the re-engineering of biosynthetic gene clusters for expression in various hosts.653 The innovative concept of microbial swarmbots encapsulates the synergy of multiple engineered microbes within microcapsules, working collectively to perform high-throughput functions.654

In the realm of microbiome research, equity is a critical issue.655 Studies from developing or impoverished nations are significantly disadvantaged and underrepresented compared to those from developed countries. In this regard, international professional associations, relevant governmental and societal research funding bodies, and academic journals should consider policy inclinations towards regions or research that are underrepresented. In areas or countries where it is challenging to organize large-scale population studies, the success of citizen science methods adopted by Belgium118 and the recent proposal of the African Equitable Scheme by Ovokeraye H. Oduaran and colleagues are worthy of emulation.656

We are presently on the trajectory of comprehending natural phenomena, deciphering intricate mechanisms, and harnessing the potential of microbes to optimize human health. In the end, if it is truly possible for humans to colonize other planets, focusing merely on our innate genome while ignoring our adaptive genome could lead to wider health issues. Consequently, in all conceivable scenarios, contemplating an interplanetary microbiome initiative becomes an inevitable necessity.

Acknowledgements

The authors highly appreciate the research community worldwide conducting microbial-related research that underpins the presented framework. We apologize for not being able to cite all relevant studies due to knowledge and space limitations. We thank the reviewers for their valuable and constructive suggestions in refining our work. We also extend our gratitude to potential readers for taking their valuable time to read our work. This work is funded by the German Research Foundation (Deutsche Forschungsgemeinschaft) (Grant No. RA 2717/4-1 and FR 1289/17-1). ZM received funding from the China Scholarship Council (Grant No. 202208060183) and the German Centre for Cardiovascular Research (DZHK) training program. For the publication fee, we acknowledge financial support by Heidelberg University. All the figures were created with Biorender.com.

Author contributions

Z.M. and A.R. conceived and presented the ideas. A.R. coordinated discussions among Z.M., T.Z., and N.F. to refine the concepts and models. Z.M. performed the literature search, wrote the manuscript and created the original figures. T.Z., N.F. and A.R provided feedback and made revisions to the manuscript. N.F. and A.R. provided financial support. All authors have reviewed and approved the article.

Funding

Open Access funding enabled and organized by Projekt DEAL.

Competing interests

The authors declare no competing interests.
==== Refs
References

1. Nurk S The complete sequence of a human genome Science 2022 376 44 53 10.1126/science.abj6987 35357919
Nurk, S. et al. The complete sequence of a human genome. Science 376, 44–53 (2022).35357919
2. Vollger MR Segmental duplications and their variation in a complete human genome Science 2022 376 eabj6965 10.1126/science.abj6965 35357917
Vollger, M. R. et al. Segmental duplications and their variation in a complete human genome. Science 376, eabj6965 (2022).35357917
3. Hoyt SJ From telomere to telomere: the transcriptional and epigenetic state of human repeat elements Science 2022 376 eabk3112 10.1126/science.abk3112 35357925
Hoyt, S. J. et al. From telomere to telomere: the transcriptional and epigenetic state of human repeat elements. Science 376, eabk3112 (2022).35357925
4. Gershman A Epigenetic patterns in a complete human genome Science 2022 376 eabj5089 10.1126/science.abj5089 35357915
Gershman, A. et al. Epigenetic patterns in a complete human genome. Science 376, eabj5089 (2022).35357915
5. Altemose N Complete genomic and epigenetic maps of human centromeres Science 2022 376 eabl4178 10.1126/science.abl4178 35357911
Altemose, N. et al. Complete genomic and epigenetic maps of human centromeres. Science 376, eabl4178 (2022).35357911
6. Aganezov S A complete reference genome improves analysis of human genetic variation Science 2022 376 eabl3533 10.1126/science.abl3533 35357935
Aganezov, S. et al. A complete reference genome improves analysis of human genetic variation. Science 376, eabl3533 (2022).35357935
7. Liao W-W A draft human pangenome reference Nature 2023 617 312 324 10.1038/s41586-023-05896-x 37165242
Liao, W.-W. et al. A draft human pangenome reference. Nature 617, 312–324 (2023).37165242
8. Gao, Y. et al. A pangenome reference of 36 Chinese populations. Nature 619, 112–121 (2023).
9. Wang T The Human Pangenome Project: a global resource to map genomic diversity Nature 2022 604 437 446 10.1038/s41586-022-04601-8 35444317
Wang, T. et al. The Human Pangenome Project: a global resource to map genomic diversity. Nature 604, 437–446 (2022).35444317
10. Huang T Shu Y Cai Y-D Genetic differences among ethnic groups BMC Genomics 2015 16 1093 10.1186/s12864-015-2328-0 26690364
Huang, T., Shu, Y. & Cai, Y.-D. Genetic differences among ethnic groups. BMC Genomics 16, 1093 (2015).26690364
11. Gest H The discovery of microorganisms by Robert Hooke and Antoni van Leeuwenhoek, Fellows of The Royal Society Notes Rec. R. Soc. Lond. 2004 58 187 201 10.1098/rsnr.2004.0055 15209075
Gest, H. The discovery of microorganisms by Robert Hooke and Antoni van Leeuwenhoek, Fellows of The Royal Society. Notes Rec. R. Soc. Lond. 58, 187–201 (2004).15209075
12. The Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project Nature 2019 569 641 648 10.1038/s41586-019-1238-8 31142853
The Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project. Nature 569, 641–648 (2019).31142853
13. Lloyd-Price J Strains, functions and dynamics in the expanded Human Microbiome Project Nature 2017 550 61 66 10.1038/nature23889 28953883
Lloyd-Price, J. et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature 550, 61–66 (2017).28953883
14. Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project: dynamic analysis of microbiome-host omics profiles during periods of human health and disease. Cell Host Microbe 16, 276–289 (2014).
15. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome Nature 2012 486 207 214 10.1038/nature11234 22699609
The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012).22699609
16. MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing Nature 2010 464 59 65 10.1038/nature08821 20203603
MetaHIT Consortium. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).20203603
17. Le Chatelier E Richness of human gut microbiome correlates with metabolic markers Nature 2013 500 541 546 10.1038/nature12506 23985870
Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541–546 (2013).23985870
18. MetaHIT Consortium. An integrated catalog of reference genes in the human gut microbiome Nat. Biotechnol. 2014 32 834 841 10.1038/nbt.2942 24997786
MetaHIT Consortium. et al. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834–841 (2014).24997786
19. MetaHIT Consortium (additional members). et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
20. MetaHIT consortium. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota Nature 2015 528 262 266 10.1038/nature15766 26633628
MetaHIT consortium. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262–266 (2015).26633628
21. McDonald D American gut: an open platform for citizen science microbiome research mSystems 2018 3 e00031 18 10.1128/mSystems.00031-18 29795809
McDonald, D. et al. American gut: an open platform for citizen science microbiome research. mSystems 3, e00031–18 (2018).29795809
22. Lopera-Maya EA Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project Nat. Genet. 2022 54 143 151 10.1038/s41588-021-00992-y 35115690
Lopera-Maya, E. A. et al. Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project. Nat. Genet. 54, 143–151 (2022).35115690
23. López-Otín C Kroemer G Hallmarks of Health Cell 2021 184 33 63 10.1016/j.cell.2020.11.034 33340459
López-Otín, C. & Kroemer, G. Hallmarks of Health. Cell 184, 33–63 (2021).33340459
24. Schmauck-Medina T New hallmarks of ageing: a 2022 Copenhagen ageing meeting summary Aging 2022 14 6829 6839 10.18632/aging.204248 36040386
Schmauck-Medina, T. et al. New hallmarks of ageing: a 2022 Copenhagen ageing meeting summary. Aging 14, 6829–6839 (2022).36040386
25. López-Otín C Blasco MA Partridge L Serrano M Kroemer G Hallmarks of aging: an expanding universe Cell 2023 186 243 278 10.1016/j.cell.2022.11.001 36599349
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243–278 (2023).36599349
26. Nicholson JK Host-gut microbiota metabolic interactions Science 2012 336 1262 1267 10.1126/science.1223813 22674330
Nicholson, J. K. et al. Host-gut microbiota metabolic interactions. Science 336, 1262–1267 (2012).22674330
27. Cho I Blaser MJ The human microbiome: at the interface of health and disease Nat. Rev. Genet. 2012 13 260 270 10.1038/nrg3182 22411464
Cho, I. & Blaser, M. J. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13, 260–270 (2012).22411464
28. Gilbert JA Current understanding of the human microbiome Nat. Med. 2018 24 392 400 10.1038/nm.4517 29634682
Gilbert, J. A. et al. Current understanding of the human microbiome. Nat. Med. 24, 392–400 (2018).29634682
29. Rackaityte E Lynch SV The human microbiome in the 21st century Nat. Commun. 2020 11 5256 10.1038/s41467-020-18983-8 33067429
Rackaityte, E. & Lynch, S. V. The human microbiome in the 21st century. Nat. Commun. 11, 5256 (2020).33067429
30. Cani PD Human gut microbiome: hopes, threats and promises Gut 2018 67 1716 1725 10.1136/gutjnl-2018-316723 29934437
Cani, P. D. Human gut microbiome: hopes, threats and promises. Gut 67, 1716–1725 (2018).29934437
31. de Vos WM Tilg H Van Hul M Cani PD Gut microbiome and health: mechanistic insights Gut 2022 71 1020 1032 10.1136/gutjnl-2021-326789 35105664
de Vos, W. M., Tilg, H., Van Hul, M. & Cani, P. D. Gut microbiome and health: mechanistic insights. Gut 71, 1020–1032 (2022).35105664
32. Clemente JC Ursell LK Parfrey LW Knight R The impact of the gut microbiota on human health: an integrative view Cell 2012 148 1258 1270 10.1016/j.cell.2012.01.035 22424233
Clemente, J. C., Ursell, L. K., Parfrey, L. W. & Knight, R. The impact of the gut microbiota on human health: an integrative view. Cell 148, 1258–1270 (2012).22424233
33. Brodin P Immune-microbe interactions early in life: a determinant of health and disease long term Science 2022 376 945 950 10.1126/science.abk2189 35617387
Brodin, P. Immune-microbe interactions early in life: a determinant of health and disease long term. Science 376, 945–950 (2022).35617387
34. McFall-Ngai M Animals in a bacterial world, a new imperative for the life sciences Proc. Natl Acad. Sci. 2013 110 3229 3236 10.1073/pnas.1218525110 23391737
McFall-Ngai, M. et al. Animals in a bacterial world, a new imperative for the life sciences. Proc. Natl Acad. Sci. 110, 3229–3236 (2013).23391737
35. Valdes, A. M., Walter, J., Segal, E. & Spector, T. D. Role of the gut microbiota in nutrition and health. BMJ 361, k2179 (2018).
36. Lynch SV Pedersen O The human intestinal microbiome in health and disease N. Engl. J. Med. 2016 375 2369 2379 10.1056/NEJMra1600266 27974040
Lynch, S. V. & Pedersen, O. The human intestinal microbiome in health and disease. N. Engl. J. Med. 375, 2369–2379 (2016).27974040
37. Martino C Microbiota succession throughout life from the cradle to the grave Nat. Rev. Microbiol. 2022 20 707 720 10.1038/s41579-022-00768-z 35906422
Martino, C. et al. Microbiota succession throughout life from the cradle to the grave. Nat. Rev. Microbiol. 20, 707–720 (2022).35906422
38. Gilbert JA Microbiome-wide association studies link dynamic microbial consortia to disease Nature 2016 535 94 103 10.1038/nature18850 27383984
Gilbert, J. A. et al. Microbiome-wide association studies link dynamic microbial consortia to disease. Nature 535, 94–103 (2016).27383984
39. Ayres JS Cooperative microbial tolerance behaviors in host-microbiota mutualism Cell 2016 165 1323 1331 10.1016/j.cell.2016.05.049 27259146
Ayres, J. S. Cooperative microbial tolerance behaviors in host-microbiota mutualism. Cell 165, 1323–1331 (2016).27259146
40. Clemente JC Manasson J Scher JU The role of the gut microbiome in systemic inflammatory disease BMJ 2018 360 j5145 10.1136/bmj.j5145 29311119
Clemente, J. C., Manasson, J. & Scher, J. U. The role of the gut microbiome in systemic inflammatory disease. BMJ 360, j5145 (2018).29311119
41. Lee J-Y Tsolis RM Bäumler AJ The microbiome and gut homeostasis Science 2022 377 eabp9960 10.1126/science.abp9960 35771903
Lee, J.-Y., Tsolis, R. M. & Bäumler, A. J. The microbiome and gut homeostasis. Science 377, eabp9960 (2022).35771903
42. Schmidt TSB Raes J Bork P The human gut microbiome: from association to modulation Cell 2018 172 1198 1215 10.1016/j.cell.2018.02.044 29522742
Schmidt, T. S. B., Raes, J. & Bork, P. The human gut microbiome: from association to modulation. Cell 172, 1198–1215 (2018).29522742
43. Bäckhed F Ley RE Sonnenburg JL Peterson DA Gordon JI Host-bacterial mutualism in the human intestine Science 2005 307 1915 1920 10.1126/science.1104816 15790844
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. & Gordon, J. I. Host-bacterial mutualism in the human intestine. Science 307, 1915–1920 (2005).15790844
44. Bordenstein SR Theis KR Host biology in light of the microbiome: ten principles of holobionts and hologenomes PLoS Biol. 2015 13 e1002226 10.1371/journal.pbio.1002226 26284777
Bordenstein, S. R. & Theis, K. R. Host biology in light of the microbiome: ten principles of holobionts and hologenomes. PLoS Biol. 13, e1002226 (2015).26284777
45. The Superorganism. in Biophilia 23–38 (Harvard University Press, 1984). 10.4159/9780674045231-003.
46. Bell G Model metaorganism Science 1998 282 248 248 10.1126/science.282.5387.248
Bell, G. Model metaorganism. Science 282, 248–248 (1998).
47. Theis KR Getting the hologenome concept right: an eco-evolutionary framework for hosts and their microbiomes mSystems 2016 1 e00028 16 10.1128/mSystems.00028-16 27822520
Theis, K. R. et al. Getting the hologenome concept right: an eco-evolutionary framework for hosts and their microbiomes. mSystems 1, e00028–16 (2016).27822520
48. Brown JM Hazen SL The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases Annu. Rev. Med. 2015 66 343 359 10.1146/annurev-med-060513-093205 25587655
Brown, J. M. & Hazen, S. L. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu. Rev. Med. 66, 343–359 (2015).25587655
49. Bach J-F The hygiene hypothesis in autoimmunity: the role of pathogens and commensals Nat. Rev. Immunol. 2018 18 105 120 10.1038/nri.2017.111 29034905
Bach, J.-F. The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat. Rev. Immunol. 18, 105–120 (2018).29034905
50. Rook GAW A Darwinian View of the Hygiene or “Old Friends” Hypothesis: When urban living reduced contacts of humans with microbes and worms, it increased our risk for chronic inflammatory disorders Microbe Mag. 2012 7 173 180
Rook, G. A. W. A Darwinian View of the Hygiene or “Old Friends” Hypothesis: When urban living reduced contacts of humans with microbes and worms, it increased our risk for chronic inflammatory disorders. Microbe Mag. 7, 173–180 (2012).
51. Noverr MC Huffnagle GB The ‘microflora hypothesis’ of allergic diseases Clin. Exp. Allergy 2005 35 1511 1520 10.1111/j.1365-2222.2005.02379.x 16393316
Noverr, M. C. & Huffnagle, G. B. The ‘microflora hypothesis’ of allergic diseases. Clin. Exp. Allergy 35, 1511–1520 (2005).16393316
52. Quagliariello A Ancient oral microbiomes support gradual Neolithic dietary shifts towards agriculture Nat. Commun. 2022 13 6927 10.1038/s41467-022-34416-0 36414613
Quagliariello, A. et al. Ancient oral microbiomes support gradual Neolithic dietary shifts towards agriculture. Nat. Commun. 13, 6927 (2022).36414613
53. Suzuki TA Codiversification of gut microbiota with humans Science 2022 377 1328 1332 10.1126/science.abm7759 36108023
Suzuki, T. A. et al. Codiversification of gut microbiota with humans. Science 377, 1328–1332 (2022).36108023
54. Moeller AH Cospeciation of gut microbiota with hominids Science 2016 353 380 382 10.1126/science.aaf3951 27463672
Moeller, A. H. et al. Cospeciation of gut microbiota with hominids. Science 353, 380–382 (2016).27463672
55. Rook G Bäckhed F Levin BR McFall-Ngai MJ McLean AR Evolution, human-microbe interactions, and life history plasticity Lancet 2017 390 521 530 10.1016/S0140-6736(17)30566-4 28792414
Rook, G., Bäckhed, F., Levin, B. R., McFall-Ngai, M. J. & McLean, A. R. Evolution, human-microbe interactions, and life history plasticity. Lancet 390, 521–530 (2017).28792414
56. Sharp C Foster KR Host control and the evolution of cooperation in host microbiomes Nat. Commun. 2022 13 3567 10.1038/s41467-022-30971-8 35732630
Sharp, C. & Foster, K. R. Host control and the evolution of cooperation in host microbiomes. Nat. Commun. 13, 3567 (2022).35732630
57. Hector TE Hoang KL Li J King KC Symbiosis and host responses to heating Trends Ecol. Evol. 2022 37 611 624 10.1016/j.tree.2022.03.011 35491290
Hector, T. E., Hoang, K. L., Li, J. & King, K. C. Symbiosis and host responses to heating. Trends Ecol. Evol. 37, 611–624 (2022).35491290
58. Frazão N Two modes of evolution shape bacterial strain diversity in the mammalian gut for thousands of generations Nat. Commun. 2022 13 5604 10.1038/s41467-022-33412-8 36153389
Frazão, N. et al. Two modes of evolution shape bacterial strain diversity in the mammalian gut for thousands of generations. Nat. Commun. 13, 5604 (2022).36153389
59. Ley RE Evolution of mammals and their gut microbes Science 2008 320 1647 1651 10.1126/science.1155725 18497261
Ley, R. E. et al. Evolution of mammals and their gut microbes. Science 320, 1647–1651 (2008).18497261
60. Davenport ER The human microbiome in evolution BMC Biol. 2017 15 127 10.1186/s12915-017-0454-7 29282061
Davenport, E. R. et al. The human microbiome in evolution. BMC Biol. 15, 127 (2017).29282061
61. Barreto, H. C. & Gordo, I. Intrahost evolution of the gut microbiota. Nat. Rev. Microbiol. 21, 590–603 (2023).
62. The NIH HMP Working Group. The NIH Human Microbiome Project Genome Res. 2009 19 2317 2323 10.1101/gr.096651.109 19819907
The NIH HMP Working Group. et al. The NIH Human Microbiome Project. Genome Res. 19, 2317–2323 (2009).19819907
63. Koren O Human oral, gut, and plaque microbiota in patients with atherosclerosis Proc. Natl Acad. Sci. 2011 108 4592 4598 10.1073/pnas.1011383107 20937873
Koren, O. et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc. Natl Acad. Sci. 108, 4592–4598 (2011).20937873
64. Clifford A Hoffman GS Evidence for a vascular microbiome and its role in vessel health and disease Curr. Opin. Rheumatol. 2015 27 397 405 10.1097/BOR.0000000000000184 26002032
Clifford, A. & Hoffman, G. S. Evidence for a vascular microbiome and its role in vessel health and disease. Curr. Opin. Rheumatol. 27, 397–405 (2015).26002032
65. Hidi L Human blood vessel microbiota in healthy adults based on common femoral arteries of brain-dead multi-organ donors Front. Cell. Infect. Microbiol. 2022 12 1056319 10.3389/fcimb.2022.1056319 36530429
Hidi, L. et al. Human blood vessel microbiota in healthy adults based on common femoral arteries of brain-dead multi-organ donors. Front. Cell. Infect. Microbiol. 12, 1056319 (2022).36530429
66. Tan CCS No evidence for a common blood microbiome based on a population study of 9770 healthy humans Nat. Microbiol. 2023 8 973 985 10.1038/s41564-023-01350-w 36997797
Tan, C. C. S. et al. No evidence for a common blood microbiome based on a population study of 9770 healthy humans. Nat. Microbiol. 8, 973–985 (2023).36997797
67. Lu LJ Liu J Human microbiota and ophthalmic disease Yale J. Biol. Med. 2016 89 325 330 27698616
Lu, L. J. & Liu, J. Human microbiota and ophthalmic disease. Yale J. Biol. Med. 89, 325–330 (2016).27698616
68. Ozkan J Biogeography of the human ocular microbiota Ocul. Surf. 2019 17 111 118 10.1016/j.jtos.2018.11.005 30445178
Ozkan, J. et al. Biogeography of the human ocular microbiota. Ocul. Surf. 17, 111–118 (2019).30445178
69. Lyon J Even the eye has a microbiome JAMA 2017 318 689 28829858
Lyon, J. Even the eye has a microbiome. JAMA 318, 689 (2017).28829858
70. St. Leger AJ An ocular commensal protects against corneal infection by driving an interleukin-17 response from mucosal γδ t cells Immunity 2017 47 148 158.e5 10.1016/j.immuni.2017.06.014 28709803
St. Leger, A. J. et al. An ocular commensal protects against corneal infection by driving an interleukin-17 response from mucosal γδ t cells. Immunity 47, 148–158.e5 (2017).28709803
71. Castellani G Croese T Peralta Ramos JM Schwartz M Transforming the understanding of brain immunity Science 2023 380 eabo7649 10.1126/science.abo7649 37023203
Castellani, G., Croese, T., Peralta Ramos, J. M. & Schwartz, M. Transforming the understanding of brain immunity. Science 380, eabo7649 (2023).37023203
72. Servick, K. Do gut bacteria make a second home in our brains? Science10.1126/science.aaw0147 (2018).
73. Link CD Is there a brain microbiome? Neurosci. Insights 2021 16 263310552110187 10.1177/26331055211018709
Link, C. D. Is there a brain microbiome? Neurosci. Insights 16, 263310552110187 (2021).
74. Molinero N The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile Microbiome 2019 7 100 10.1186/s40168-019-0712-8 31272480
Molinero, N. et al. The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile. Microbiome 7, 100 (2019).31272480
75. Urbaniak C Microbiota of human breast tissue Appl. Environ. Microbiol. 2014 80 3007 3014 10.1128/AEM.00242-14 24610844
Urbaniak, C. et al. Microbiota of human breast tissue. Appl. Environ. Microbiol. 80, 3007–3014 (2014).24610844
76. De Goffau MC Human placenta has no microbiome but can contain potential pathogens Nature 2019 572 329 334 10.1038/s41586-019-1451-5 31367035
De Goffau, M. C. et al. Human placenta has no microbiome but can contain potential pathogens. Nature 572, 329–334 (2019).31367035
77. Younge N Fetal exposure to the maternal microbiota in humans and mice JCI Insight 2019 4 e127806 10.1172/jci.insight.127806 31479427
Younge, N. et al. Fetal exposure to the maternal microbiota in humans and mice. JCI Insight 4, e127806 (2019).31479427
78. Hornef M Penders J Does a prenatal bacterial microbiota exist? Mucosal Immunol. 2017 10 598 601 10.1038/mi.2016.141 28120852
Hornef, M. & Penders, J. Does a prenatal bacterial microbiota exist? Mucosal Immunol. 10, 598–601 (2017).28120852
79. Mishra A Microbial exposure during early human development primes fetal immune cells Cell 2021 184 3394 3409.e20 10.1016/j.cell.2021.04.039 34077752
Mishra, A. et al. Microbial exposure during early human development primes fetal immune cells. Cell 184, 3394–3409.e20 (2021).34077752
80. Perez-Muñoz ME Arrieta M-C Ramer-Tait AE Walter J A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome Microbiome 2017 5 48 10.1186/s40168-017-0268-4 28454555
Perez-Muñoz, M. E., Arrieta, M.-C., Ramer-Tait, A. E. & Walter, J. A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: implications for research on the pioneer infant microbiome. Microbiome 5, 48 (2017).28454555
81. Kennedy KM Fetal meconium does not have a detectable microbiota before birth Nat. Microbiol. 2021 6 865 873 10.1038/s41564-021-00904-0 33972766
Kennedy, K. M. et al. Fetal meconium does not have a detectable microbiota before birth. Nat. Microbiol. 6, 865–873 (2021).33972766
82. Kennedy KM Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies Nature 2023 613 639 649 10.1038/s41586-022-05546-8 36697862
Kennedy, K. M. et al. Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. Nature 613, 639–649 (2023).36697862
83. Dominguez-Bello MG Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns Proc. Natl Acad. Sci. 2010 107 11971 11975 10.1073/pnas.1002601107 20566857
Dominguez-Bello, M. G. et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci. 107, 11971–11975 (2010).20566857
84. Faith JJ The long-term stability of the human gut microbiota Science 2013 341 1237439 10.1126/science.1237439 23828941
Faith, J. J. et al. The long-term stability of the human gut microbiota. Science 341, 1237439 (2013).23828941
85. Liang G Bushman FD The human virome: assembly, composition and host interactions Nat. Rev. Microbiol. 2021 19 514 527 10.1038/s41579-021-00536-5 33785903
Liang, G. & Bushman, F. D. The human virome: assembly, composition and host interactions. Nat. Rev. Microbiol. 19, 514–527 (2021).33785903
86. McCallum G Tropini C The gut microbiota and its biogeography Nat. Rev. Microbiol. 2024 22 105 118 10.1038/s41579-023-00969-0 37740073
McCallum, G. & Tropini, C. The gut microbiota and its biogeography. Nat. Rev. Microbiol. 22, 105–118 (2024).37740073
87. Yassour, M. et al. Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability. Sci. Transl. Med. 8 (2016).
88. Odamaki T Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study BMC Microbiol. 2016 16 90 10.1186/s12866-016-0708-5 27220822
Odamaki, T. et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 16, 90 (2016).27220822
89. Folz J Human metabolome variation along the upper intestinal tract Nat. Metab. 2023 5 777 788 10.1038/s42255-023-00777-z 37165176
Folz, J. et al. Human metabolome variation along the upper intestinal tract. Nat. Metab. 5, 777–788 (2023).37165176
90. Shalon D Profiling the human intestinal environment under physiological conditions Nature 2023 617 581 591 10.1038/s41586-023-05989-7 37165188
Shalon, D. et al. Profiling the human intestinal environment under physiological conditions. Nature 617, 581–591 (2023).37165188
91. She J-J Defining the biogeographical map and potential bacterial translocation of microbiome in human ‘surface organs’ Nat. Commun. 2024 15 427 10.1038/s41467-024-44720-6 38199995
She, J.-J. et al. Defining the biogeographical map and potential bacterial translocation of microbiome in human ‘surface organs’. Nat. Commun. 15, 427 (2024).38199995
92. Mason MR Chambers S Dabdoub SM Thikkurissy S Kumar PS Characterizing oral microbial communities across dentition states and colonization niches Microbiome 2018 6 67 10.1186/s40168-018-0443-2 29631628
Mason, M. R., Chambers, S., Dabdoub, S. M., Thikkurissy, S. & Kumar, P. S. Characterizing oral microbial communities across dentition states and colonization niches. Microbiome 6, 67 (2018).29631628
93. Sampaio-Maia B Monteiro-Silva F Acquisition and maturation of oral microbiome throughout childhood: an update Dent. Res. J. 2014 11 291 301
Sampaio-Maia, B. & Monteiro-Silva, F. Acquisition and maturation of oral microbiome throughout childhood: an update. Dent. Res. J. 11, 291–301 (2014).
94. Dzidic M Oral microbiome development during childhood: an ecological succession influenced by postnatal factors and associated with tooth decay ISME J. 2018 12 2292 2306 10.1038/s41396-018-0204-z 29899505
Dzidic, M. et al. Oral microbiome development during childhood: an ecological succession influenced by postnatal factors and associated with tooth decay. ISME J. 12, 2292–2306 (2018).29899505
95. Merglova V Polenik P Early colonization of the oral cavity in 6- and 12-month-old infants by cariogenic and periodontal pathogens: a case-control study Folia Microbiol. (Praha) 2016 61 423 429 10.1007/s12223-016-0453-z 26914065
Merglova, V. & Polenik, P. Early colonization of the oral cavity in 6- and 12-month-old infants by cariogenic and periodontal pathogens: a case-control study. Folia Microbiol. (Praha) 61, 423–429 (2016).26914065
96. Crielaard W Exploring the oral microbiota of children at various developmental stages of their dentition in the relation to their oral health BMC Med. Genomics 2011 4 22 10.1186/1755-8794-4-22 21371338
Crielaard, W. et al. Exploring the oral microbiota of children at various developmental stages of their dentition in the relation to their oral health. BMC Med. Genomics 4, 22 (2011).21371338
97. Ruan X Luo J Zhang P Howell K The salivary microbiome shows a high prevalence of core bacterial members yet variability across human populations Npj Biofilms Microbiomes 2022 8 85 10.1038/s41522-022-00343-7 36266278
Ruan, X., Luo, J., Zhang, P. & Howell, K. The salivary microbiome shows a high prevalence of core bacterial members yet variability across human populations. Npj Biofilms Microbiomes 8, 85 (2022).36266278
98. Gaitanis G Variation of cultured skin microbiota in mothers and their infants during the first year postpartum Pediatr. Dermatol. 2019 36 460 465 10.1111/pde.13829 31025407
Gaitanis, G. et al. Variation of cultured skin microbiota in mothers and their infants during the first year postpartum. Pediatr. Dermatol. 36, 460–465 (2019).31025407
99. Chu DM Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery Nat. Med. 2017 23 314 326 10.1038/nm.4272 28112736
Chu, D. M. et al. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat. Med. 23, 314–326 (2017).28112736
100. NISC Comparative Sequencing Program. Biogeography and individuality shape function in the human skin metagenome Nature 2014 514 59 64 10.1038/nature13786 25279917
NISC Comparative Sequencing Program. et al. Biogeography and individuality shape function in the human skin metagenome. Nature 514, 59–64 (2014).25279917
101. Saheb Kashaf S Integrating cultivation and metagenomics for a multi-kingdom view of skin microbiome diversity and functions Nat. Microbiol. 2021 7 169 179 10.1038/s41564-021-01011-w 34952941
Saheb Kashaf, S. et al. Integrating cultivation and metagenomics for a multi-kingdom view of skin microbiome diversity and functions. Nat. Microbiol. 7, 169–179 (2021).34952941
102. Harris-Tryon TA Grice EA Microbiota and maintenance of skin barrier function Science 2022 376 940 945 10.1126/science.abo0693 35617415
Harris-Tryon, T. A. & Grice, E. A. Microbiota and maintenance of skin barrier function. Science 376, 940–945 (2022).35617415
103. Byrd AL Belkaid Y Segre JA The human skin microbiome Nat. Rev. Microbiol. 2018 16 143 155 10.1038/nrmicro.2017.157 29332945
Byrd, A. L., Belkaid, Y. & Segre, J. A. The human skin microbiome. Nat. Rev. Microbiol. 16, 143–155 (2018).29332945
104. Yildirim S Primate vaginal microbiomes exhibit species specificity without universal Lactobacillus dominance ISME J. 2014 8 2431 2444 10.1038/ismej.2014.90 25036926
Yildirim, S. et al. Primate vaginal microbiomes exhibit species specificity without universal Lactobacillus dominance. ISME J. 8, 2431–2444 (2014).25036926
105. Łaniewski P Herbst-Kralovetz MM Connecting microbiome and menopause for healthy ageing Nat. Microbiol. 2022 7 354 358 10.1038/s41564-022-01071-6 35246661
Łaniewski, P. & Herbst-Kralovetz, M. M. Connecting microbiome and menopause for healthy ageing. Nat. Microbiol. 7, 354–358 (2022).35246661
106. Reid G Therapeutic Opportunities in the Vaginal Microbiome Microbiol. Spectr. 2017 5 5.3.06 10.1128/microbiolspec.BAD-0001-2016
Reid, G. Therapeutic Opportunities in the Vaginal Microbiome. Microbiol. Spectr. 5, 5.3.06 (2017).
107. Gliniewicz K Comparison of the Vaginal Microbiomes of Premenopausal and Postmenopausal Women Front. Microbiol. 2019 10 193 10.3389/fmicb.2019.00193 30837959
Gliniewicz, K. et al. Comparison of the Vaginal Microbiomes of Premenopausal and Postmenopausal Women. Front. Microbiol. 10, 193 (2019).30837959
108. Brotman RM Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy Menopause 2014 21 450 458 10.1097/GME.0b013e3182a4690b 24080849
Brotman, R. M. et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause 21, 450–458 (2014).24080849
109. Hillier SL Lau RJ Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy Clin. Infect. Dis. 1997 25 S123 S126 10.1086/516221 9310650
Hillier, S. L. & Lau, R. J. Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy. Clin. Infect. Dis. 25, S123–S126 (1997).9310650
110. Ravel J Vaginal microbiome of reproductive-age women Proc. Natl Acad. Sci. USA 2011 108 4680 4687 10.1073/pnas.1002611107 20534435
Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl Acad. Sci. USA 108, 4680–4687 (2011).20534435
111. Zhou X The vaginal bacterial communities of Japanese women resemble those of women in other racial groups FEMS Immunol. Med. Microbiol. 2010 58 169 181 10.1111/j.1574-695X.2009.00618.x 19912342
Zhou, X. et al. The vaginal bacterial communities of Japanese women resemble those of women in other racial groups. FEMS Immunol. Med. Microbiol. 58, 169–181 (2010).19912342
112. Shi Y Chen L Tong J Xu C Preliminary characterization of vaginal microbiota in healthy Chinese women using cultivation‐independent methods J. Obstet. Gynaecol. Res. 2009 35 525 532 10.1111/j.1447-0756.2008.00971.x 19527394
Shi, Y., Chen, L., Tong, J. & Xu, C. Preliminary characterization of vaginal microbiota in healthy Chinese women using cultivation‐independent methods. J. Obstet. Gynaecol. Res. 35, 525–532 (2009).19527394
113. France MT VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition Microbiome 2020 8 166 10.1186/s40168-020-00934-6 33228810
France, M. T. et al. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition. Microbiome 8, 166 (2020).33228810
114. Marconi C Characterization of the vaginal microbiome in women of reproductive age from 5 regions in Brazil Sex. Transm. Dis. 2020 47 562 569 10.1097/OLQ.0000000000001204 32520883
Marconi, C. et al. Characterization of the vaginal microbiome in women of reproductive age from 5 regions in Brazil. Sex. Transm. Dis. 47, 562–569 (2020).32520883
115. Borgdorff H The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands PLoS ONE 2017 12 e0181135 10.1371/journal.pone.0181135 28700747
Borgdorff, H. et al. The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands. PLoS ONE 12, e0181135 (2017).28700747
116. France M Alizadeh M Brown S Ma B Ravel J Towards a deeper understanding of the vaginal microbiota Nat. Microbiol. 2022 7 367 378 10.1038/s41564-022-01083-2 35246662
France, M., Alizadeh, M., Brown, S., Ma, B. & Ravel, J. Towards a deeper understanding of the vaginal microbiota. Nat. Microbiol. 7, 367–378 (2022).35246662
117. Muliyil, S. Linking the vaginal microbiome to women’s health. Nat. Med. 10.1038/d41591-023-00096-6 (2023).
118. Lebeer S A citizen-science-enabled catalogue of the vaginal microbiome and associated factors Nat. Microbiol. 2023 8 2183 2195 10.1038/s41564-023-01500-0 37884815
Lebeer, S. et al. A citizen-science-enabled catalogue of the vaginal microbiome and associated factors. Nat. Microbiol. 8, 2183–2195 (2023).37884815
119. Kumpitsch C Koskinen K Schöpf V Moissl-Eichinger C The microbiome of the upper respiratory tract in health and disease BMC Biol. 2019 17 87 10.1186/s12915-019-0703-z 31699101
Kumpitsch, C., Koskinen, K., Schöpf, V. & Moissl-Eichinger, C. The microbiome of the upper respiratory tract in health and disease. BMC Biol. 17, 87 (2019).31699101
120. Natalini JG Singh S Segal LN The dynamic lung microbiome in health and disease Nat. Rev. Microbiol. 2023 21 222 235 10.1038/s41579-022-00821-x 36385637
Natalini, J. G., Singh, S. & Segal, L. N. The dynamic lung microbiome in health and disease. Nat. Rev. Microbiol. 21, 222–235 (2023).36385637
121. Pattaroni C Early-life formation of the microbial and immunological environment of the human airways Cell Host Microbe 2018 24 857 865.e4 10.1016/j.chom.2018.10.019 30503510
Pattaroni, C. et al. Early-life formation of the microbial and immunological environment of the human airways. Cell Host Microbe 24, 857–865.e4 (2018).30503510
122. Li R Li J Zhou X Lung microbiome: new insights into the pathogenesis of respiratory diseases Signal Transduct. Target. Ther. 2024 9 19 10.1038/s41392-023-01722-y 38228603
Li, R., Li, J. & Zhou, X. Lung microbiome: new insights into the pathogenesis of respiratory diseases. Signal Transduct. Target. Ther. 9, 19 (2024).38228603
123. Wypych TP Wickramasinghe LC Marsland BJ The influence of the microbiome on respiratory health Nat. Immunol. 2019 20 1279 1290 10.1038/s41590-019-0451-9 31501577
Wypych, T. P., Wickramasinghe, L. C. & Marsland, B. J. The influence of the microbiome on respiratory health. Nat. Immunol. 20, 1279–1290 (2019).31501577
124. Chen L The long-term genetic stability and individual specificity of the human gut microbiome Cell 2021 184 2302 2315.e12 10.1016/j.cell.2021.03.024 33838112
Chen, L. et al. The long-term genetic stability and individual specificity of the human gut microbiome. Cell 184, 2302–2315.e12 (2021).33838112
125. Lozupone CA Stombaugh JI Gordon JI Jansson JK Knight R Diversity, stability and resilience of the human gut microbiota Nature 2012 489 220 230 10.1038/nature11550 22972295
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K. & Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220–230 (2012).22972295
126. Fassarella M Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health Gut 2021 70 595 605 10.1136/gutjnl-2020-321747 33051190
Fassarella, M. et al. Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health. Gut 70, 595–605 (2021).33051190
127. Sommer F Anderson JM Bharti R Raes J Rosenstiel P The resilience of the intestinal microbiota influences health and disease Nat. Rev. Microbiol. 2017 15 630 638 10.1038/nrmicro.2017.58 28626231
Sommer, F., Anderson, J. M., Bharti, R., Raes, J. & Rosenstiel, P. The resilience of the intestinal microbiota influences health and disease. Nat. Rev. Microbiol. 15, 630–638 (2017).28626231
128. Zhou X Longitudinal profiling of the microbiome at four body sites reveals core stability and individualized dynamics during health and disease Cell Host Microbe 2024 32 506 526.e9 10.1016/j.chom.2024.02.012 38479397
Zhou, X. et al. Longitudinal profiling of the microbiome at four body sites reveals core stability and individualized dynamics during health and disease. Cell Host Microbe 32, 506–526.e9 (2024).38479397
129. Huang S Human skin, oral, and gut microbiomes predict chronological age mSystems 2020 5 e00630 19 10.1128/msystems.00630-19 32047061
Huang, S. et al. Human skin, oral, and gut microbiomes predict chronological age. mSystems 5, e00630–19 (2020).32047061
130. Wang L MIAOME: Human microbiome affect the host epigenome Comput. Struct. Biotechnol. J. 2022 20 2455 2463 10.1016/j.csbj.2022.05.024 35664224
Wang, L. et al. MIAOME: Human microbiome affect the host epigenome. Comput. Struct. Biotechnol. J. 20, 2455–2463 (2022).35664224
131. Kapil V The noncanonical pathway for in vivo nitric oxide generation: the nitrate-nitrite-nitric oxide pathway Pharmacol. Rev. 2020 72 692 766 10.1124/pr.120.019240 32576603
Kapil, V. et al. The noncanonical pathway for in vivo nitric oxide generation: the nitrate-nitrite-nitric oxide pathway. Pharmacol. Rev. 72, 692–766 (2020).32576603
132. Lundberg JO Weitzberg E Gladwin MT The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics Nat. Rev. Drug Discov. 2008 7 156 167 10.1038/nrd2466 18167491
Lundberg, J. O., Weitzberg, E. & Gladwin, M. T. The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 7, 156–167 (2008).18167491
133. Chai X Liu L Chen F Oral nitrate-reducing bacteria as potential probiotics for blood pressure homeostasis Front. Cardiovasc. Med. 2024 11 1337281 10.3389/fcvm.2024.1337281 38638884
Chai, X., Liu, L. & Chen, F. Oral nitrate-reducing bacteria as potential probiotics for blood pressure homeostasis. Front. Cardiovasc. Med. 11, 1337281 (2024).38638884
134. Doel JJ Benjamin N Hector MP Rogers M Allaker RP Evaluation of bacterial nitrate reduction in the human oral cavity Eur. J. Oral. Sci. 2005 113 14 19 10.1111/j.1600-0722.2004.00184.x 15693824
Doel, J. J., Benjamin, N., Hector, M. P., Rogers, M. & Allaker, R. P. Evaluation of bacterial nitrate reduction in the human oral cavity. Eur. J. Oral. Sci. 113, 14–19 (2005).15693824
135. Goh CE Nitrite generating and depleting capacity of the oral microbiome and cardiometabolic risk: results from ORIGINS J. Am. Heart Assoc. 2022 11 e023038 10.1161/JAHA.121.023038 35574962
Goh, C. E. et al. Nitrite generating and depleting capacity of the oral microbiome and cardiometabolic risk: results from ORIGINS. J. Am. Heart Assoc. 11, e023038 (2022).35574962
136. Blekkenhorst LC Nitrate, the oral microbiome, and cardiovascular health: a systematic literature review of human and animal studies Am. J. Clin. Nutr. 2018 107 504 522 10.1093/ajcn/nqx046 29635489
Blekkenhorst, L. C. et al. Nitrate, the oral microbiome, and cardiovascular health: a systematic literature review of human and animal studies. Am. J. Clin. Nutr. 107, 504–522 (2018).29635489
137. Kapil V Physiological role for nitrate-reducing oral bacteria in blood pressure control Free Radic. Biol. Med. 2013 55 93 100 10.1016/j.freeradbiomed.2012.11.013 23183324
Kapil, V. et al. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic. Biol. Med. 55, 93–100 (2013).23183324
138. Krautkramer KA Fan J Bäckhed F Gut microbial metabolites as multi-kingdom intermediates Nat. Rev. Microbiol. 2021 19 77 94 10.1038/s41579-020-0438-4 32968241
Krautkramer, K. A., Fan, J. & Bäckhed, F. Gut microbial metabolites as multi-kingdom intermediates. Nat. Rev. Microbiol. 19, 77–94 (2021).32968241
139. Sommer F Bäckhed F The gut microbiota—masters of host development and physiology Nat. Rev. Microbiol. 2013 11 227 238 10.1038/nrmicro2974 23435359
Sommer, F. & Bäckhed, F. The gut microbiota—masters of host development and physiology. Nat. Rev. Microbiol. 11, 227–238 (2013).23435359
140. Oliphant K Allen-Vercoe E Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health Microbiome 2019 7 91 10.1186/s40168-019-0704-8 31196177
Oliphant, K. & Allen-Vercoe, E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome 7, 91 (2019).31196177
141. Hill JH Round JL SnapShot: Microbiota effects on host physiology Cell 2021 184 2796 2796.e1 10.1016/j.cell.2021.04.026 33989551
Hill, J. H. & Round, J. L. SnapShot: Microbiota effects on host physiology. Cell 184, 2796–2796.e1 (2021).33989551
142. Koh A De Vadder F Kovatcheva-Datchary P Bäckhed F From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites Cell 2016 165 1332 1345 10.1016/j.cell.2016.05.041 27259147
Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & Bäckhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332–1345 (2016).27259147
143. Cummings JH Pomare EW Branch WJ Naylor CP Macfarlane GT Short chain fatty acids in human large intestine, portal, hepatic and venous blood Gut 1987 28 1221 1227 10.1136/gut.28.10.1221 3678950
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P. & Macfarlane, G. T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221–1227 (1987).3678950
144. Beynen AC Buechler KF Van Der Molen AJ Geelen MJH The effects of lactate and acetate on fatty acid and cholesterol biosynthesis by isolated rat hepatocytes Int. J. Biochem. 1982 14 165 169 10.1016/0020-711X(82)90135-5 6121723
Beynen, A. C., Buechler, K. F., Van Der Molen, A. J. & Geelen, M. J. H. The effects of lactate and acetate on fatty acid and cholesterol biosynthesis by isolated rat hepatocytes. Int. J. Biochem. 14, 165–169 (1982).6121723
145. Yoshida H Ishii M Akagawa M Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway Arch. Biochem. Biophys. 2019 672 108057 10.1016/j.abb.2019.07.022 31356781
Yoshida, H., Ishii, M. & Akagawa, M. Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway. Arch. Biochem. Biophys. 672, 108057 (2019).31356781
146. Wang GY Propionate promotes gluconeogenesis by regulating mechanistic target of rapamycin (mTOR) pathway in calf hepatocytes Anim. Nutr. 2023 15 88 98 10.1016/j.aninu.2023.07.001 37841648
Wang, G. Y. et al. Propionate promotes gluconeogenesis by regulating mechanistic target of rapamycin (mTOR) pathway in calf hepatocytes. Anim. Nutr. 15, 88–98 (2023).37841648
147. Demigné C Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes Br. J. Nutr. 1995 74 209 219 10.1079/BJN19950124 7547838
Demigné, C. et al. Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br. J. Nutr. 74, 209–219 (1995).7547838
148. Chambers ES Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults Gut 2015 64 1744 1754 10.1136/gutjnl-2014-307913 25500202
Chambers, E. S. et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64, 1744–1754 (2015).25500202
149. Li Z Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit Gut 2018 67 1269 1279 10.1136/gutjnl-2017-314050 29101261
Li, Z. et al. Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit. Gut 67, 1269–1279 (2018).29101261
150. Trompette A Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation Mucosal Immunol. 2022 15 908 926 10.1038/s41385-022-00524-9 35672452
Trompette, A. et al. Gut-derived short-chain fatty acids modulate skin barrier integrity by promoting keratinocyte metabolism and differentiation. Mucosal Immunol. 15, 908–926 (2022).35672452
151. Jangi S Microbial butyrate capacity is reduced in inflamed mucosa in patients with ulcerative colitis Sci. Rep. 2024 14 3479 10.1038/s41598-024-54257-9 38347087
Jangi, S. et al. Microbial butyrate capacity is reduced in inflamed mucosa in patients with ulcerative colitis. Sci. Rep. 14, 3479 (2024).38347087
152. Kang X Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8 + T cells Gut 2023 72 2112 2122 10.1136/gutjnl-2023-330291 37491158
Kang, X. et al. Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8 + T cells. Gut 72, 2112–2122 (2023).37491158
153. Zhang Y Tao Y Gu Y Ma Q Butyrate facilitates immune clearance of colorectal cancer cells by suppressing STAT1-mediated PD-L1 expression Clinics 2023 78 100303 10.1016/j.clinsp.2023.100303 37931529
Zhang, Y., Tao, Y., Gu, Y. & Ma, Q. Butyrate facilitates immune clearance of colorectal cancer cells by suppressing STAT1-mediated PD-L1 expression. Clinics 78, 100303 (2023).37931529
154. Okumura S Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion Nat. Commun. 2021 12 5674 10.1038/s41467-021-25965-x 34584098
Okumura, S. et al. Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion. Nat. Commun. 12, 5674 (2021).34584098
155. Wahlström A Sayin SI Marschall H-U Bäckhed F Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism Cell Metab. 2016 24 41 50 10.1016/j.cmet.2016.05.005 27320064
Wahlström, A., Sayin, S. I., Marschall, H.-U. & Bäckhed, F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24, 41–50 (2016).27320064
156. Collins SL Stine JG Bisanz JE Okafor CD Patterson AD Bile acids and the gut microbiota: metabolic interactions and impacts on disease Nat. Rev. Microbiol. 2023 21 236 247 10.1038/s41579-022-00805-x 36253479
Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D. & Patterson, A. D. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat. Rev. Microbiol. 21, 236–247 (2023).36253479
157. Fogelson, K. A., Dorrestein, P. C., Zarrinpar, A. & Knight, R. The gut microbial bile acid modulation and its relevance to digestive health and diseases. Gastroenterology 164, 1069–1085 (2023).
158. Xie, S. et al. Novel tripeptide RKH derived from Akkermansia muciniphila protects against lethal sepsis. Gut 73, 78–91 (2023).
159. Jiang J The gut metabolite indole-3-propionic acid activates ERK1 to restore social function and hippocampal inhibitory synaptic transmission in a 16p11.2 microdeletion mouse model Microbiome 2024 12 66 10.1186/s40168-024-01755-7 38549163
Jiang, J. et al. The gut metabolite indole-3-propionic acid activates ERK1 to restore social function and hippocampal inhibitory synaptic transmission in a 16p11.2 microdeletion mouse model. Microbiome 12, 66 (2024).38549163
160. Zhao M Gut bacteria-driven homovanillic acid alleviates depression by modulating synaptic integrity Cell Metab. 2024 36 1000 1012.e6 10.1016/j.cmet.2024.03.010 38582087
Zhao, M. et al. Gut bacteria-driven homovanillic acid alleviates depression by modulating synaptic integrity. Cell Metab. 36, 1000–1012.e6 (2024).38582087
161. Enamorado M Immunity to the microbiota promotes sensory neuron regeneration Cell 2023 186 607 620.e17 10.1016/j.cell.2022.12.037 36640762
Enamorado, M. et al. Immunity to the microbiota promotes sensory neuron regeneration. Cell 186, 607–620.e17 (2023).36640762
162. Hosang L The lung microbiome regulates brain autoimmunity Nature 2022 603 138 144 10.1038/s41586-022-04427-4 35197636
Hosang, L. et al. The lung microbiome regulates brain autoimmunity. Nature 603, 138–144 (2022).35197636
163. Oh ES Petronis A Origins of human disease: the chrono-epigenetic perspective Nat. Rev. Genet. 2021 22 533 546 10.1038/s41576-021-00348-6 33903745
Oh, E. S. & Petronis, A. Origins of human disease: the chrono-epigenetic perspective. Nat. Rev. Genet. 22, 533–546 (2021).33903745
164. Carter B Zhao K The epigenetic basis of cellular heterogeneity Nat. Rev. Genet. 2021 22 235 250 10.1038/s41576-020-00300-0 33244170
Carter, B. & Zhao, K. The epigenetic basis of cellular heterogeneity. Nat. Rev. Genet. 22, 235–250 (2021).33244170
165. Fitz-James MH Cavalli G Molecular mechanisms of transgenerational epigenetic inheritance Nat. Rev. Genet. 2022 23 325 341 10.1038/s41576-021-00438-5 34983971
Fitz-James, M. H. & Cavalli, G. Molecular mechanisms of transgenerational epigenetic inheritance. Nat. Rev. Genet. 23, 325–341 (2022).34983971
166. Cavalli G Heard E Advances in epigenetics link genetics to the environment and disease Nature 2019 571 489 499 10.1038/s41586-019-1411-0 31341302
Cavalli, G. & Heard, E. Advances in epigenetics link genetics to the environment and disease. Nature 571, 489–499 (2019).31341302
167. Pepke, M. L., Hansen, S. B. & Limborg, M. T. Unraveling host regulation of gut microbiota through the epigenome–microbiome axis. Trends Microbiol. (2024) 10.1016/j.tim.2024.05.006 (2024).
168. Ansari I The microbiota programs DNA methylation to control intestinal homeostasis and inflammation Nat. Microbiol. 2020 5 610 619 10.1038/s41564-019-0659-3 32015497
Ansari, I. et al. The microbiota programs DNA methylation to control intestinal homeostasis and inflammation. Nat. Microbiol. 5, 610–619 (2020).32015497
169. Mattei AL Bailly N Meissner A DNA methylation: a historical perspective Trends Genet 2022 38 676 707 10.1016/j.tig.2022.03.010 35504755
Mattei, A. L., Bailly, N. & Meissner, A. DNA methylation: a historical perspective. Trends Genet 38, 676–707 (2022).35504755
170. Crider KS Yang TP Berry RJ Bailey LB Folate and DNA methylation: a review of molecular mechanisms and the evidence for Folate’s role Adv. Nutr. 2012 3 21 38 10.3945/an.111.000992 22332098
Crider, K. S., Yang, T. P., Berry, R. J. & Bailey, L. B. Folate and DNA methylation: a review of molecular mechanisms and the evidence for Folate’s role. Adv. Nutr. 3, 21–38 (2012).22332098
171. Bannister AJ Kouzarides T Regulation of chromatin by histone modifications Cell Res. 2011 21 381 395 10.1038/cr.2011.22 21321607
Bannister, A. J. & Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res. 21, 381–395 (2011).21321607
172. Millán-Zambrano G Burton A Bannister AJ Schneider R Histone post-translational modifications—cause and consequence of genome function Nat. Rev. Genet. 2022 23 563 580 10.1038/s41576-022-00468-7 35338361
Millán-Zambrano, G., Burton, A., Bannister, A. J. & Schneider, R. Histone post-translational modifications—cause and consequence of genome function. Nat. Rev. Genet. 23, 563–580 (2022).35338361
173. Furusawa Y Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells Nature 2013 504 446 450 10.1038/nature12721 24226770
Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446–450 (2013).24226770
174. Davison JM Microbiota regulate intestinal epithelial gene expression by suppressing the transcription factor Hepatocyte nuclear factor 4 alpha Genome Res. 2017 27 1195 1206 10.1101/gr.220111.116 28385711
Davison, J. M. et al. Microbiota regulate intestinal epithelial gene expression by suppressing the transcription factor Hepatocyte nuclear factor 4 alpha. Genome Res. 27, 1195–1206 (2017).28385711
175. Mattick JS Long non-coding RNAs: definitions, functions, challenges and recommendations Nat. Rev. Mol. Cell Biol. 2023 24 430 447 10.1038/s41580-022-00566-8 36596869
Mattick, J. S. et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell Biol. 24, 430–447 (2023).36596869
176. Nemeth K Bayraktar R Ferracin M Calin GA Non-coding RNAs in disease: from mechanisms to therapeutics Nat. Rev. Genet. 2024 25 211 232 10.1038/s41576-023-00662-1 37968332
Nemeth, K., Bayraktar, R., Ferracin, M. & Calin, G. A. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat. Rev. Genet. 25, 211–232 (2024).37968332
177. Virtue AT The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs Sci. Transl. Med. 2019 11 eaav1892 10.1126/scitranslmed.aav1892 31189717
Virtue, A. T. et al. The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs. Sci. Transl. Med. 11, eaav1892 (2019).31189717
178. Statello L Guo C-J Chen L-L Huarte M Gene regulation by long non-coding RNAs and its biological functions Nat. Rev. Mol. Cell Biol. 2021 22 96 118 10.1038/s41580-020-00315-9 33353982
Statello, L., Guo, C.-J., Chen, L.-L. & Huarte, M. Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell Biol. 22, 96–118 (2021).33353982
179. Liang L Ai L Qian J Fang J-Y Xu J Long noncoding RNA expression profiles in gut tissues constitute molecular signatures that reflect the types of microbes Sci. Rep. 2015 5 11763 10.1038/srep11763 26123364
Liang, L., Ai, L., Qian, J., Fang, J.-Y. & Xu, J. Long noncoding RNA expression profiles in gut tissues constitute molecular signatures that reflect the types of microbes. Sci. Rep. 5, 11763 (2015).26123364
180. Bach J-F The effect of infections on susceptibility to autoimmune and allergic diseases N. Engl. J. Med. 2002 347 911 920 10.1056/NEJMra020100 12239261
Bach, J.-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911–920 (2002).12239261
181. Ege MJ Exposure to environmental microorganisms and childhood asthma N. Engl. J. Med. 2011 364 701 709 10.1056/NEJMoa1007302 21345099
Ege, M. J. et al. Exposure to environmental microorganisms and childhood asthma. N. Engl. J. Med. 364, 701–709 (2011).21345099
182. Kuehni CE Strippoli MF Low N Silverman M Asthma in young South Asian women living in the United Kingdom: the importance of early life Clin. Exp. Allergy 2007 37 47 53 10.1111/j.1365-2222.2006.02627.x 17210041
Kuehni, C. E., Strippoli, M. F., Low, N. & Silverman, M. Asthma in young South Asian women living in the United Kingdom: the importance of early life. Clin. Exp. Allergy 37, 47–53 (2007).17210041
183. Feltbower RG Trends in the incidence of childhood diabetes in South Asians and other children in Bradford, UK Diabet. Med. 2002 19 162 166 10.1046/j.1464-5491.2002.00691.x 11874434
Feltbower, R. G. et al. Trends in the incidence of childhood diabetes in South Asians and other children in Bradford, UK. Diabet. Med. 19, 162–166 (2002).11874434
184. Bodansky HJ Staines A Stephenson C Haigh D Cartwright R Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population BMJ 1992 304 1020 1022 10.1136/bmj.304.6833.1020 1586783
Bodansky, H. J., Staines, A., Stephenson, C., Haigh, D. & Cartwright, R. Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. BMJ 304, 1020–1022 (1992).1586783
185. Dean G Elian M Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis J. Neurol. Neurosurg. Psychiatry 1997 63 565 568 10.1136/jnnp.63.5.565 9408093
Dean, G. & Elian, M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 63, 565–568 (1997).9408093
186. Gale CR Martyn CN Migrant studies in multiple sclerosis Prog. Neurobiol. 1995 47 425 448 10.1016/0301-0082(95)80008-V 8966212
Gale, C. R. & Martyn, C. N. Migrant studies in multiple sclerosis. Prog. Neurobiol. 47, 425–448 (1995).8966212
187. Strachan DP Hay fever, hygiene, and household size BMJ 1989 299 1259 1260 10.1136/bmj.299.6710.1259 2513902
Strachan, D. P. Hay fever, hygiene, and household size. BMJ 299, 1259–1260 (1989).2513902
188. Strachan D Family size, infection and atopy: the first decade of the ‘hygiene hypothesis’ Thorax 2000 55 2S 10S 10.1136/thorax.55.suppl_1.S2
Strachan, D. Family size, infection and atopy: the first decade of the ‘hygiene hypothesis’. Thorax 55, 2S–10S (2000).
189. Finlay BB The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome Proc. Natl Acad. Sci. 2021 118 e2010217118 10.1073/pnas.2010217118 33472859
Finlay, B. B. et al. The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome. Proc. Natl Acad. Sci. 118, e2010217118 (2021).33472859
190. Parker W The ‘hygiene hypothesis’ for allergic disease is a misnomer BMJ 2014 349 g5267 g5267 10.1136/bmj.g5267
Parker, W. The ‘hygiene hypothesis’ for allergic disease is a misnomer. BMJ 349, g5267–g5267 (2014).
191. Rook GAW Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders Springe. Semin. Immunopathol. 2004 25 237 255 10.1007/s00281-003-0148-9
Rook, G. A. W. et al. Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springe. Semin. Immunopathol. 25, 237–255 (2004).
192. Rook GAW Microbes, immunoregulation, and the gut Gut 2005 54 317 320 10.1136/gut.2004.053785 15710972
Rook, G. A. W. Microbes, immunoregulation, and the gut. Gut 54, 317–320 (2005).15710972
193. Donald, K. & Finlay, B. B. Early-life interactions between the microbiota and immune system: impact on immune system development and atopic disease. Nat. Rev. Immunol. 23, 735–748 (2023).
194. Van Der Waaij D Berghuis-de Vries JM Lekkerkerk-van Der Wees JEC Colonization resistance of the digestive tract in conventional and antibiotic-treated mice J. Hyg. (Lond.) 1971 69 405 411 10.1017/S0022172400021653 4999450
Van Der Waaij, D., Berghuis-de Vries, J. M. & Lekkerkerk-van Der Wees, J. E. C. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J. Hyg. (Lond.) 69, 405–411 (1971).4999450
195. Caballero-Flores, G., Pickard, J. M. & Núñez, G. Microbiota-mediated colonization resistance: mechanisms and regulation. Nat. Rev. Microbiol. 21, 347–360. 10.1038/s41579-022-00833-7 (2022).
196. Bohnhoff M Miller CP Enhanced susceptibility to salmonella infection in streptomycin-treated mice* J. Infect. Dis. 1962 111 117 127 10.1093/infdis/111.2.117 13968487
Bohnhoff, M. & Miller, C. P. Enhanced susceptibility to salmonella infection in streptomycin-treated mice*. J. Infect. Dis. 111, 117–127 (1962).13968487
197. Murray CJL Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis Lancet 2022 399 629 655 10.1016/S0140-6736(21)02724-0 35065702
Murray, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).35065702
198. Blaser MJ Antibiotic use and its consequences for the normal microbiome Science 2016 352 544 545 10.1126/science.aad9358 27126037
Blaser, M. J. Antibiotic use and its consequences for the normal microbiome. Science 352, 544–545 (2016).27126037
199. Lee SM Bacterial colonization factors control specificity and stability of the gut microbiota Nature 2013 501 426 429 10.1038/nature12447 23955152
Lee, S. M. et al. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 501, 426–429 (2013).23955152
200. Tanzer JM Kurasz AB Clive J Competitive displacement of mutans streptococci and inhibition of tooth decay by Streptococcus salivarius TOVE-R Infect. Immun. 1985 48 44 50 10.1128/iai.48.1.44-50.1985 3980093
Tanzer, J. M., Kurasz, A. B. & Clive, J. Competitive displacement of mutans streptococci and inhibition of tooth decay by Streptococcus salivarius TOVE-R. Infect. Immun. 48, 44–50 (1985).3980093
201. Van Hoogmoed CG Reduction of periodontal pathogens adhesion by antagonistic strains Oral. Microbiol. Immunol. 2008 23 43 48 10.1111/j.1399-302X.2007.00388.x 18173797
Van Hoogmoed, C. G. et al. Reduction of periodontal pathogens adhesion by antagonistic strains. Oral. Microbiol. Immunol. 23, 43–48 (2008).18173797
202. Zipperer A Human commensals producing a novel antibiotic impair pathogen colonization Nature 2016 535 511 516 10.1038/nature18634 27466123
Zipperer, A. et al. Human commensals producing a novel antibiotic impair pathogen colonization. Nature 535, 511–516 (2016).27466123
203. Sugimoto S Staphylococcus epidermidis esp degrades specific proteins associated with staphylococcus aureus biofilm formation and host-pathogen interaction J. Bacteriol. 2013 195 1645 1655 10.1128/JB.01672-12 23316041
Sugimoto, S. et al. Staphylococcus epidermidis esp degrades specific proteins associated with staphylococcus aureus biofilm formation and host-pathogen interaction. J. Bacteriol. 195, 1645–1655 (2013).23316041
204. Torres Salazar BO Commensal production of a broad-spectrum and short-lived antimicrobial peptide polyene eliminates nasal Staphylococcus aureus Nat. Microbiol. 2023 9 200 213 10.1038/s41564-023-01544-2 38110697
Torres Salazar, B. O. et al. Commensal production of a broad-spectrum and short-lived antimicrobial peptide polyene eliminates nasal Staphylococcus aureus. Nat. Microbiol. 9, 200–213 (2023).38110697
205. King AM Systematic mining of the human microbiome identifies antimicrobial peptides with diverse activity spectra Nat. Microbiol. 2023 8 2420 2434 10.1038/s41564-023-01524-6 37973865
King, A. M. et al. Systematic mining of the human microbiome identifies antimicrobial peptides with diverse activity spectra. Nat. Microbiol. 8, 2420–2434 (2023).37973865
206. Shin R Suzuki M Morishita Y Influence of intestinal anaerobes and organic acids on the growth of enterohaemorrhagic Escherichia coli O157:H7 J. Med. Microbiol. 2002 51 201 206 10.1099/0022-1317-51-3-201 11871614
Shin, R., Suzuki, M. & Morishita, Y. Influence of intestinal anaerobes and organic acids on the growth of enterohaemorrhagic Escherichia coli O157:H7. J. Med. Microbiol. 51, 201–206 (2002).11871614
207. Rolfe RD Role of volatile fatty acids in colonization resistance to Clostridium difficile Infect. Immun. 1984 45 185 191 10.1128/iai.45.1.185-191.1984 6735467
Rolfe, R. D. Role of volatile fatty acids in colonization resistance to Clostridium difficile. Infect. Immun. 45, 185–191 (1984).6735467
208. Bohnhoff M Miller CP Martin WR Resistance of the mouse’s intestinal tract to experimental Salmonella infection J. Exp. Med. 1964 120 805 816 10.1084/jem.120.5.805 14247721
Bohnhoff, M., Miller, C. P. & Martin, W. R. Resistance of the mouse’s intestinal tract to experimental Salmonella infection. J. Exp. Med. 120, 805–816 (1964).14247721
209. Buffie CG Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile Nature 2015 517 205 208 10.1038/nature13828 25337874
Buffie, C. G. et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517, 205–208 (2015).25337874
210. Aoki SK Contact-dependent inhibition of growth in Escherichia coli Science 2005 309 1245 1248 10.1126/science.1115109 16109881
Aoki, S. K. et al. Contact-dependent inhibition of growth in Escherichia coli. Science 309, 1245–1248 (2005).16109881
211. Aoki SK A widespread family of polymorphic contact-dependent toxin delivery systems in bacteria Nature 2010 468 439 442 10.1038/nature09490 21085179
Aoki, S. K. et al. A widespread family of polymorphic contact-dependent toxin delivery systems in bacteria. Nature 468, 439–442 (2010).21085179
212. Flaugnatti N Human commensal gut Proteobacteria withstand type VI secretion attacks through immunity protein-independent mechanisms Nat. Commun. 2021 12 5751 10.1038/s41467-021-26041-0 34599171
Flaugnatti, N. et al. Human commensal gut Proteobacteria withstand type VI secretion attacks through immunity protein-independent mechanisms. Nat. Commun. 12, 5751 (2021).34599171
213. Ross BD Human gut bacteria contain acquired interbacterial defence systems Nature 2019 575 224 228 10.1038/s41586-019-1708-z 31666699
Ross, B. D. et al. Human gut bacteria contain acquired interbacterial defence systems. Nature 575, 224–228 (2019).31666699
214. Chatzidaki-Livanis M Geva-Zatorsky N Comstock LE Bacteroides fragilis type VI secretion systems use novel effector and immunity proteins to antagonize human gut Bacteroidales species Proc. Natl Acad. Sci. 2016 113 3627 3632 10.1073/pnas.1522510113 26951680
Chatzidaki-Livanis, M., Geva-Zatorsky, N. & Comstock, L. E. Bacteroides fragilis type VI secretion systems use novel effector and immunity proteins to antagonize human gut Bacteroidales species. Proc. Natl Acad. Sci. 113, 3627–3632 (2016).26951680
215. Russell AB A type VI secretion-related pathway in bacteroidetes mediates interbacterial antagonism Cell Host Microbe 2014 16 227 236 10.1016/j.chom.2014.07.007 25070807
Russell, A. B. et al. A type VI secretion-related pathway in bacteroidetes mediates interbacterial antagonism. Cell Host Microbe 16, 227–236 (2014).25070807
216. Voravuthikunchai SP Bilasoi S Supamala O Antagonistic activity against pathogenic bacteria by human vaginal lactobacilli Anaerobe 2006 12 221 226 10.1016/j.anaerobe.2006.06.003 16931064
Voravuthikunchai, S. P., Bilasoi, S. & Supamala, O. Antagonistic activity against pathogenic bacteria by human vaginal lactobacilli. Anaerobe 12, 221–226 (2006).16931064
217. Turovskiy Y Sutyak Noll K Chikindas ML The aetiology of bacterial vaginosis: aetiology of bacterial vaginosis J. Appl. Microbiol. 2011 110 1105 1128 10.1111/j.1365-2672.2011.04977.x 21332897
Turovskiy, Y., Sutyak Noll, K. & Chikindas, M. L. The aetiology of bacterial vaginosis: aetiology of bacterial vaginosis. J. Appl. Microbiol. 110, 1105–1128 (2011).21332897
218. Osbelt, L. et al. Klebsiella oxytoca inhibits Salmonella infection through multiple microbiota-context-dependent mechanisms. Nat. Microbiol. 9, 1792–1811 (2024).
219. Stekel D First report of antimicrobial resistance pre-dates penicillin Nature 2018 562 192 192 10.1038/d41586-018-06983-0 30305753
Stekel, D. First report of antimicrobial resistance pre-dates penicillin. Nature 562, 192–192 (2018).30305753
220. Hutchings MI Truman AW Wilkinson B Antibiotics: past, present and future Curr. Opin. Microbiol. 2019 51 72 80 10.1016/j.mib.2019.10.008 31733401
Hutchings, M. I., Truman, A. W. & Wilkinson, B. Antibiotics: past, present and future. Curr. Opin. Microbiol. 51, 72–80 (2019).31733401
221. Varadan, S. R. et al. A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance. Lancet 403, 2766–2767 (2023).
222. Kimura I Maternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice Science 2020 367 eaaw8429 10.1126/science.aaw8429 32108090
Kimura, I. et al. Maternal gut microbiota in pregnancy influences offspring metabolic phenotype in mice. Science 367, eaaw8429 (2020).32108090
223. Vuong HE The maternal microbiome modulates fetal neurodevelopment in mice Nature 2020 586 281 286 10.1038/s41586-020-2745-3 32968276
Vuong, H. E. et al. The maternal microbiome modulates fetal neurodevelopment in mice. Nature 586, 281–286 (2020).32968276
224. Sun Z Revealing the importance of prenatal gut microbiome in offspring neurodevelopment in humans eBioMedicine 2023 90 104491 10.1016/j.ebiom.2023.104491 36868051
Sun, Z. et al. Revealing the importance of prenatal gut microbiome in offspring neurodevelopment in humans. eBioMedicine 90, 104491 (2023).36868051
225. Gomez de Agüero M The maternal microbiota drives early postnatal innate immune development Science 2016 351 1296 1302 10.1126/science.aad2571 26989247
Gomez de Agüero, M. et al. The maternal microbiota drives early postnatal innate immune development. Science 351, 1296–1302 (2016).26989247
226. Bogaert D Mother-to-infant microbiota transmission and infant microbiota development across multiple body sites Cell Host Microbe 2023 31 447 460.e6 10.1016/j.chom.2023.01.018 36893737
Bogaert, D. et al. Mother-to-infant microbiota transmission and infant microbiota development across multiple body sites. Cell Host Microbe 31, 447–460.e6 (2023).36893737
227. Selma-Royo M Birthmode and environment-dependent microbiota transmission dynamics are complemented by breastfeeding during the first year Cell Host Microbe 2024 32 996 1010.e4 10.1016/j.chom.2024.05.005 38870906
Selma-Royo, M. et al. Birthmode and environment-dependent microbiota transmission dynamics are complemented by breastfeeding during the first year. Cell Host Microbe 32, 996–1010.e4 (2024).38870906
228. Paredes A γ-Linolenic acid in maternal milk drives cardiac metabolic maturation Nature 2023 618 365 373 10.1038/s41586-023-06068-7 37225978
Paredes, A. et al. γ-Linolenic acid in maternal milk drives cardiac metabolic maturation. Nature 618, 365–373 (2023).37225978
229. Caballero-Flores G Maternal immunization confers protection to the offspring against an attaching and effacing pathogen through delivery of IgG in breast milk Cell Host Microbe 2019 25 313 323.e4 10.1016/j.chom.2018.12.015 30686564
Caballero-Flores, G. et al. Maternal immunization confers protection to the offspring against an attaching and effacing pathogen through delivery of IgG in breast milk. Cell Host Microbe 25, 313–323.e4 (2019).30686564
230. Atyeo C Alter G The multifaceted roles of breast milk antibodies Cell 2021 184 1486 1499 10.1016/j.cell.2021.02.031 33740451
Atyeo, C. & Alter, G. The multifaceted roles of breast milk antibodies. Cell 184, 1486–1499 (2021).33740451
231. Zhong Z Bifidobacterium animalis subsp. lactis Probio-M8 undergoes host adaptive evolution by glcU mutation and translocates to the infant’s gut via oral-/entero-mammary routes through lactation Microbiome 2022 10 197 10.1186/s40168-022-01398-6 36419187
Zhong, Z. et al. Bifidobacterium animalis subsp. lactis Probio-M8 undergoes host adaptive evolution by glcU mutation and translocates to the infant’s gut via oral-/entero-mammary routes through lactation. Microbiome 10, 197 (2022).36419187
232. Barnett DJM Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study Gut Microbes 2023 15 2164152 10.1080/19490976.2022.2164152 36617628
Barnett, D. J. M. et al. Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study. Gut Microbes 15, 2164152 (2023).36617628
233. Cheung, K. Y. et al. Health and nutrition claims for infant formula: International Cross Sectional Survey. BMJ 380, e071075 (2023).
234. Baumann-Dudenhoeffer AM D’Souza AW Tarr PI Warner BB Dantas G Infant diet and maternal gestational weight gain predict early metabolic maturation of gut microbiomes Nat. Med. 2018 24 1822 1829 10.1038/s41591-018-0216-2 30374198
Baumann-Dudenhoeffer, A. M., D’Souza, A. W., Tarr, P. I., Warner, B. B. & Dantas, G. Infant diet and maternal gestational weight gain predict early metabolic maturation of gut microbiomes. Nat. Med. 24, 1822–1829 (2018).30374198
235. Mills DA German JB Lebrilla CB Underwood MA Translating neonatal microbiome science into commercial innovation: metabolism of human milk oligosaccharides as a basis for probiotic efficacy in breast-fed infants Gut Microbes 2023 15 2192458 10.1080/19490976.2023.2192458 37013357
Mills, D. A., German, J. B., Lebrilla, C. B. & Underwood, M. A. Translating neonatal microbiome science into commercial innovation: metabolism of human milk oligosaccharides as a basis for probiotic efficacy in breast-fed infants. Gut Microbes 15, 2192458 (2023).37013357
236. Pérez-Escamilla R Breastfeeding: crucially important, but increasingly challenged in a market-driven world Lancet 2023 401 472 485 10.1016/S0140-6736(22)01932-8 36764313
Pérez-Escamilla, R. et al. Breastfeeding: crucially important, but increasingly challenged in a market-driven world. Lancet 401, 472–485 (2023).36764313
237. Baker P The political economy of infant and young child feeding: confronting corporate power, overcoming structural barriers, and accelerating progress Lancet 2023 401 503 524 10.1016/S0140-6736(22)01933-X 36764315
Baker, P. et al. The political economy of infant and young child feeding: confronting corporate power, overcoming structural barriers, and accelerating progress. Lancet 401, 503–524 (2023).36764315
238. Stinson LF Geddes DT Microbial metabolites: the next frontier in human milk Trends Microbiol. 2022 30 408 410 10.1016/j.tim.2022.02.007 35282976
Stinson, L. F. & Geddes, D. T. Microbial metabolites: the next frontier in human milk. Trends Microbiol. 30, 408–410 (2022).35282976
239. Dubois L Paternal and induced gut microbiota seeding complement mother-to-infant transmission Cell Host Microbe 2024 32 1011 1024.e4 10.1016/j.chom.2024.05.004 38870892
Dubois, L. et al. Paternal and induced gut microbiota seeding complement mother-to-infant transmission. Cell Host Microbe 32, 1011–1024.e4 (2024).38870892
240. Argaw-Denboba, A. et al. Paternal microbiome perturbations impact offspring fitness. Nature 629, 652–659 (2024).
241. Lawrence RJ David the ‘bubble boy’ and the boundaries of the human J. Am. Med. Assoc. 1985 253 74 10.1001/jama.1985.03350250082028
Lawrence, R. J. David the ‘bubble boy’ and the boundaries of the human. J. Am. Med. Assoc. 253, 74 (1985).
242. Williams SCP Gnotobiotics Proc. Natl Acad. Sci. 2014 111 1661 1661 10.1073/pnas.1324049111 24497491
Williams, S. C. P. Gnotobiotics. Proc. Natl Acad. Sci. 111, 1661–1661 (2014).24497491
243. Wostmann BS The GERMFREE animal in nutritional studies Annu. Rev. Nutr. 1981 1 257 279 10.1146/annurev.nu.01.070181.001353 6764717
Wostmann, B. S. The GERMFREE animal in nutritional studies. Annu. Rev. Nutr. 1, 257–279 (1981).6764717
244. Basic M Bleich A Gnotobiotics: past, present and future Lab. Anim. 2019 53 232 243 10.1177/0023677219836715 31096878
Basic, M. & Bleich, A. Gnotobiotics: past, present and future. Lab. Anim. 53, 232–243 (2019).31096878
245. Fiebiger U Bereswill S Heimesaat MM Dissecting the interplay between intestinal microbiota and host immunity in health and disease: Lessons learned from germfree and gnotobiotic animal models Eur. J. Microbiol. Immunol. 2016 6 253 271 10.1556/1886.2016.00036
Fiebiger, U., Bereswill, S. & Heimesaat, M. M. Dissecting the interplay between intestinal microbiota and host immunity in health and disease: Lessons learned from germfree and gnotobiotic animal models. Eur. J. Microbiol. Immunol. 6, 253–271 (2016).
246. Schwarzer M Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition Science 2016 351 854 857 10.1126/science.aad8588 26912894
Schwarzer, M. et al. Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition. Science 351, 854–857 (2016).26912894
247. Edwards JM Microbiota are critical for vascular physiology: Germ-free status weakens contractility and induces sex-specific vascular remodeling in mice Vasc. Pharmacol. 2020 125–126 106633 10.1016/j.vph.2019.106633
Edwards, J. M. et al. Microbiota are critical for vascular physiology: Germ-free status weakens contractility and induces sex-specific vascular remodeling in mice. Vasc. Pharmacol. 125–126, 106633 (2020).
248. Gordon HA Wostmann BS Bruckner-Kardoss E Effects of microbial flora on cardiac output and other elements of blood circulation Exp. Biol. Med. 1963 114 301 304 10.3181/00379727-114-28658
Gordon, H. A., Wostmann, B. S. & Bruckner-Kardoss, E. Effects of microbial flora on cardiac output and other elements of blood circulation. Exp. Biol. Med. 114, 301–304 (1963).
249. Zhou D Microbiota modulates cardiac transcriptional responses to intermittent hypoxia and hypercapnia Front. Physiol. 2021 12 680275 10.3389/fphys.2021.680275 34248668
Zhou, D. et al. Microbiota modulates cardiac transcriptional responses to intermittent hypoxia and hypercapnia. Front. Physiol. 12, 680275 (2021).34248668
250. Crawford PA Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation Proc. Natl Acad. Sci. 2009 106 11276 11281 10.1073/pnas.0902366106 19549860
Crawford, P. A. et al. Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation. Proc. Natl Acad. Sci. 106, 11276–11281 (2009).19549860
251. Jain R Waldvogel‐Thurlow S Darveau R Douglas R Differences in the paranasal sinuses between germ‐free and pathogen‐free mice Int. Forum Allergy Rhinol. 2016 6 631 637 10.1002/alr.21712 27028583
Jain, R., Waldvogel‐Thurlow, S., Darveau, R. & Douglas, R. Differences in the paranasal sinuses between germ‐free and pathogen‐free mice. Int. Forum Allergy Rhinol. 6, 631–637 (2016).27028583
252. Yun Y Environmentally determined differences in the murine lung microbiota and their relation to alveolar architecture PLoS ONE 2014 9 e113466 10.1371/journal.pone.0113466 25470730
Yun, Y. et al. Environmentally determined differences in the murine lung microbiota and their relation to alveolar architecture. PLoS ONE 9, e113466 (2014).25470730
253. Woodward B A Study of the influence of the ambient microflora on the structure of lung alveolar macrophages and an ultrastructural comparison of lung and peritoneal macrophages in germ‐free and conventionally reared mice J. Morphol. 1981 169 283 291 10.1002/jmor.1051690304 7053129
Woodward, B. A Study of the influence of the ambient microflora on the structure of lung alveolar macrophages and an ultrastructural comparison of lung and peritoneal macrophages in germ‐free and conventionally reared mice. J. Morphol. 169, 283–291 (1981).7053129
254. Dolma K Effects of hyperoxia on alveolar and pulmonary vascular development in germ-free mice Am. J. Physiol. -Lung Cell. Mol. Physiol. 2020 318 L421 L428 10.1152/ajplung.00316.2019 31644312
Dolma, K. et al. Effects of hyperoxia on alveolar and pulmonary vascular development in germ-free mice. Am. J. Physiol. -Lung Cell. Mol. Physiol. 318, L421–L428 (2020).31644312
255. Ashley, S. L. et al. Lung and gut microbiota are altered by hyperoxia and contribute to oxygen-induced lung injury in mice. Sci. Transl. Med. 12, eaau9959 (2020).
256. Wostmann, B. S. Germfree and Gnotobiotic Animal Models: Background and Applications. (CRC Press, 2020). 10.1201/9780138753320.
257. Al-Asmakh M Zadjali F Use of germ-free animal models in microbiota-related research J. Microbiol. Biotechnol. 2015 25 1583 1588 10.4014/jmb.1501.01039 26032361
Al-Asmakh, M. & Zadjali, F. Use of germ-free animal models in microbiota-related research. J. Microbiol. Biotechnol. 25, 1583–1588 (2015).26032361
258. Geissinger HD Abandowitz HM Scanning electron and light microscopy of the cecum of germ-free and conventional mice Trans. Am. Microsc. Soc. 1977 96 254 10.2307/3226102 878146
Geissinger, H. D. & Abandowitz, H. M. Scanning electron and light microscopy of the cecum of germ-free and conventional mice. Trans. Am. Microsc. Soc. 96, 254 (1977).878146
259. Khoury KA Floch MH Hersh T Small intestinal mucosal cell proliferation and bacterial flora in the conventionalization of the germfree mouse J. Exp. Med. 1969 130 659 670 10.1084/jem.130.3.659 4896909
Khoury, K. A., Floch, M. H. & Hersh, T. Small intestinal mucosal cell proliferation and bacterial flora in the conventionalization of the germfree mouse. J. Exp. Med. 130, 659–670 (1969).4896909
260. Bolsega S The genetic background is shaping cecal enlargement in the absence of intestinal microbiota Nutrients 2023 15 636 10.3390/nu15030636 36771343
Bolsega, S. et al. The genetic background is shaping cecal enlargement in the absence of intestinal microbiota. Nutrients 15, 636 (2023).36771343
261. Loesche WJ Accumulation of endogenous carbohydrate-containing compounds in the cecum of the germfree rat Exp. Biol. Med. 1969 131 387 392 10.3181/00379727-131-33885
Loesche, W. J. Accumulation of endogenous carbohydrate-containing compounds in the cecum of the germfree rat. Exp. Biol. Med. 131, 387–392 (1969).
262. McVey Neufeld KA Perez‐Burgos A Mao YK Bienenstock J Kunze WA The gut microbiome restores intrinsic and extrinsic nerve function in germ‐free mice accompanied by changes in calbindin Neurogastroenterol. Motil. 2015 27 627 636 10.1111/nmo.12534 25727007
McVey Neufeld, K. A., Perez‐Burgos, A., Mao, Y. K., Bienenstock, J. & Kunze, W. A. The gut microbiome restores intrinsic and extrinsic nerve function in germ‐free mice accompanied by changes in calbindin. Neurogastroenterol. Motil. 27, 627–636 (2015).25727007
263. McVey Neufeld KA Mao YK Bienenstock J Foster JA Kunze WA The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse Neurogastroenterol. Motil. 2013 25 183 10.1111/nmo.12049 23181420
McVey Neufeld, K. A., Mao, Y. K., Bienenstock, J., Foster, J. A. & Kunze, W. A. The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse. Neurogastroenterol. Motil. 25, 183 (2013).23181420
264. Touw K Mutual reinforcement of pathophysiological host‐microbe interactions in intestinal stasis models Physiol. Rep. 2017 5 e13182 10.14814/phy2.13182 28320888
Touw, K. et al. Mutual reinforcement of pathophysiological host‐microbe interactions in intestinal stasis models. Physiol. Rep. 5, e13182 (2017).28320888
265. Niimi K Takahashi E New system to examine the activity and water and food intake of germ-free mice in a sealed positive-pressure cage Heliyon 2019 5 e02176 10.1016/j.heliyon.2019.e02176 31463382
Niimi, K. & Takahashi, E. New system to examine the activity and water and food intake of germ-free mice in a sealed positive-pressure cage. Heliyon 5, e02176 (2019).31463382
266. Jervis HR Biggers DC Mucosal enzymes in the cecum of conventional and germfree mice Anat. Rec. 1964 148 591 597 10.1002/ar.1091480410 14138162
Jervis, H. R. & Biggers, D. C. Mucosal enzymes in the cecum of conventional and germfree mice. Anat. Rec. 148, 591–597 (1964).14138162
267. Sumi Y Miyakawa M Kanzaki M Kotake Y Vitamin B-6 deficiency in germfree rats J. Nutr. 1977 107 1707 1714 10.1093/jn/107.9.1707 894368
Sumi, Y., Miyakawa, M., Kanzaki, M. & Kotake, Y. Vitamin B-6 deficiency in germfree rats. J. Nutr. 107, 1707–1714 (1977).894368
268. Ikeda M The differences of the metabolism related to vitamin B6-dependent enzymes among vitamin B6-deficient germ-free and conventional rats J. Nutr. Sci. Vitaminol. (Tokyo) 1979 25 131 139 10.3177/jnsv.25.131 501446
Ikeda, M. et al. The differences of the metabolism related to vitamin B6-dependent enzymes among vitamin B6-deficient germ-free and conventional rats. J. Nutr. Sci. Vitaminol. (Tokyo) 25, 131–139 (1979).501446
269. Hirayama K Uetsuka K Kuwabara Y Tamura M Itoh K Vitamin K deficiency of germfree mice caused by feeding standard purified diet sterilized by.GAMMA.-irradiation Exp. Anim. 2007 56 273 278 10.1538/expanim.56.273 17660681
Hirayama, K., Uetsuka, K., Kuwabara, Y., Tamura, M. & Itoh, K. Vitamin K deficiency of germfree mice caused by feeding standard purified diet sterilized by.GAMMA.-irradiation. Exp. Anim. 56, 273–278 (2007).17660681
270. Mishima E Germ-free conditions modulate host purine metabolism, exacerbating adenine-induced kidney damage Toxins 2020 12 547 10.3390/toxins12090547 32859011
Mishima, E. et al. Germ-free conditions modulate host purine metabolism, exacerbating adenine-induced kidney damage. Toxins 12, 547 (2020).32859011
271. Koopman, J. P. in Encyclopedia of Immunology 990–992 (Elsevier, 1998). 10.1006/rwei.1999.0256.
272. Hoces D Metabolic reconstitution of germ-free mice by a gnotobiotic microbiota varies over the circadian cycle PLoS Biol. 2022 20 e3001743 10.1371/journal.pbio.3001743 36126044
Hoces, D. et al. Metabolic reconstitution of germ-free mice by a gnotobiotic microbiota varies over the circadian cycle. PLoS Biol. 20, e3001743 (2022).36126044
273. Weger BD The mouse microbiome is required for sex-specific diurnal rhythms of gene expression and metabolism Cell Metab. 2019 29 362 382.e8 10.1016/j.cmet.2018.09.023 30344015
Weger, B. D. et al. The mouse microbiome is required for sex-specific diurnal rhythms of gene expression and metabolism. Cell Metab. 29, 362–382.e8 (2019).30344015
274. Sharma SP Suk KT Microbial influence on liver regeneration: understanding gut microbiota and hepatic recovery post partial hepatectomy Hepatobiliary Surg. Nutr. 2024 13 314 316 10.21037/hbsn-23-663 38617487
Sharma, S. P. & Suk, K. T. Microbial influence on liver regeneration: understanding gut microbiota and hepatic recovery post partial hepatectomy. Hepatobiliary Surg. Nutr. 13, 314–316 (2024).38617487
275. Xu Z Jiang N Xiao Y Yuan K Wang Z The role of gut microbiota in liver regeneration Front. Immunol. 2022 13 1003376 10.3389/fimmu.2022.1003376 36389782
Xu, Z., Jiang, N., Xiao, Y., Yuan, K. & Wang, Z. The role of gut microbiota in liver regeneration. Front. Immunol. 13, 1003376 (2022).36389782
276. Kennedy EA King KY Baldridge MT Mouse microbiota models: comparing germ-free mice and antibiotics treatment as tools for modifying gut bacteria Front. Physiol. 2018 9 1534 10.3389/fphys.2018.01534 30429801
Kennedy, E. A., King, K. Y. & Baldridge, M. T. Mouse microbiota models: comparing germ-free mice and antibiotics treatment as tools for modifying gut bacteria. Front. Physiol. 9, 1534 (2018).30429801
277. Wostmann BS Pleasants JR Bealmear P Kincade PW Serum proteins and lymphoid tissues in germ-free mice fed a chemically defined, water soluble, low molecular weight diet Immunology 1970 19 443 448 5471828
Wostmann, B. S., Pleasants, J. R., Bealmear, P. & Kincade, P. W. Serum proteins and lymphoid tissues in germ-free mice fed a chemically defined, water soluble, low molecular weight diet. Immunology 19, 443–448 (1970).5471828
278. Jung C Hugot J-P Barreau F Peyer’s patches: the immune sensors of the intestine Int. J. Inflamm. 2010 2010 1 12 10.4061/2010/823710
Jung, C., Hugot, J.-P. & Barreau, F. Peyer’s patches: the immune sensors of the intestine. Int. J. Inflamm. 2010, 1–12 (2010).
279. Konjar Š Ferreira C Blankenhaus B Veldhoen M Intestinal barrier interactions with specialized CD8 T cells Front. Immunol. 2017 8 1281 10.3389/fimmu.2017.01281 29075263
Konjar, Š., Ferreira, C., Blankenhaus, B. & Veldhoen, M. Intestinal barrier interactions with specialized CD8 T cells. Front. Immunol. 8, 1281 (2017).29075263
280. Ivanov II Induction of Intestinal Th17 Cells Segmented Filamentous Bact. Cell 2009 139 485 498
Ivanov, I. I. et al. Induction of Intestinal Th17. Cells Segmented Filamentous Bact. Cell 139, 485–498 (2009).
281. Schoenborn AA The enteric microbiota regulates jejunal Paneth cell number and function without impacting intestinal stem cells Gut Microbes 2019 10 45 58 10.1080/19490976.2018.1474321 29883265
Schoenborn, A. A. et al. The enteric microbiota regulates jejunal Paneth cell number and function without impacting intestinal stem cells. Gut Microbes 10, 45–58 (2019).29883265
282. Macpherson AJ McCoy KD Johansen F-E Brandtzaeg P The immune geography of IgA induction and function Mucosal Immunol. 2008 1 11 22 10.1038/mi.2007.6 19079156
Macpherson, A. J., McCoy, K. D., Johansen, F.-E. & Brandtzaeg, P. The immune geography of IgA induction and function. Mucosal Immunol. 1, 11–22 (2008).19079156
283. Round JL Mazmanian SK The gut microbiota shapes intestinal immune responses during health and disease Nat. Rev. Immunol. 2009 9 313 323 10.1038/nri2515 19343057
Round, J. L. & Mazmanian, S. K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313–323 (2009).19343057
284. Zaph C Commensal-dependent expression of IL-25 regulates the IL-23–IL-17 axis in the intestine J. Exp. Med. 2008 205 2191 2198 10.1084/jem.20080720 18762568
Zaph, C. et al. Commensal-dependent expression of IL-25 regulates the IL-23–IL-17 axis in the intestine. J. Exp. Med. 205, 2191–2198 (2008).18762568
285. Sprinz H The response of the germfree guinea pig to oral bacterial challenge with Escherichia coli and Shigella flexneri Am. J. Pathol. 1961 39 681 695 13915950
Sprinz, H. et al. The response of the germfree guinea pig to oral bacterial challenge with Escherichia coli and Shigella flexneri. Am. J. Pathol. 39, 681–695 (1961).13915950
286. Wang C Sjögren-like lacrimal keratoconjunctivitis in germ-free mice Int. J. Mol. Sci. 2018 19 565 10.3390/ijms19020565 29438346
Wang, C. et al. Sjögren-like lacrimal keratoconjunctivitis in germ-free mice. Int. J. Mol. Sci. 19, 565 (2018).29438346
287. Braniste, V. et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6 (2014).
288. Lu J Microbiota influence the development of the brain and behaviors in C57BL/6J mice PLoS ONE 2018 13 e0201829 10.1371/journal.pone.0201829 30075011
Lu, J. et al. Microbiota influence the development of the brain and behaviors in C57BL/6J mice. PLoS ONE 13, e0201829 (2018).30075011
289. Luczynski P Adult microbiota‐deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus Eur. J. Neurosci. 2016 44 2654 2666 10.1111/ejn.13291 27256072
Luczynski, P. et al. Adult microbiota‐deficient mice have distinct dendritic morphological changes: differential effects in the amygdala and hippocampus. Eur. J. Neurosci. 44, 2654–2666 (2016).27256072
290. Luczynski P Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior Int. J. Neuropsychopharmacol. 2016 19 pyw020 10.1093/ijnp/pyw020 26912607
Luczynski, P. et al. Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior. Int. J. Neuropsychopharmacol. 19, pyw020 (2016).26912607
291. Wu W-L Microbiota regulate social behaviour via stress response neurons in the brain Nature 2021 595 409 414 10.1038/s41586-021-03669-y 34194038
Wu, W.-L. et al. Microbiota regulate social behaviour via stress response neurons in the brain. Nature 595, 409–414 (2021).34194038
292. Cescon M Gut microbiota depletion delays somatic peripheral nerve development and impairs neuromuscular junction maturation Gut Microbes 2024 16 2363015 10.1080/19490976.2024.2363015 38845453
Cescon, M. et al. Gut microbiota depletion delays somatic peripheral nerve development and impairs neuromuscular junction maturation. Gut Microbes 16, 2363015 (2024).38845453
293. Mai, H. et al. Whole-body cellular mapping in mouse using standard IgG antibodies. Nat. Biotechnol. 42, 617–627. 10.1038/s41587-023-01846-0 (2023).
294. De Vadder F Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks Proc. Natl Acad. Sci. 2018 115 6458 6463 10.1073/pnas.1720017115 29866843
De Vadder, F. et al. Gut microbiota regulates maturation of the adult enteric nervous system via enteric serotonin networks. Proc. Natl Acad. Sci. 115, 6458–6463 (2018).29866843
295. Kabouridis PS Microbiota controls the homeostasis of glial cells in the gut lamina propria Neuron 2015 85 289 295 10.1016/j.neuron.2014.12.037 25578362
Kabouridis, P. S. et al. Microbiota controls the homeostasis of glial cells in the gut lamina propria. Neuron 85, 289–295 (2015).25578362
296. Shimizu K Normalization of reproductive function in germfree mice following bacterial contamination Exp. Anim. 1998 47 151 158 10.1538/expanim.47.151 9816490
Shimizu, K. et al. Normalization of reproductive function in germfree mice following bacterial contamination. Exp. Anim. 47, 151–158 (1998).9816490
297. Al-Asmakh M The gut microbiota and developmental programming of the testis in mice PLoS ONE 2014 9 e103809 10.1371/journal.pone.0103809 25118984
Al-Asmakh, M. et al. The gut microbiota and developmental programming of the testis in mice. PLoS ONE 9, e103809 (2014).25118984
298. Vahidi G Germ‐free C57BL /6 mice have increased bone mass and altered matrix properties but not decreased bone fracture resistance J. Bone Miner. Res. 2023 38 1154 1174 10.1002/jbmr.4835 37221143
Vahidi, G. et al. Germ‐free C57BL /6 mice have increased bone mass and altered matrix properties but not decreased bone fracture resistance. J. Bone Miner. Res. 38, 1154–1174 (2023).37221143
299. Ohlsson C Regulation of bone mass by the gut microbiota is dependent on NOD1 and NOD2 signaling Cell. Immunol. 2017 317 55 58 10.1016/j.cellimm.2017.05.003 28576260
Ohlsson, C. et al. Regulation of bone mass by the gut microbiota is dependent on NOD1 and NOD2 signaling. Cell. Immunol. 317, 55–58 (2017).28576260
300. Czernik PJ Reconstitution of the host holobiont in germ-free born male rats acutely increases bone growth and affects marrow cellular content Physiol. Genomics 2021 53 518 533 10.1152/physiolgenomics.00017.2021 34714176
Czernik, P. J. et al. Reconstitution of the host holobiont in germ-free born male rats acutely increases bone growth and affects marrow cellular content. Physiol. Genomics 53, 518–533 (2021).34714176
301. Lahiri S The gut microbiota influences skeletal muscle mass and function in mice Sci. Transl. Med. 2019 11 eaan5662 10.1126/scitranslmed.aan5662 31341063
Lahiri, S. et al. The gut microbiota influences skeletal muscle mass and function in mice. Sci. Transl. Med. 11, eaan5662 (2019).31341063
302. Qiu Y Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling Ann. Med. 2021 53 508 522 10.1080/07853890.2021.1900593 33783283
Qiu, Y. et al. Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling. Ann. Med. 53, 508–522 (2021).33783283
303. Yan H Gut microbiota can transfer fiber characteristics and lipid metabolic profiles of skeletal muscle from pigs to germ-free mice Sci. Rep. 2016 6 31786 10.1038/srep31786 27545196
Yan, H. et al. Gut microbiota can transfer fiber characteristics and lipid metabolic profiles of skeletal muscle from pigs to germ-free mice. Sci. Rep. 6, 31786 (2016).27545196
304. Bäckhed F The gut microbiota as an environmental factor that regulates fat storage Proc. Natl Acad. Sci. 2004 101 15718 15723 10.1073/pnas.0407076101 15505215
Bäckhed, F. et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. 101, 15718–15723 (2004).15505215
305. Mestdagh R Gut microbiota modulate the metabolism of brown adipose tissue in mice J. Proteome Res. 2012 11 620 630 10.1021/pr200938v 22053906
Mestdagh, R. et al. Gut microbiota modulate the metabolism of brown adipose tissue in mice. J. Proteome Res. 11, 620–630 (2012).22053906
306. Suárez-Zamorano N Microbiota depletion promotes browning of white adipose tissue and reduces obesity Nat. Med. 2015 21 1497 1501 10.1038/nm.3994 26569380
Suárez-Zamorano, N. et al. Microbiota depletion promotes browning of white adipose tissue and reduces obesity. Nat. Med. 21, 1497–1501 (2015).26569380
307. Bäckhed F Manchester JK Semenkovich CF Gordon JI Mechanisms underlying the resistance to diet-induced obesity in germ-free mice Proc. Natl Acad. Sci. 2007 104 979 984 10.1073/pnas.0605374104 17210919
Bäckhed, F., Manchester, J. K., Semenkovich, C. F. & Gordon, J. I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl Acad. Sci. 104, 979–984 (2007).17210919
308. Kim HJ Microbiota influences host exercise capacity via modulation of skeletal muscle glucose metabolism in mice Exp. Mol. Med. 2023 55 1820 1830 10.1038/s12276-023-01063-4 37542180
Kim, H. J. et al. Microbiota influences host exercise capacity via modulation of skeletal muscle glucose metabolism in mice. Exp. Mol. Med. 55, 1820–1830 (2023).37542180
309. Uberoi A Commensal microbiota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor Cell Host Microbe 2021 29 1235 1248.e8 10.1016/j.chom.2021.05.011 34214492
Uberoi, A. et al. Commensal microbiota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor. Cell Host Microbe 29, 1235–1248.e8 (2021).34214492
310. Wang G Bacteria induce skin regeneration via IL-1β signaling Cell Host Microbe 2021 29 777 791.e6 10.1016/j.chom.2021.03.003 33798492
Wang, G. et al. Bacteria induce skin regeneration via IL-1β signaling. Cell Host Microbe 29, 777–791.e6 (2021).33798492
311. Tazume S Effects of germfree status and food restriction on longevity and growth of mice Exp. Anim. 1991 40 517 522 10.1538/expanim1978.40.4_517
Tazume, S. et al. Effects of germfree status and food restriction on longevity and growth of mice. Exp. Anim. 40, 517–522 (1991).
312. Gordon HA Bruckner-kardoss E Wostmann BS Aging in germ-free mice: life tables and lesions observed at natural death J. Gerontol. 1966 21 380 387 10.1093/geronj/21.3.380 5944800
Gordon, H. A., Bruckner-kardoss, E. & Wostmann, B. S. Aging in germ-free mice: life tables and lesions observed at natural death. J. Gerontol. 21, 380–387 (1966).5944800
313. Gilbert JA Neufeld JD Life in a world without microbes PLoS Biol. 2014 12 e1002020 10.1371/journal.pbio.1002020 25513890
Gilbert, J. A. & Neufeld, J. D. Life in a world without microbes. PLoS Biol. 12, e1002020 (2014).25513890
314. Olm MR Robust variation in infant gut microbiome assembly across a spectrum of lifestyles Science 2022 376 1220 1223 10.1126/science.abj2972 35679413
Olm, M. R. et al. Robust variation in infant gut microbiome assembly across a spectrum of lifestyles. Science 376, 1220–1223 (2022).35679413
315. Blaser MJ Falkow S What are the consequences of the disappearing human microbiota? Nat. Rev. Microbiol. 2009 7 887 894 10.1038/nrmicro2245 19898491
Blaser, M. J. & Falkow, S. What are the consequences of the disappearing human microbiota? Nat. Rev. Microbiol. 7, 887–894 (2009).19898491
316. Clemente JC The microbiome of uncontacted Amerindians Sci. Adv. 2015 1 e1500183 10.1126/sciadv.1500183 26229982
Clemente, J. C. et al. The microbiome of uncontacted Amerindians. Sci. Adv. 1, e1500183 (2015).26229982
317. Sonnenburg ED Diet-induced extinctions in the gut microbiota compound over generations Nature 2016 529 212 215 10.1038/nature16504 26762459
Sonnenburg, E. D. et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature 529, 212–215 (2016).26762459
318. Carter, M. M. et al. Ultra-deep sequencing of Hadza hunter-gatherers recovers vanishing gut microbes. Cell 186, 3111–3124.e13 (2023).
319. Wu, J., Wang, Q., Wang, D., Wong, A. C. N. & Wang, G.-H. Axenic and gnotobiotic insect technologies in research on host–microbiota interactions. Trends Microbiol. 31, 858–871 (2023).
320. Sagan L On the origin of mitosing cells J. Theor. Biol. 1967 14 225 IN6 10.1016/0022-5193(67)90079-3
Sagan, L. On the origin of mitosing cells. J. Theor. Biol. 14, 225–IN6 (1967).
321. Moreira D Le Guyader H Philippe H The origin of red algae and the evolution of chloroplasts Nature 2000 405 69 72 10.1038/35011054 10811219
Moreira, D., Le Guyader, H. & Philippe, H. The origin of red algae and the evolution of chloroplasts. Nature 405, 69–72 (2000).10811219
322. Fan L Phylogenetic analyses with systematic taxon sampling show that mitochondria branch within Alphaproteobacteria Nat. Ecol. Evol. 2020 4 1213 1219 10.1038/s41559-020-1239-x 32661403
Fan, L. et al. Phylogenetic analyses with systematic taxon sampling show that mitochondria branch within Alphaproteobacteria. Nat. Ecol. Evol. 4, 1213–1219 (2020).32661403
323. Gogoi J Switching a conflicted bacterial DTD-tRNA code is essential for the emergence of mitochondria Sci. Adv. 2022 8 eabj7307 10.1126/sciadv.abj7307 35020439
Gogoi, J. et al. Switching a conflicted bacterial DTD-tRNA code is essential for the emergence of mitochondria. Sci. Adv. 8, eabj7307 (2022).35020439
324. Lederberg J Infectious History Science 2000 288 287 293 10.1126/science.288.5464.287 10777411
Lederberg, J. Infectious History. Science 288, 287–293 (2000).10777411
325. Coale TH Nitrogen-fixing organelle in a marine alga Science 2024 384 217 222 10.1126/science.adk1075 38603509
Coale, T. H. et al. Nitrogen-fixing organelle in a marine alga. Science 384, 217–222 (2024).38603509
326. Boyd BM Stochasticity, determinism, and contingency shape genome evolution of endosymbiotic bacteria Nat. Commun. 2024 15 4571 10.1038/s41467-024-48784-2 38811551
Boyd, B. M. et al. Stochasticity, determinism, and contingency shape genome evolution of endosymbiotic bacteria. Nat. Commun. 15, 4571 (2024).38811551
327. Baedke J Fábregas‐Tejeda A Nieves Delgado A The holobiont concept before Margulis J. Exp. Zool. B: Mol. Dev. Evol. 2020 334 149 155 10.1002/jez.b.22931 32039567
Baedke, J., Fábregas‐Tejeda, A. & Nieves Delgado, A. The holobiont concept before Margulis. J. Exp. Zool. B: Mol. Dev. Evol. 334, 149–155 (2020).32039567
328. Margulis L Fester R Bellagio conference and book. Symbiosis as Source of Evolutionary Innovation: Speciation and Morphogenesis. Conference-June 25-30, 1989, Bellagio Conference Center, Italy Symbiosis Phila. Pa 1991 11 93 101
Margulis, L. & Fester, R. Bellagio conference and book. Symbiosis as Source of Evolutionary Innovation: Speciation and Morphogenesis. Conference-June 25-30, 1989, Bellagio Conference Center, Italy. Symbiosis Phila. Pa 11, 93–101 (1991).
329. Turnbaugh PJ The Human Microbiome Project Nature 2007 449 804 810 10.1038/nature06244 17943116
Turnbaugh, P. J. et al. The Human Microbiome Project. Nature 449, 804–810 (2007).17943116
330. King IL Divangahi M Training the metaorganism: the microbial counterpart Cell 2021 184 574 576 10.1016/j.cell.2021.01.009 33545033
King, I. L. & Divangahi, M. Training the metaorganism: the microbial counterpart. Cell 184, 574–576 (2021).33545033
331. Gill SR Metagenomic analysis of the human distal gut microbiome Science 2006 312 1355 1359 10.1126/science.1124234 16741115
Gill, S. R. et al. Metagenomic analysis of the human distal gut microbiome. Science 312, 1355–1359 (2006).16741115
332. Macpherson AJ Do the microbiota influence vaccines and protective immunity to pathogens?: issues of sovereignty, federalism, and points-testing in the prokaryotic and eukaryotic spaces of the host-microbial superorganism Cold Spring Harb. Perspect. Biol. 2018 10 a029363 10.1101/cshperspect.a029363 28432128
Macpherson, A. J. Do the microbiota influence vaccines and protective immunity to pathogens?: issues of sovereignty, federalism, and points-testing in the prokaryotic and eukaryotic spaces of the host-microbial superorganism. Cold Spring Harb. Perspect. Biol. 10, a029363 (2018).28432128
333. Thaiss CA Zeevi D Levy M Segal E Elinav E A day in the life of the meta-organism: diurnal rhythms of the intestinal microbiome and its host Gut Microbes 2015 6 137 142 10.1080/19490976.2015.1016690 25901892
Thaiss, C. A., Zeevi, D., Levy, M., Segal, E. & Elinav, E. A day in the life of the meta-organism: diurnal rhythms of the intestinal microbiome and its host. Gut Microbes 6, 137–142 (2015).25901892
334. Muegge BD Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans Science 2011 332 970 974 10.1126/science.1198719 21596990
Muegge, B. D. et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 332, 970–974 (2011).21596990
335. Segre JA Salafsky N Hominid superorganisms Science 2016 353 350 351 10.1126/science.aag2788 27463659
Segre, J. A. & Salafsky, N. Hominid superorganisms. Science 353, 350–351 (2016).27463659
336. Wenseleers T The superorganism revisited BioScience 2009 59 702 705 10.1525/bio.2009.59.8.12
Wenseleers, T. The superorganism revisited. BioScience 59, 702–705 (2009).
337. Jefferson, R. Agriculture and the Third World. 1089446492 Bytes. 10.6084/M9.FIGSHARE.7945781 (2019).
338. Rosenberg E Koren O Reshef L Efrony R Zilber-Rosenberg I The role of microorganisms in coral health, disease and evolution Nat. Rev. Microbiol. 2007 5 355 362 10.1038/nrmicro1635 17384666
Rosenberg, E., Koren, O., Reshef, L., Efrony, R. & Zilber-Rosenberg, I. The role of microorganisms in coral health, disease and evolution. Nat. Rev. Microbiol. 5, 355–362 (2007).17384666
339. Zilber-Rosenberg I Rosenberg E Role of microorganisms in the evolution of animals and plants: the hologenome theory of evolution FEMS Microbiol. Rev. 2008 32 723 735 10.1111/j.1574-6976.2008.00123.x 18549407
Zilber-Rosenberg, I. & Rosenberg, E. Role of microorganisms in the evolution of animals and plants: the hologenome theory of evolution. FEMS Microbiol. Rev. 32, 723–735 (2008).18549407
340. Rosenberg E Zilber-Rosenberg I The hologenome concept of evolution after 10 years Microbiome 2018 6 78 10.1186/s40168-018-0457-9 29695294
Rosenberg, E. & Zilber-Rosenberg, I. The hologenome concept of evolution after 10 years. Microbiome 6, 78 (2018).29695294
341. Alberdi A Andersen SB Limborg MT Dunn RR Gilbert MTP Disentangling host–microbiota complexity through hologenomics Nat. Rev. Genet. 2022 23 281 297 10.1038/s41576-021-00421-0 34675394
Alberdi, A., Andersen, S. B., Limborg, M. T., Dunn, R. R. & Gilbert, M. T. P. Disentangling host–microbiota complexity through hologenomics. Nat. Rev. Genet. 23, 281–297 (2022).34675394
342. Liu H Symbiodinium genomes reveal adaptive evolution of functions related to coral-dinoflagellate symbiosis Commun. Biol. 2018 1 95 10.1038/s42003-018-0098-3 30271976
Liu, H. et al. Symbiodinium genomes reveal adaptive evolution of functions related to coral-dinoflagellate symbiosis. Commun. Biol. 1, 95 (2018).30271976
343. Rosado PM Marine probiotics: increasing coral resistance to bleaching through microbiome manipulation ISME J. 2019 13 921 936 10.1038/s41396-018-0323-6 30518818
Rosado, P. M. et al. Marine probiotics: increasing coral resistance to bleaching through microbiome manipulation. ISME J. 13, 921–936 (2019).30518818
344. Dove SG Brown KT Van Den Heuvel A Chai A Hoegh-Guldberg O Ocean warming and acidification uncouple calcification from calcifier biomass which accelerates coral reef decline Commun. Earth Environ. 2020 1 55 10.1038/s43247-020-00054-x
Dove, S. G., Brown, K. T., Van Den Heuvel, A., Chai, A. & Hoegh-Guldberg, O. Ocean warming and acidification uncouple calcification from calcifier biomass which accelerates coral reef decline. Commun. Earth Environ. 1, 55 (2020).
345. Vanwonterghem I Webster NS Coral reef microorganisms in a changing climate iScience 2020 23 100972 10.1016/j.isci.2020.100972 32208346
Vanwonterghem, I. & Webster, N. S. Coral reef microorganisms in a changing climate. iScience 23, 100972 (2020).32208346
346. Biget M Evaluating the hologenome concept by analyzing the root-endosphere microbiota of chimeric plants iScience 2023 26 106031 10.1016/j.isci.2023.106031 36824281
Biget, M. et al. Evaluating the hologenome concept by analyzing the root-endosphere microbiota of chimeric plants. iScience 26, 106031 (2023).36824281
347. Suárez J Triviño V What Is a hologenomic adaptation? emergent individuality and inter-identity in multispecies systems Front. Psychol. 2020 11 187 10.3389/fpsyg.2020.00187 32194470
Suárez, J. & Triviño, V. What Is a hologenomic adaptation? emergent individuality and inter-identity in multispecies systems. Front. Psychol. 11, 187 (2020).32194470
348. Zepeda Mendoza ML Hologenomic adaptations underlying the evolution of sanguivory in the common vampire bat Nat. Ecol. Evol. 2018 2 659 668 10.1038/s41559-018-0476-8 29459707
Zepeda Mendoza, M. L. et al. Hologenomic adaptations underlying the evolution of sanguivory in the common vampire bat. Nat. Ecol. Evol. 2, 659–668 (2018).29459707
349. Shigenobu S Watanabe H Hattori M Sakaki Y Ishikawa H Genome sequence of the endocellular bacterial symbiont of aphids Buchnera sp. APS Nature 2000 407 81 86 10.1038/35024074 10993077
Shigenobu, S., Watanabe, H., Hattori, M., Sakaki, Y. & Ishikawa, H. Genome sequence of the endocellular bacterial symbiont of aphids Buchnera sp. APS. Nature 407, 81–86 (2000).10993077
350. Hansen AK Moran NA Aphid genome expression reveals host–symbiont cooperation in the production of amino acids Proc. Natl Acad. Sci. 2011 108 2849 2854 10.1073/pnas.1013465108 21282658
Hansen, A. K. & Moran, N. A. Aphid genome expression reveals host–symbiont cooperation in the production of amino acids. Proc. Natl Acad. Sci. 108, 2849–2854 (2011).21282658
351. Bennett GM Moran NA Heritable symbiosis: the advantages and perils of an evolutionary rabbit hole Proc. Natl Acad. Sci. 2015 112 10169 10176 10.1073/pnas.1421388112 25713367
Bennett, G. M. & Moran, N. A. Heritable symbiosis: the advantages and perils of an evolutionary rabbit hole. Proc. Natl Acad. Sci. 112, 10169–10176 (2015).25713367
352. Moran NA Symbiosis as an adaptive process and source of phenotypic complexity Proc. Natl Acad. Sci. 2007 104 8627 8633 10.1073/pnas.0611659104 17494762
Moran, N. A. Symbiosis as an adaptive process and source of phenotypic complexity. Proc. Natl Acad. Sci. 104, 8627–8633 (2007).17494762
353. Lebreton F Tracing the enterococci from paleozoic origins to the hospital Cell 2017 169 849 861.e13 10.1016/j.cell.2017.04.027 28502769
Lebreton, F. et al. Tracing the enterococci from paleozoic origins to the hospital. Cell 169, 849–861.e13 (2017).28502769
354. Kutschera U Darwin–Wallace principle of natural selection Nature 2008 453 27 27 10.1038/453027b 18451834
Kutschera, U. Darwin–Wallace principle of natural selection. Nature 453, 27–27 (2008).18451834
355. Wallace, R. Extending the modern synthesis: the evolution of ecosystems. Nat. Preced. 10.1038/npre.2010.4496.2 (2010).
356. Gardner A The genetical theory of multilevel selection J. Evol. Biol. 2015 28 305 319 10.1111/jeb.12566 25475922
Gardner, A. The genetical theory of multilevel selection. J. Evol. Biol. 28, 305–319 (2015).25475922
357. Suzuki TA Ley RE The role of the microbiota in human genetic adaptation Science 2020 370 eaaz6827 10.1126/science.aaz6827 33273073
Suzuki, T. A. & Ley, R. E. The role of the microbiota in human genetic adaptation. Science 370, eaaz6827 (2020).33273073
358. Henry LP Bruijning M Forsberg SKG Ayroles JF The microbiome extends host evolutionary potential Nat. Commun. 2021 12 5141 10.1038/s41467-021-25315-x 34446709
Henry, L. P., Bruijning, M., Forsberg, S. K. G. & Ayroles, J. F. The microbiome extends host evolutionary potential. Nat. Commun. 12, 5141 (2021).34446709
359. Ferreiro A Crook N Gasparrini AJ Dantas G Multiscale evolutionary dynamics of host-associated microbiomes Cell 2018 172 1216 1227 10.1016/j.cell.2018.02.015 29522743
Ferreiro, A., Crook, N., Gasparrini, A. J. & Dantas, G. Multiscale evolutionary dynamics of host-associated microbiomes. Cell 172, 1216–1227 (2018).29522743
360. Grice EA Segre JA The human microbiome: our second genome Annu. Rev. Genomics Hum. Genet. 2012 13 151 170 10.1146/annurev-genom-090711-163814 22703178
Grice, E. A. & Segre, J. A. The human microbiome: our second genome. Annu. Rev. Genomics Hum. Genet. 13, 151–170 (2012).22703178
361. Zhang X Brain control of humoral immune responses amenable to behavioural modulation Nature 2020 581 204 208 10.1038/s41586-020-2235-7 32405000
Zhang, X. et al. Brain control of humoral immune responses amenable to behavioural modulation. Nature 581, 204–208 (2020).32405000
362. Akkaya M Kwak K Pierce SK B cell memory: building two walls of protection against pathogens Nat. Rev. Immunol. 2020 20 229 238 10.1038/s41577-019-0244-2 31836872
Akkaya, M., Kwak, K. & Pierce, S. K. B cell memory: building two walls of protection against pathogens. Nat. Rev. Immunol. 20, 229–238 (2020).31836872
363. Jin, H., Li, M., Jeong, E., Castro-Martinez, F. & Zuker, C. S. A body–brain circuit that regulates body inflammatory responses. Nature 630, 695–703 (2024).
364. Nagashima, K. et al. Mapping the T cell repertoire to a complex gut bacterial community. Nature 621, 162–170 (2023).
365. Omenetti S The intestine harbors functionally distinct homeostatic tissue-resident and inflammatory Th17 cells Immunity 2019 51 77 89.e6 10.1016/j.immuni.2019.05.004 31229354
Omenetti, S. et al. The intestine harbors functionally distinct homeostatic tissue-resident and inflammatory Th17 cells. Immunity 51, 77–89.e6 (2019).31229354
366. Moor K High-avidity IgA protects the intestine by enchaining growing bacteria Nature 2017 544 498 502 10.1038/nature22058 28405025
Moor, K. et al. High-avidity IgA protects the intestine by enchaining growing bacteria. Nature 544, 498–502 (2017).28405025
367. Rollenske T Parallelism of intestinal secretory IgA shapes functional microbial fitness Nature 2021 598 657 661 10.1038/s41586-021-03973-7 34646015
Rollenske, T. et al. Parallelism of intestinal secretory IgA shapes functional microbial fitness. Nature 598, 657–661 (2021).34646015
368. Huus KE Petersen C Finlay BB Diversity and dynamism of IgA−microbiota interactions Nat. Rev. Immunol. 2021 21 514 525 10.1038/s41577-021-00506-1 33568782
Huus, K. E., Petersen, C. & Finlay, B. B. Diversity and dynamism of IgA−microbiota interactions. Nat. Rev. Immunol. 21, 514–525 (2021).33568782
369. Moreno-Sabater, A. et al. Intestinal Candida albicans overgrowth in IgA deficiency. J. Allergy Clin. Immunol. 152, 748–759.e3. (2023).
370. Conrey PE IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulation Sci. Immunol. 2023 8 eade2335 10.1126/sciimmunol.ade2335 37235682
Conrey, P. E. et al. IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulation. Sci. Immunol. 8, eade2335 (2023).37235682
371. Zhang C An overview of host‐derived molecules that interact with gut microbiota iMeta 2023 2 e88 10.1002/imt2.88 38868433
Zhang, C. et al. An overview of host‐derived molecules that interact with gut microbiota. iMeta 2, e88 (2023).38868433
372. Herr AB White CL Milburn C Wu C Bjorkman PJ Bivalent binding of IgA1 to FcαRI suggests a mechanism for cytokine activation of IgA phagocytosis J. Mol. Biol. 2003 327 645 657 10.1016/S0022-2836(03)00149-9 12634059
Herr, A. B., White, C. L., Milburn, C., Wu, C. & Bjorkman, P. J. Bivalent binding of IgA1 to FcαRI suggests a mechanism for cytokine activation of IgA phagocytosis. J. Mol. Biol. 327, 645–657 (2003).12634059
373. Donaldson GP Gut microbiota utilize immunoglobulin A for mucosal colonization Science 2018 360 795 800 10.1126/science.aaq0926 29724905
Donaldson, G. P. et al. Gut microbiota utilize immunoglobulin A for mucosal colonization. Science 360, 795–800 (2018).29724905
374. Li Y Wang J Wang R Chang Y Wang X Gut bacteria induce IgA expression in pituitary hormone-secreting cells during aging iScience 2023 26 107747 10.1016/j.isci.2023.107747 37692284
Li, Y., Wang, J., Wang, R., Chang, Y. & Wang, X. Gut bacteria induce IgA expression in pituitary hormone-secreting cells during aging. iScience 26, 107747 (2023).37692284
375. Lazzaro BP Zasloff M Rolff J Antimicrobial peptides: application informed by evolution Science 2020 368 eaau5480 10.1126/science.aau5480 32355003
Lazzaro, B. P., Zasloff, M. & Rolff, J. Antimicrobial peptides: application informed by evolution. Science 368, eaau5480 (2020).32355003
376. Mookherjee N Anderson MA Haagsman HP Davidson DJ Antimicrobial host defence peptides: functions and clinical potential Nat. Rev. Drug Discov. 2020 19 311 332 10.1038/s41573-019-0058-8 32107480
Mookherjee, N., Anderson, M. A., Haagsman, H. P. & Davidson, D. J. Antimicrobial host defence peptides: functions and clinical potential. Nat. Rev. Drug Discov. 19, 311–332 (2020).32107480
377. Jarret A Enteric nervous system-derived IL-18 orchestrates mucosal barrier immunity Cell 2020 180 50 63.e12 10.1016/j.cell.2019.12.016 31923399
Jarret, A. et al. Enteric nervous system-derived IL-18 orchestrates mucosal barrier immunity. Cell 180, 50–63.e12 (2020).31923399
378. Pierre JF Peptide YY: a Paneth cell antimicrobial peptide that maintains Candida gut commensalism Science 2023 381 502 508 10.1126/science.abq3178 37535745
Pierre, J. F. et al. Peptide YY: a Paneth cell antimicrobial peptide that maintains Candida gut commensalism. Science 381, 502–508 (2023).37535745
379. Unckless RL Howick VM Lazzaro BP Convergent balancing selection on an antimicrobial peptide in Drosophila Curr. Biol. 2016 26 257 262 10.1016/j.cub.2015.11.063 26776733
Unckless, R. L., Howick, V. M. & Lazzaro, B. P. Convergent balancing selection on an antimicrobial peptide in Drosophila. Curr. Biol. 26, 257–262 (2016).26776733
380. Unckless RL Lazzaro BP The potential for adaptive maintenance of diversity in insect antimicrobial peptides Philos. Trans. R. Soc. B: Biol. Sci. 2016 371 20150291 10.1098/rstb.2015.0291
Unckless, R. L. & Lazzaro, B. P. The potential for adaptive maintenance of diversity in insect antimicrobial peptides. Philos. Trans. R. Soc. B: Biol. Sci. 371, 20150291 (2016).
381. Zanchi C Johnston PR Rolff J Evolution of defence cocktails: antimicrobial peptide combinations reduce mortality and persistent infection Mol. Ecol. 2017 26 5334 5343 10.1111/mec.14267 28762573
Zanchi, C., Johnston, P. R. & Rolff, J. Evolution of defence cocktails: antimicrobial peptide combinations reduce mortality and persistent infection. Mol. Ecol. 26, 5334–5343 (2017).28762573
382. Hanson MA Grollmus L Lemaitre B Ecology-relevant bacteria drive the evolution of host antimicrobial peptides in Drosoph. Sci. 2023 381 eadg5725 10.1126/science.adg5725
Hanson, M. A., Grollmus, L. & Lemaitre, B. Ecology-relevant bacteria drive the evolution of host antimicrobial peptides in. Drosoph. Sci. 381, eadg5725 (2023).
383. Nakatsuji T Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis Sci. Transl. Med. 2017 9 eaah4680 10.1126/scitranslmed.aah4680 28228596
Nakatsuji, T. et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci. Transl. Med. 9, eaah4680 (2017).28228596
384. Mukherjee S Hooper LV Antimicrobial defense of the Intestine Immunity 2015 42 28 39 10.1016/j.immuni.2014.12.028 25607457
Mukherjee, S. & Hooper, L. V. Antimicrobial defense of the Intestine. Immunity 42, 28–39 (2015).25607457
385. McDonough KA Rodriguez A The myriad roles of cyclic AMP in microbial pathogens: from signal to sword Nat. Rev. Microbiol. 2012 10 27 38 10.1038/nrmicro2688
McDonough, K. A. & Rodriguez, A. The myriad roles of cyclic AMP in microbial pathogens: from signal to sword. Nat. Rev. Microbiol. 10, 27–38 (2012).
386. Friedman ES Microbes vs. chemistry in the origin of the anaerobic gut lumen Proc. Natl Acad. Sci. 2018 115 4170 4175 10.1073/pnas.1718635115 29610310
Friedman, E. S. et al. Microbes vs. chemistry in the origin of the anaerobic gut lumen. Proc. Natl Acad. Sci. 115, 4170–4175 (2018).29610310
387. Litvak Y Byndloss MX Bäumler AJ Colonocyte metabolism shapes the gut microbiota Science 2018 362 eaat9076 10.1126/science.aat9076 30498100
Litvak, Y., Byndloss, M. X. & Bäumler, A. J. Colonocyte metabolism shapes the gut microbiota. Science 362, eaat9076 (2018).30498100
388. Yang H ABO genotype alters the gut microbiota by regulating GalNAc levels in pigs Nature 2022 606 358 367 10.1038/s41586-022-04769-z 35477154
Yang, H. et al. ABO genotype alters the gut microbiota by regulating GalNAc levels in pigs. Nature 606, 358–367 (2022).35477154
389. Zhernakova DV Host genetic regulation of human gut microbial structural variation Nature 2024 625 813 821 10.1038/s41586-023-06893-w 38172637
Zhernakova, D. V. et al. Host genetic regulation of human gut microbial structural variation. Nature 625, 813–821 (2024).38172637
390. Berry D Host-compound foraging by intestinal microbiota revealed by single-cell stable isotope probing Proc. Natl Acad. Sci. 2013 110 4720 4725 10.1073/pnas.1219247110 23487774
Berry, D. et al. Host-compound foraging by intestinal microbiota revealed by single-cell stable isotope probing. Proc. Natl Acad. Sci. 110, 4720–4725 (2013).23487774
391. Cani, P. D., Depommier, C., Derrien, M., Everard, A. & de Vos, W. M. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat. Rev. Gastroenterol. Hepatol. 19, 625–637 (2022).
392. Schwerd T NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease Mucosal Immunol. 2018 11 562 574 10.1038/mi.2017.74 29091079
Schwerd, T. et al. NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunol. 11, 562–574 (2018).29091079
393. Murdoch, C. C. & Skaar, E. P. Nutritional immunity: the battle for nutrient metals at the host–pathogen interface. Nat. Rev. Microbiol. 20, 657–670. 10.1038/s41579-022-00745-6 (2022).
394. Bessman NJ Dendritic cell–derived hepcidin sequesters iron from the microbiota to promote mucosal healing Science 2020 368 186 189 10.1126/science.aau6481 32273468
Bessman, N. J. et al. Dendritic cell–derived hepcidin sequesters iron from the microbiota to promote mucosal healing. Science 368, 186–189 (2020).32273468
395. Van Niel G D’Angelo G Raposo G Shedding light on the cell biology of extracellular vesicles Nat. Rev. Mol. Cell Biol. 2018 19 213 228 10.1038/nrm.2017.125 29339798
Van Niel, G., D’Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213–228 (2018).29339798
396. Malmuthuge N Guan LL Noncoding RNAs: regulatory molecules of host–microbiome crosstalk Trends Microbiol. 2021 29 713 724 10.1016/j.tim.2020.12.003 33419590
Malmuthuge, N. & Guan, L. L. Noncoding RNAs: regulatory molecules of host–microbiome crosstalk. Trends Microbiol. 29, 713–724 (2021).33419590
397. Liu S The host shapes the gut microbiota via fecal MicroRNA Cell Host Microbe 2016 19 32 43 10.1016/j.chom.2015.12.005 26764595
Liu, S. et al. The host shapes the gut microbiota via fecal MicroRNA. Cell Host Microbe 19, 32–43 (2016).26764595
398. Zhu Z Gut microbiota regulate tumor metastasis via circRNA/miRNA networks Gut Microbes 2020 12 1788891 10.1080/19490976.2020.1788891 32686598
Zhu, Z. et al. Gut microbiota regulate tumor metastasis via circRNA/miRNA networks. Gut Microbes 12, 1788891 (2020).32686598
399. Abdullah ST Role of circular RNAs and gut microbiome in gastrointestinal cancers and therapeutic targets Non-Coding RNA Res. 2024 9 236 252 10.1016/j.ncrna.2023.12.002
Abdullah, S. T. et al. Role of circular RNAs and gut microbiome in gastrointestinal cancers and therapeutic targets. Non-Coding RNA Res. 9, 236–252 (2024).
400. Lyte M Ernst S Catecholamine induced growth of gram negative bacteria Life Sci. 1992 50 203 212 10.1016/0024-3205(92)90273-R 1731173
Lyte, M. & Ernst, S. Catecholamine induced growth of gram negative bacteria. Life Sci. 50, 203–212 (1992).1731173
401. Lyte M The role of microbial endocrinology in infectious disease J. Endocrinol. 1993 137 343 345 10.1677/joe.0.1370343 8371072
Lyte, M. The role of microbial endocrinology in infectious disease. J. Endocrinol. 137, 343–345 (1993).8371072
402. Gao A Sexual dimorphism in glucose metabolism is shaped by androgen-driven gut microbiome Nat. Commun. 2021 12 7080 10.1038/s41467-021-27187-7 34873153
Gao, A. et al. Sexual dimorphism in glucose metabolism is shaped by androgen-driven gut microbiome. Nat. Commun. 12, 7080 (2021).34873153
403. Ibrahim A Colitis‐induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity Int. J. Cancer 2019 144 3086 3098 10.1002/ijc.32037 30515752
Ibrahim, A. et al. Colitis‐induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity. Int. J. Cancer 144, 3086–3098 (2019).30515752
404. Guan Z Estrogen deficiency induces bone loss through the gut microbiota Pharmacol. Res. 2023 196 106930 10.1016/j.phrs.2023.106930 37722518
Guan, Z. et al. Estrogen deficiency induces bone loss through the gut microbiota. Pharmacol. Res. 196, 106930 (2023).37722518
405. Li J-Y Sex steroid deficiency–associated bone loss is microbiota dependent and prevented by probiotics J. Clin. Invest. 2016 126 2049 2063 10.1172/JCI86062 27111232
Li, J.-Y. et al. Sex steroid deficiency–associated bone loss is microbiota dependent and prevented by probiotics. J. Clin. Invest. 126, 2049–2063 (2016).27111232
406. Hiller CC Influence of catecholamines on biofilm formation by Salmonella Enteritidis Microb. Pathog. 2019 130 54 58 10.1016/j.micpath.2019.02.032 30831229
Hiller, C. C. et al. Influence of catecholamines on biofilm formation by Salmonella Enteritidis. Microb. Pathog. 130, 54–58 (2019).30831229
407. Asano Y Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice Am. J. Physiol.—Gastrointest. Liver Physiol. 2012 303 G1288 G1295 10.1152/ajpgi.00341.2012 23064760
Asano, Y. et al. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am. J. Physiol.—Gastrointest. Liver Physiol. 303, G1288–G1295 (2012).23064760
408. Yang D Kong Y Sun W Kong W Shi Y A dopamine-responsive signal transduction controls transcription of Salmonella enterica serovar typhimurium virulence genes mBio 2019 10 e02772 18 10.1128/mBio.02772-18 30992361
Yang, D., Kong, Y., Sun, W., Kong, W. & Shi, Y. A dopamine-responsive signal transduction controls transcription of Salmonella enterica serovar typhimurium virulence genes. mBio 10, e02772–18 (2019).30992361
409. Scheiman J Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism Nat. Med. 2019 25 1104 1109 10.1038/s41591-019-0485-4 31235964
Scheiman, J. et al. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat. Med. 25, 1104–1109 (2019).31235964
410. Priest C Tontonoz P Inter-organ cross-talk in metabolic syndrome Nat. Metab. 2019 1 1177 1188 10.1038/s42255-019-0145-5 32694672
Priest, C. & Tontonoz, P. Inter-organ cross-talk in metabolic syndrome. Nat. Metab. 1, 1177–1188 (2019).32694672
411. Koren O Host remodeling of the gut microbiome and metabolic changes during pregnancy Cell 2012 150 470 480 10.1016/j.cell.2012.07.008 22863002
Koren, O. et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150, 470–480 (2012).22863002
412. Tarracchini C Genetic strategies for sex-biased persistence of gut microbes across human life Nat. Commun. 2023 14 4220 10.1038/s41467-023-39931-2 37452041
Tarracchini, C. et al. Genetic strategies for sex-biased persistence of gut microbes across human life. Nat. Commun. 14, 4220 (2023).37452041
413. Brown K Microbiota alters the metabolome in an age- and sex-dependent manner in mice Nat. Commun. 2023 14 1348 10.1038/s41467-023-37055-1 36906623
Brown, K. et al. Microbiota alters the metabolome in an age- and sex-dependent manner in mice. Nat. Commun. 14, 1348 (2023).36906623
414. Mayneris-Perxachs J Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids: influences of obesity and menopausal status Microbiome 2020 8 136 10.1186/s40168-020-00913-x 32951609
Mayneris-Perxachs, J. et al. Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids: influences of obesity and menopausal status. Microbiome 8, 136 (2020).32951609
415. Ghosh TS Shanahan F O’Toole PW The gut microbiome as a modulator of healthy ageing Nat. Rev. Gastroenterol. Hepatol. 2022 19 565 584 10.1038/s41575-022-00605-x 35468952
Ghosh, T. S., Shanahan, F. & O’Toole, P. W. The gut microbiome as a modulator of healthy ageing. Nat. Rev. Gastroenterol. Hepatol. 19, 565–584 (2022).35468952
416. Goodrich JK Human genetics shape the gut microbiome Cell 2014 159 789 799 10.1016/j.cell.2014.09.053 25417156
Goodrich, J. K. et al. Human genetics shape the gut microbiome. Cell 159, 789–799 (2014).25417156
417. Deschasaux M Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography Nat. Med. 2018 24 1526 1531 10.1038/s41591-018-0160-1 30150717
Deschasaux, M. et al. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat. Med. 24, 1526–1531 (2018).30150717
418. Sen P Microbiota and sleep: awakening the gut feeling Trends Mol. Med. 2021 27 935 945 10.1016/j.molmed.2021.07.004 34364787
Sen, P. et al. Microbiota and sleep: awakening the gut feeling. Trends Mol. Med. 27, 935–945 (2021).34364787
419. Almand AT The influence of perceived stress on the human microbiome BMC Res. Notes 2022 15 193 10.1186/s13104-022-06066-4 35659718
Almand, A. T. et al. The influence of perceived stress on the human microbiome. BMC Res. Notes 15, 193 (2022).35659718
420. Dohnalová L A microbiome-dependent gut–brain pathway regulates motivation for exercise Nature 2022 612 739 747 10.1038/s41586-022-05525-z 36517598
Dohnalová, L. et al. A microbiome-dependent gut–brain pathway regulates motivation for exercise. Nature 612, 739–747 (2022).36517598
421. Thirion F The gut microbiota in multiple sclerosis varies with disease activity Genome Med. 2023 15 1 10.1186/s13073-022-01148-1 36604748
Thirion, F. et al. The gut microbiota in multiple sclerosis varies with disease activity. Genome Med. 15, 1 (2023).36604748
422. Wang X Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents Gut 2020 69 2131 2142 10.1136/gutjnl-2019-319766 32241904
Wang, X. et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut 69, 2131–2142 (2020).32241904
423. Yannakoulia M Scarmeas N Diets N. Engl. J. Med. 2024 390 2098 2106 10.1056/NEJMra2211889 38865662
Yannakoulia, M. & Scarmeas, N. Diets. N. Engl. J. Med. 390, 2098–2106 (2024).38865662
424. Singh RK Influence of diet on the gut microbiome and implications for human health J. Transl. Med. 2017 15 73 10.1186/s12967-017-1175-y 28388917
Singh, R. K. et al. Influence of diet on the gut microbiome and implications for human health. J. Transl. Med. 15, 73 (2017).28388917
425. Wu GD Linking long-term dietary patterns with gut microbial enterotypes Science 2011 334 105 108 10.1126/science.1208344 21885731
Wu, G. D. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105–108 (2011).21885731
426. Zmora N Suez J Elinav E You are what you eat: diet, health and the gut microbiota Nat. Rev. Gastroenterol. Hepatol. 2019 16 35 56 10.1038/s41575-018-0061-2 30262901
Zmora, N., Suez, J. & Elinav, E. You are what you eat: diet, health and the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 16, 35–56 (2019).30262901
427. De Filippo C Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa Proc. Natl Acad. Sci. 2010 107 14691 14696 10.1073/pnas.1005963107 20679230
De Filippo, C. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl Acad. Sci. 107, 14691–14696 (2010).20679230
428. Bourdeau-Julien I The diet rapidly and differentially affects the gut microbiota and host lipid mediators in a healthy population Microbiome 2023 11 26 10.1186/s40168-023-01469-2 36774515
Bourdeau-Julien, I. et al. The diet rapidly and differentially affects the gut microbiota and host lipid mediators in a healthy population. Microbiome 11, 26 (2023).36774515
429. David LA Diet rapidly and reproducibly alters the human gut microbiome Nature 2014 505 559 563 10.1038/nature12820 24336217
David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563 (2014).24336217
430. Chen J A high-fat diet promotes cancer progression by inducing gut microbiota–mediated leucine production and PMN-MDSC differentiation Proc. Natl Acad. Sci. 2024 121 e2306776121 10.1073/pnas.2306776121 38709933
Chen, J. et al. A high-fat diet promotes cancer progression by inducing gut microbiota–mediated leucine production and PMN-MDSC differentiation. Proc. Natl Acad. Sci. 121, e2306776121 (2024).38709933
431. Dohrn, G. Gut microbes linked to fatty diet drive tumour growth. Nature10.1038/d41586-024-01443-4 (2024).
432. Suez J Artificial sweeteners induce glucose intolerance by altering the gut microbiota Nature 2014 514 181 186 10.1038/nature13793 25231862
Suez, J. et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514, 181–186 (2014).25231862
433. Makki K Deehan EC Walter J Bäckhed F The impact of dietary fiber on gut microbiota in host health and disease Cell Host Microbe 2018 23 705 715 10.1016/j.chom.2018.05.012 29902436
Makki, K., Deehan, E. C., Walter, J. & Bäckhed, F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe 23, 705–715 (2018).29902436
434. Ze X Duncan SH Louis P Flint HJ Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon ISME J. 2012 6 1535 1543 10.1038/ismej.2012.4 22343308
Ze, X., Duncan, S. H., Louis, P. & Flint, H. J. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J. 6, 1535–1543 (2012).22343308
435. Shigehisa A Characterization of a bifidobacterial system that utilizes galacto-oligosaccharides Microbiology 2015 161 1463 1470 10.1099/mic.0.000100 25903756
Shigehisa, A. et al. Characterization of a bifidobacterial system that utilizes galacto-oligosaccharides. Microbiology 161, 1463–1470 (2015).25903756
436. Clark RL Design of synthetic human gut microbiome assembly and butyrate production Nat. Commun. 2021 12 3254 10.1038/s41467-021-22938-y 34059668
Clark, R. L. et al. Design of synthetic human gut microbiome assembly and butyrate production. Nat. Commun. 12, 3254 (2021).34059668
437. Crost EH Mechanistic Insights Into the Cross-Feeding of Ruminococcus gnavus and Ruminococcus bromii on Host and Dietary Carbohydrates Front. Microbiol. 2018 9 2558 10.3389/fmicb.2018.02558 30455672
Crost, E. H. et al. Mechanistic Insights Into the Cross-Feeding of Ruminococcus gnavus and Ruminococcus bromii on Host and Dietary Carbohydrates. Front. Microbiol. 9, 2558 (2018).30455672
438. Nie Q Targeted modification of gut microbiota and related metabolites via dietary fiber Carbohydr. Polym. 2023 316 120986 10.1016/j.carbpol.2023.120986 37321707
Nie, Q. et al. Targeted modification of gut microbiota and related metabolites via dietary fiber. Carbohydr. Polym. 316, 120986 (2023).37321707
439. Rodriguez CI Curated and harmonized gut microbiome 16S rRNA amplicon data from dietary fiber intervention studies in humans Sci. Data 2023 10 346 10.1038/s41597-023-02254-4 37268699
Rodriguez, C. I. et al. Curated and harmonized gut microbiome 16S rRNA amplicon data from dietary fiber intervention studies in humans. Sci. Data 10, 346 (2023).37268699
440. Zhang J Diet mediate the impact of host habitat on gut microbiome and influence clinical indexes by modulating gut microbes and serum metabolites Adv. Sci. 2024 11 2310068 10.1002/advs.202310068
Zhang, J. et al. Diet mediate the impact of host habitat on gut microbiome and influence clinical indexes by modulating gut microbes and serum metabolites. Adv. Sci. 11, 2310068 (2024).
441. Zinöcker M Lindseth I The western diet–microbiome-host interaction and its role in metabolic disease Nutrients 2018 10 365 10.3390/nu10030365 29562591
Zinöcker, M. & Lindseth, I. The western diet–microbiome-host interaction and its role in metabolic disease. Nutrients 10, 365 (2018).29562591
442. Latorre-Pérez A The Spanish gut microbiome reveals links between microorganisms and Mediterranean diet Sci. Rep. 2021 11 21602 10.1038/s41598-021-01002-1 34759297
Latorre-Pérez, A. et al. The Spanish gut microbiome reveals links between microorganisms and Mediterranean diet. Sci. Rep. 11, 21602 (2021).34759297
443. Meslier V Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake Gut 2020 69 1258 1268 10.1136/gutjnl-2019-320438 32075887
Meslier, V. et al. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut 69, 1258–1268 (2020).32075887
444. Ben-Yacov, O. et al. Gut microbiome modulates the effects of a personalised postprandial-targeting (PPT) diet on cardiometabolic markers: a diet intervention in pre-diabetes. Gut 72, 1486–1496 (2023).
445. Wang DD The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk Nat. Med. 2021 27 333 343 10.1038/s41591-020-01223-3 33574608
Wang, D. D. et al. The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk. Nat. Med. 27, 333–343 (2021).33574608
446. Hansen TH Impact of a vegan diet on the human salivary microbiota Sci. Rep. 2018 8 5847 10.1038/s41598-018-24207-3 29643500
Hansen, T. H. et al. Impact of a vegan diet on the human salivary microbiota. Sci. Rep. 8, 5847 (2018).29643500
447. Landberg R Hanhineva K Biomarkers of a Healthy Nordic Diet—From Dietary Exposure Biomarkers to Microbiota Signatures in the Metabolome Nutrients 2019 12 27 10.3390/nu12010027 31877633
Landberg, R. & Hanhineva, K. Biomarkers of a Healthy Nordic Diet—From Dietary Exposure Biomarkers to Microbiota Signatures in the Metabolome. Nutrients 12, 27 (2019).31877633
448. Jama HA Beale A Shihata WA Marques FZ The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immunometabolism? Cardiovasc. Res. 2019 115 1435 1447 10.1093/cvr/cvz091 30951169
Jama, H. A., Beale, A., Shihata, W. A. & Marques, F. Z. The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immunometabolism? Cardiovasc. Res. 115, 1435–1447 (2019).30951169
449. Xue Z The bamboo-eating giant panda harbors a carnivore-like gut microbiota, with excessive seasonal variations mBio 2015 6 e00022 15 10.1128/mBio.00022-15 25991678
Xue, Z. et al. The bamboo-eating giant panda harbors a carnivore-like gut microbiota, with excessive seasonal variations. mBio 6, e00022–15 (2015).25991678
450. Ang QY Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells Cell 2020 181 1263 1275.e16 10.1016/j.cell.2020.04.027 32437658
Ang, Q. Y. et al. Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells. Cell 181, 1263–1275.e16 (2020).32437658
451. Miao Z Gut microbiota signatures of long-term and short-term plant-based dietary pattern and cardiometabolic health: a prospective cohort study BMC Med. 2022 20 204 10.1186/s12916-022-02402-4 35701845
Miao, Z. et al. Gut microbiota signatures of long-term and short-term plant-based dietary pattern and cardiometabolic health: a prospective cohort study. BMC Med. 20, 204 (2022).35701845
452. Von Schwartzenberg RJ Caloric restriction disrupts the microbiota and colonization resistance Nature 2021 595 272 277 10.1038/s41586-021-03663-4 34163067
Von Schwartzenberg, R. J. et al. Caloric restriction disrupts the microbiota and colonization resistance. Nature 595, 272–277 (2021).34163067
453. Ismail IH Dietary patterns in childhood and their effect on gut microbiota—an Asian perspective on atopy risk J. Allergy Clin. Immunol. 2020 146 1005 1007 10.1016/j.jaci.2020.05.057 32860819
Ismail, I. H. et al. Dietary patterns in childhood and their effect on gut microbiota—an Asian perspective on atopy risk. J. Allergy Clin. Immunol. 146, 1005–1007 (2020).32860819
454. Sonnenburg JL Bäckhed F Diet–microbiota interactions as moderators of human metabolism Nature 2016 535 56 64 10.1038/nature18846 27383980
Sonnenburg, J. L. & Bäckhed, F. Diet–microbiota interactions as moderators of human metabolism. Nature 535, 56–64 (2016).27383980
455. Rothschild D Environment dominates over host genetics in shaping human gut microbiota Nature 2018 555 210 215 10.1038/nature25973 29489753
Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210–215 (2018).29489753
456. Gacesa R Environmental factors shaping the gut microbiome in a Dutch population Nature 2022 604 732 739 10.1038/s41586-022-04567-7 35418674
Gacesa, R. et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature 604, 732–739 (2022).35418674
457. Linz B An African origin for the intimate association between humans and Helicobacter pylori Nature 2007 445 915 918 10.1038/nature05562 17287725
Linz, B. et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 445, 915–918 (2007).17287725
458. Falush D Traces of human migrations in Helicobacter pylori populations Science 2003 299 1582 1585 10.1126/science.1080857 12624269
Falush, D. et al. Traces of human migrations in Helicobacter pylori populations. Science 299, 1582–1585 (2003).12624269
459. Thorpe HA Repeated out-of-Africa expansions of Helicobacter pylori driven by replacement of deleterious mutations Nat. Commun. 2022 13 6842 10.1038/s41467-022-34475-3 36369175
Thorpe, H. A. et al. Repeated out-of-Africa expansions of Helicobacter pylori driven by replacement of deleterious mutations. Nat. Commun. 13, 6842 (2022).36369175
460. Coelho LP Towards the biogeography of prokaryotic genes Nature 2022 601 252 256 10.1038/s41586-021-04233-4 34912116
Coelho, L. P. et al. Towards the biogeography of prokaryotic genes. Nature 601, 252–256 (2022).34912116
461. Gupta VK Paul S Dutta C Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity Front. Microbiol. 2017 8 1162 10.3389/fmicb.2017.01162 28690602
Gupta, V. K., Paul, S. & Dutta, C. Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity. Front. Microbiol. 8, 1162 (2017).28690602
462. Lin, L. et al. The airway microbiome mediates the interaction between environmental exposure and respiratory health in humans. Nat. Med. 29, 1750–1759. 10.1038/s41591-023-02424-2 (2023).
463. Ying S The influence of age and gender on skin-associated microbial communities in urban and rural human populations PLoS ONE 2015 10 e0141842 10.1371/journal.pone.0141842 26510185
Ying, S. et al. The influence of age and gender on skin-associated microbial communities in urban and rural human populations. PLoS ONE 10, e0141842 (2015).26510185
464. Zhang Y-D Greenspace and human microbiota: a systematic review Environ. Int. 2024 187 108662 10.1016/j.envint.2024.108662 38653130
Zhang, Y.-D. et al. Greenspace and human microbiota: a systematic review. Environ. Int. 187, 108662 (2024).38653130
465. He Y Regional variation limits applications of healthy gut microbiome reference ranges and disease models Nat. Med. 2018 24 1532 1535 10.1038/s41591-018-0164-x 30150716
He, Y. et al. Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nat. Med. 24, 1532–1535 (2018).30150716
466. Tierney, B. T. et al. Longitudinal multi-omics analysis of host microbiome architecture and immune responses during short-term spaceflight. Nat. Microbiol. 9, 1661–1675 (2024).
467. Weersma RK Zhernakova A Fu J Interaction between drugs and the gut microbiome Gut 2020 69 1510 1519 10.1136/gutjnl-2019-320204 32409589
Weersma, R. K., Zhernakova, A. & Fu, J. Interaction between drugs and the gut microbiome. Gut 69, 1510–1519 (2020).32409589
468. Lam KN Alexander M Turnbaugh PJ Precision medicine goes microscopic: engineering the microbiome to improve drug outcomes Cell Host Microbe 2019 26 22 34 10.1016/j.chom.2019.06.011 31295421
Lam, K. N., Alexander, M. & Turnbaugh, P. J. Precision medicine goes microscopic: engineering the microbiome to improve drug outcomes. Cell Host Microbe 26, 22–34 (2019).31295421
469. Wollein Waldetoft K Sundius S Kuske R Brown SP Defining the benefits of antibiotic resistance in commensals and the scope for resistance optimization mBio 2023 14 e01349 22 10.1128/mbio.01349-22 36475750
Wollein Waldetoft, K., Sundius, S., Kuske, R. & Brown, S. P. Defining the benefits of antibiotic resistance in commensals and the scope for resistance optimization. mBio 14, e01349–22 (2023).36475750
470. Bhattarai SK Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption Sci. Transl. Med. 2024 16 eadi9711 10.1126/scitranslmed.adi9711 38232140
Bhattarai, S. K. et al. Commensal antimicrobial resistance mediates microbiome resilience to antibiotic disruption. Sci. Transl. Med. 16, eadi9711 (2024).38232140
471. Wang Y Antidepressants can induce mutation and enhance persistence toward multiple antibiotics Proc. Natl Acad. Sci. 2023 120 e2208344120 10.1073/pnas.2208344120 36689653
Wang, Y. et al. Antidepressants can induce mutation and enhance persistence toward multiple antibiotics. Proc. Natl Acad. Sci. 120, e2208344120 (2023).36689653
472. Maier L Extensive impact of non-antibiotic drugs on human gut bacteria Nature 2018 555 623 628 10.1038/nature25979 29555994
Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623–628 (2018).29555994
473. Jackson MA Proton pump inhibitors alter the composition of the gut microbiota Gut 2016 65 749 756 10.1136/gutjnl-2015-310861 26719299
Jackson, M. A. et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut 65, 749–756 (2016).26719299
474. Imhann F Proton pump inhibitors affect the gut microbiome Gut 2016 65 740 748 10.1136/gutjnl-2015-310376 26657899
Imhann, F. et al. Proton pump inhibitors affect the gut microbiome. Gut 65, 740–748 (2016).26657899
475. De La Cuesta-Zuluaga J Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid–producing microbiota in the gut Diabetes Care 2017 40 54 62 10.2337/dc16-1324 27999002
De La Cuesta-Zuluaga, J. et al. Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid–producing microbiota in the gut. Diabetes Care 40, 54–62 (2017).27999002
476. Forslund SK Combinatorial, additive and dose-dependent drug–microbiome associations Nature 2021 600 500 505 10.1038/s41586-021-04177-9 34880489
Forslund, S. K. et al. Combinatorial, additive and dose-dependent drug–microbiome associations. Nature 600, 500–505 (2021).34880489
477. Sousa T On the colonic bacterial metabolism of azo-bonded prodrugsof 5-aminosalicylic acid J. Pharm. Sci. 2014 103 3171 3175 10.1002/jps.24103 25091594
Sousa, T. et al. On the colonic bacterial metabolism of azo-bonded prodrugsof 5-aminosalicylic acid. J. Pharm. Sci. 103, 3171–3175 (2014).25091594
478. Haiser HJ Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta Science 2013 341 295 298 10.1126/science.1235872 23869020
Haiser, H. J. et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 341, 295–298 (2013).23869020
479. Klatt NR Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women Science 2017 356 938 945 10.1126/science.aai9383 28572388
Klatt, N. R. et al. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science 356, 938–945 (2017).28572388
480. Wallace BD Alleviating cancer drug toxicity by inhibiting a bacterial enzyme Science 2010 330 831 835 10.1126/science.1191175 21051639
Wallace, B. D. et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330, 831–835 (2010).21051639
481. Zimmermann M Zimmermann-Kogadeeva M Wegmann R Goodman AL Mapping human microbiome drug metabolism by gut bacteria and their genes Nature 2019 570 462 467 10.1038/s41586-019-1291-3 31158845
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R. & Goodman, A. L. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570, 462–467 (2019).31158845
482. Heinken, A. et al. Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine. Nat. Biotechnol. 41, 1320–1331 (2023).
483. Wang D-R Wu X-L Sun Y-L Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response Signal Transduct. Target. Ther. 2022 7 331 10.1038/s41392-022-01136-2 36123348
Wang, D.-R., Wu, X.-L. & Sun, Y.-L. Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response. Signal Transduct. Target. Ther. 7, 331 (2022).36123348
484. Huang J Effects of microbiota on anticancer drugs: current knowledge and potential applications eBioMedicine 2022 83 104197 10.1016/j.ebiom.2022.104197 35933808
Huang, J. et al. Effects of microbiota on anticancer drugs: current knowledge and potential applications. eBioMedicine 83, 104197 (2022).35933808
485. Stein-Thoeringer, C. K. et al. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nat. Med. 29, 906–916 (2023).
486. Faust K Raes J Microbial interactions: from networks to models Nat. Rev. Microbiol. 2012 10 538 550 10.1038/nrmicro2832 22796884
Faust, K. & Raes, J. Microbial interactions: from networks to models. Nat. Rev. Microbiol. 10, 538–550 (2012).22796884
487. Jiang, M.-Z. et al. Gut microbial interactions based on network construction and bacterial pairwise cultivation. Sci. China Life Sci. 67,1751–1762 (2024).
488. Krishnan N Csiszár V Móri TF Garay J Genesis of ectosymbiotic features based on commensalistic syntrophy Sci. Rep. 2024 14 1366 10.1038/s41598-023-47211-8 38228651
Krishnan, N., Csiszár, V., Móri, T. F. & Garay, J. Genesis of ectosymbiotic features based on commensalistic syntrophy. Sci. Rep. 14, 1366 (2024).38228651
489. Culp EJ Goodman AL Cross-feeding in the gut microbiome: ecology and mechanisms Cell Host Microbe 2023 31 485 499 10.1016/j.chom.2023.03.016 37054671
Culp, E. J. & Goodman, A. L. Cross-feeding in the gut microbiome: ecology and mechanisms. Cell Host Microbe 31, 485–499 (2023).37054671
490. Maree M Natural transformation allows transfer of SCCmec-mediated methicillin resistance in Staphylococcus aureus biofilms Nat. Commun. 2022 13 2477 10.1038/s41467-022-29877-2 35513365
Maree, M. et al. Natural transformation allows transfer of SCCmec-mediated methicillin resistance in Staphylococcus aureus biofilms. Nat. Commun. 13, 2477 (2022).35513365
491. Zhong Q Episymbiotic Saccharibacteria TM7x modulates the susceptibility of its host bacteria to phage infection and promotes their coexistence Proc. Natl Acad. Sci. 2024 121 e2319790121 10.1073/pnas.2319790121 38593079
Zhong, Q. et al. Episymbiotic Saccharibacteria TM7x modulates the susceptibility of its host bacteria to phage infection and promotes their coexistence. Proc. Natl Acad. Sci. 121, e2319790121 (2024).38593079
492. Lamkin, J. & Lavner, J. A. Antagonism and romantic relationships. in The Handbook of Antagonism 269–280 (Elsevier, 2019). 10.1016/B978-0-12-814627-9.00018-9.
493. Clardy J Fischbach MA Currie CR The natural history of antibiotics Curr. Biol. 2009 19 R437 R441 10.1016/j.cub.2009.04.001 19515346
Clardy, J., Fischbach, M. A. & Currie, C. R. The natural history of antibiotics. Curr. Biol. 19, R437–R441 (2009).19515346
494. Johnston LA Competitive interactions between cells: death, growth, and geography Science 2009 324 1679 1682 10.1126/science.1163862 19556501
Johnston, L. A. Competitive interactions between cells: death, growth, and geography. Science 324, 1679–1682 (2009).19556501
495. Sørensen MES The role of exploitation in the establishment of mutualistic microbial symbioses FEMS Microbiol. Lett. 2019 366 fnz148 10.1093/femsle/fnz148 31271421
Sørensen, M. E. S. et al. The role of exploitation in the establishment of mutualistic microbial symbioses. FEMS Microbiol. Lett. 366, fnz148 (2019).31271421
496. Shkoporov AN Turkington CJ Hill C Mutualistic interplay between bacteriophages and bacteria in the human gut Nat. Rev. Microbiol. 2022 20 737 749 10.1038/s41579-022-00755-4 35773472
Shkoporov, A. N., Turkington, C. J. & Hill, C. Mutualistic interplay between bacteriophages and bacteria in the human gut. Nat. Rev. Microbiol. 20, 737–749 (2022).35773472
497. Morin MA Morrison AJ Harms MJ Dutton RJ Higher-order interactions shape microbial interactions as microbial community complexity increases Sci. Rep. 2022 12 22640 10.1038/s41598-022-25303-1 36587027
Morin, M. A., Morrison, A. J., Harms, M. J. & Dutton, R. J. Higher-order interactions shape microbial interactions as microbial community complexity increases. Sci. Rep. 12, 22640 (2022).36587027
498. Amit G Bashan A Top-down identification of keystone taxa in the microbiome Nat. Commun. 2023 14 3951 10.1038/s41467-023-39459-5 37402745
Amit, G. & Bashan, A. Top-down identification of keystone taxa in the microbiome. Nat. Commun. 14, 3951 (2023).37402745
499. Paine RT Food web complexity and species diversity Am. Nat. 1966 100 65 75 10.1086/282400
Paine, R. T. Food web complexity and species diversity. Am. Nat. 100, 65–75 (1966).
500. Libertucci J Young VB The role of the microbiota in infectious diseases Nat. Microbiol. 2018 4 35 45 10.1038/s41564-018-0278-4 30546094
Libertucci, J. & Young, V. B. The role of the microbiota in infectious diseases. Nat. Microbiol. 4, 35–45 (2018).30546094
501. Newton WL Weinstein PP Jones MF A comparison of the development of some rat and mouse helminths in germfree and conventional guinea pigs Ann. N. Y. Acad. Sci. 2006 78 290 307 10.1111/j.1749-6632.1959.tb53114.x
Newton, W. L., Weinstein, P. P. & Jones, M. F. A comparison of the development of some rat and mouse helminths in germfree and conventional guinea pigs. Ann. N. Y. Acad. Sci. 78, 290–307 (2006).
502. Phillips BP Studies on the ameba-bacteria relationship in amebiasis; comparative results of the intracecal inoculation of germfree, monocontaminated, and conventional guinea pigs with Entamoeba histolytica Am. J. Trop. Med. Hyg. 1955 4 675 692 10.4269/ajtmh.1955.4.675 13238723
Phillips, B. P. et al. Studies on the ameba-bacteria relationship in amebiasis; comparative results of the intracecal inoculation of germfree, monocontaminated, and conventional guinea pigs with Entamoeba histolytica. Am. J. Trop. Med. Hyg. 4, 675–692 (1955).13238723
503. Phillips BP Wolfe PA The use of germfree guinea pigs in studies on the microbial interrelationships in amoebiasis* Ann. N. Y. Acad. Sci. 2006 78 308 314 10.1111/j.1749-6632.1959.tb53115.x
Phillips, B. P. & Wolfe, P. A. The use of germfree guinea pigs in studies on the microbial interrelationships in amoebiasis*. Ann. N. Y. Acad. Sci. 78, 308–314 (2006).
504. Lin T-L Gut microbiota dysbiosis-related susceptibility to nontuberculous mycobacterial lung disease Gut Microbes 2024 16 2361490 10.1080/19490976.2024.2361490 38860456
Lin, T.-L. et al. Gut microbiota dysbiosis-related susceptibility to nontuberculous mycobacterial lung disease. Gut Microbes 16, 2361490 (2024).38860456
505. Wahl, A. et al. A germ-free humanized mouse model shows the contribution of resident microbiota to human-specific pathogen infection. Nat. Biotechnol. 42, 905–915 (2023).
506. Gosmann C Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women Immunity 2017 46 29 37 10.1016/j.immuni.2016.12.013 28087240
Gosmann, C. et al. Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women. Immunity 46, 29–37 (2017).28087240
507. Sulaiman I Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome Nat. Microbiol. 2021 6 1245 1258 10.1038/s41564-021-00961-5 34465900
Sulaiman, I. et al. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome. Nat. Microbiol. 6, 1245–1258 (2021).34465900
508. Gao M Characterization of the human oropharyngeal microbiomes in SARS‐CoV‐2 infection and recovery patients Adv. Sci. 2021 8 2102785 10.1002/advs.202102785
Gao, M. et al. Characterization of the human oropharyngeal microbiomes in SARS‐CoV‐2 infection and recovery patients. Adv. Sci. 8, 2102785 (2021).
509. Zuo T Wu X Wen W Lan P Gut microbiome alterations in COVID-19 Genomics Proteom. Bioinform. 2021 19 679 688 10.1016/j.gpb.2021.09.004
Zuo, T., Wu, X., Wen, W. & Lan, P. Gut microbiome alterations in COVID-19. Genomics Proteom. Bioinform. 19, 679–688 (2021).
510. Xiao M Metatranscriptomic analysis of host response and vaginal microbiome of patients with severe COVID-19 Sci. China Life Sci. 2022 65 1473 1476 10.1007/s11427-021-2091-0 35441283
Xiao, M. et al. Metatranscriptomic analysis of host response and vaginal microbiome of patients with severe COVID-19. Sci. China Life Sci. 65, 1473–1476 (2022).35441283
511. Chen Y Six-month follow-up of gut microbiota richness in patients with COVID-19 Gut 2022 71 222 225 10.1136/gutjnl-2021-324090 33833065
Chen, Y. et al. Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut 71, 222–225 (2022).33833065
512. Yeoh YK Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 Gut 2021 70 698 706 10.1136/gutjnl-2020-323020 33431578
Yeoh, Y. K. et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70, 698–706 (2021).33431578
513. Patrier J Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults Crit. Care 2022 26 300 10.1186/s13054-022-04164-0 36192756
Patrier, J. et al. Oropharyngeal and intestinal concentrations of opportunistic pathogens are independently associated with death of SARS-CoV-2 critically ill adults. Crit. Care 26, 300 (2022).36192756
514. McDonald B Programing of an intravascular immune firewall by the gut microbiota protects against pathogen dissemination during infection Cell Host Microbe 2020 28 660 668.e4 10.1016/j.chom.2020.07.014 32810440
McDonald, B. et al. Programing of an intravascular immune firewall by the gut microbiota protects against pathogen dissemination during infection. Cell Host Microbe 28, 660–668.e4 (2020).32810440
515. Zhang F Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications Nat. Rev. Gastroenterol. Hepatol. 2023 20 323 337 10.1038/s41575-022-00698-4 36271144
Zhang, F. et al. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications. Nat. Rev. Gastroenterol. Hepatol. 20, 323–337 (2023).36271144
516. Li, J., Richards, E. M., Handberg, E. M., Pepine, C. J. & Raizada, M. K. Butyrate regulates COVID-19–relevant genes in gut epithelial organoids from normotensive rats. Hypertension 77 (2021).
517. Zhang F Prolonged impairment of short-chain fatty acid and l-isoleucine biosynthesis in gut microbiome in patients with COVID-19 Gastroenterology 2022 162 548 561.e4 10.1053/j.gastro.2021.10.013 34687739
Zhang, F. et al. Prolonged impairment of short-chain fatty acid and l-isoleucine biosynthesis in gut microbiome in patients with COVID-19. Gastroenterology 162, 548–561.e4 (2022).34687739
518. De Nies L Altered infective competence of the human gut microbiome in COVID-19 Microbiome 2023 11 46 10.1186/s40168-023-01472-7 36894986
De Nies, L. et al. Altered infective competence of the human gut microbiome in COVID-19. Microbiome 11, 46 (2023).36894986
519. Mizrahi, B. et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ 380, e072529 (2023).
520. McIntosh CM Chen L Shaiber A Eren AM Alegre M-L Gut microbes contribute to variation in solid organ transplant outcomes in mice Microbiome 2018 6 96 10.1186/s40168-018-0474-8 29793539
McIntosh, C. M., Chen, L., Shaiber, A., Eren, A. M. & Alegre, M.-L. Gut microbes contribute to variation in solid organ transplant outcomes in mice. Microbiome 6, 96 (2018).29793539
521. Swarte JC Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation Sci. Transl. Med. 2022 14 eabn7566 10.1126/scitranslmed.abn7566 36044594
Swarte, J. C. et al. Gut microbiome dysbiosis is associated with increased mortality after solid organ transplantation. Sci. Transl. Med. 14, eabn7566 (2022).36044594
522. Bocci V The neglected organ: bacterial flora has a crucial immunostimulatory role Perspect. Biol. Med. 1992 35 251 260 10.1353/pbm.1992.0004 1557302
Bocci, V. The neglected organ: bacterial flora has a crucial immunostimulatory role. Perspect. Biol. Med. 35, 251–260 (1992).1557302
523. O’Hara AM Shanahan F The gut flora as a forgotten organ EMBO Rep. 2006 7 688 693 10.1038/sj.embor.7400731 16819463
O’Hara, A. M. & Shanahan, F. The gut flora as a forgotten organ. EMBO Rep. 7, 688–693 (2006).16819463
524. Burcelin R Metagenome and metabolism: the tissue microbiota hypothesis: Burcelin et al Diabetes Obes. Metab. 2013 15 61 70 10.1111/dom.12157 24003922
Burcelin, R. et al. Metagenome and metabolism: the tissue microbiota hypothesis: Burcelin et al. Diabetes Obes. Metab. 15, 61–70 (2013).24003922
525. Byndloss MX Bäumler AJ The germ-organ theory of non-communicable diseases Nat. Rev. Microbiol. 2018 16 103 110 10.1038/nrmicro.2017.158 29307890
Byndloss, M. X. & Bäumler, A. J. The germ-organ theory of non-communicable diseases. Nat. Rev. Microbiol. 16, 103–110 (2018).29307890
526. Fucarino A The microbiota is not an organ: introducing the muco-microbiotic layer as a novel morphofunctional Struct. Anat. 2022 1 186 203
Fucarino, A. et al. The microbiota is not an organ: introducing the muco-microbiotic layer as a novel morphofunctional. Struct. Anat. 1, 186–203 (2022).
527. Chakaroun, R. M., Olsson, L. M. & Bäckhed, F. The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease. Nat. Rev. Cardiol. 20, 217–235 (2022).
528. Valles-Colomer M Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective Nat. Med. 2023 29 551 561 10.1038/s41591-023-02260-4 36932240
Valles-Colomer, M. et al. Cardiometabolic health, diet and the gut microbiome: a meta-omics perspective. Nat. Med. 29, 551–561 (2023).36932240
529. Tonelli A Lumngwena EN Ntusi NAB The oral microbiome in the pathophysiology of cardiovascular disease Nat. Rev. Cardiol. 2023 20 386 403 10.1038/s41569-022-00825-3 36624275
Tonelli, A., Lumngwena, E. N. & Ntusi, N. A. B. The oral microbiome in the pathophysiology of cardiovascular disease. Nat. Rev. Cardiol. 20, 386–403 (2023).36624275
530. Violi F Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease Nat. Rev. Cardiol. 2023 20 24 37 10.1038/s41569-022-00737-2 35840742
Violi, F. et al. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat. Rev. Cardiol. 20, 24–37 (2023).35840742
531. Brown JM Hazen SL Microbial modulation of cardiovascular disease Nat. Rev. Microbiol. 2018 16 171 181 10.1038/nrmicro.2017.149 29307889
Brown, J. M. & Hazen, S. L. Microbial modulation of cardiovascular disease. Nat. Rev. Microbiol. 16, 171–181 (2018).29307889
532. Lyon J The lung microbiome: key to respiratory ills? JAMA 2017 317 1713 10.1001/jama.2017.3023 28403451
Lyon, J. The lung microbiome: key to respiratory ills? JAMA 317, 1713 (2017).28403451
533. Budden KF Functional effects of the microbiota in chronic respiratory disease Lancet Respir. Med. 2019 7 907 920 10.1016/S2213-2600(18)30510-1 30975495
Budden, K. F. et al. Functional effects of the microbiota in chronic respiratory disease. Lancet Respir. Med. 7, 907–920 (2019).30975495
534. Barcik W Boutin RCT Sokolowska M Finlay BB The role of lung and gut microbiota in the pathology of asthma Immunity 2020 52 241 255 10.1016/j.immuni.2020.01.007 32075727
Barcik, W., Boutin, R. C. T., Sokolowska, M. & Finlay, B. B. The role of lung and gut microbiota in the pathology of asthma. Immunity 52, 241–255 (2020).32075727
535. Neish AS Microbes in gastrointestinal health and disease Gastroenterology 2009 136 65 80 10.1053/j.gastro.2008.10.080 19026645
Neish, A. S. Microbes in gastrointestinal health and disease. Gastroenterology 136, 65–80 (2009).19026645
536. Sorboni SG Moghaddam HS Jafarzadeh-Esfehani R Soleimanpour S A comprehensive review on the role of the gut microbiome in human neurological disorders Clin. Microbiol. Rev. 2022 35 e00338 20 10.1128/CMR.00338-20 34985325
Sorboni, S. G., Moghaddam, H. S., Jafarzadeh-Esfehani, R. & Soleimanpour, S. A comprehensive review on the role of the gut microbiome in human neurological disorders. Clin. Microbiol. Rev. 35, e00338–20 (2022).34985325
537. Fang P Kazmi SA Jameson KG Hsiao EY The microbiome as a modifier of neurodegenerative disease risk Cell Host Microbe 2020 28 201 222 10.1016/j.chom.2020.06.008 32791113
Fang, P., Kazmi, S. A., Jameson, K. G. & Hsiao, E. Y. The microbiome as a modifier of neurodegenerative disease risk. Cell Host Microbe 28, 201–222 (2020).32791113
538. Willyard C How gut microbes could drive brain disorders Nature 2021 590 22 25 10.1038/d41586-021-00260-3 33536656
Willyard, C. How gut microbes could drive brain disorders. Nature 590, 22–25 (2021).33536656
539. Agirman G Hsiao EY SnapShot: the microbiota-gut-brain axis Cell 2021 184 2524 2524.e1 10.1016/j.cell.2021.03.022 33930299
Agirman, G. & Hsiao, E. Y. SnapShot: the microbiota-gut-brain axis. Cell 184, 2524–2524.e1 (2021).33930299
540. Cryan JF The microbiota-gut-brain axis Physiol. Rev. 2019 99 1877 2013 10.1152/physrev.00018.2018 31460832
Cryan, J. F. et al. The microbiota-gut-brain axis. Physiol. Rev. 99, 1877–2013 (2019).31460832
541. Qi X Yun C Pang Y Qiao J The impact of the gut microbiota on the reproductive and metabolic endocrine system Gut Microbes 2021 13 1894070 10.1080/19490976.2021.1894070 33722164
Qi, X., Yun, C., Pang, Y. & Qiao, J. The impact of the gut microbiota on the reproductive and metabolic endocrine system. Gut Microbes 13, 1894070 (2021).33722164
542. Van Hul M Cani PD The gut microbiota in obesity and weight management: microbes as friends or foe? Nat. Rev. Endocrinol. 2023 19 258 271 10.1038/s41574-022-00794-0 36650295
Van Hul, M. & Cani, P. D. The gut microbiota in obesity and weight management: microbes as friends or foe? Nat. Rev. Endocrinol. 19, 258–271 (2023).36650295
543. Fan Y Pedersen O Gut microbiota in human metabolic health and disease Nat. Rev. Microbiol. 2021 19 55 71 10.1038/s41579-020-0433-9 32887946
Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19, 55–71 (2021).32887946
544. Hajishengallis G Lamont RJ Koo H Oral polymicrobial communities: assembly, function, and impact on diseases Cell Host Microbe 2023 31 528 538 10.1016/j.chom.2023.02.009 36933557
Hajishengallis, G., Lamont, R. J. & Koo, H. Oral polymicrobial communities: assembly, function, and impact on diseases. Cell Host Microbe 31, 528–538 (2023).36933557
545. Tuganbaev T Yoshida K Honda K The effects of oral microbiota on health Science 2022 376 934 936 10.1126/science.abn1890 35617380
Tuganbaev, T., Yoshida, K. & Honda, K. The effects of oral microbiota on health. Science 376, 934–936 (2022).35617380
546. Stacy A Belkaid Y Microbial guardians of skin health Science 2019 363 227 228 10.1126/science.aat4326 30655428
Stacy, A. & Belkaid, Y. Microbial guardians of skin health. Science 363, 227–228 (2019).30655428
547. Miyauchi, E., Shimokawa, C., Steimle, A., Desai, M. S. & Ohno, H. The impact of the gut microbiome on extra-intestinal autoimmune diseases. Nat. Rev. Immunol. 23, 9–23 (2022).
548. Alcazar CG-M The association between early-life gut microbiota and childhood respiratory diseases: a systematic review Lancet Microbe 2022 3 e867 e880 10.1016/S2666-5247(22)00184-7 35988549
Alcazar, C. G.-M. et al. The association between early-life gut microbiota and childhood respiratory diseases: a systematic review. Lancet Microbe 3, e867–e880 (2022).35988549
549. Ruff WE Greiling TM Kriegel MA Host–microbiota interactions in immune-mediated diseases Nat. Rev. Microbiol. 2020 18 521 538 10.1038/s41579-020-0367-2 32457482
Ruff, W. E., Greiling, T. M. & Kriegel, M. A. Host–microbiota interactions in immune-mediated diseases. Nat. Rev. Microbiol. 18, 521–538 (2020).32457482
550. Knauf F Brewer JR Flavell RA Immunity, microbiota and kidney disease Nat. Rev. Nephrol. 2019 15 263 274 10.1038/s41581-019-0118-7 30796361
Knauf, F., Brewer, J. R. & Flavell, R. A. Immunity, microbiota and kidney disease. Nat. Rev. Nephrol. 15, 263–274 (2019).30796361
551. Shoubridge AP The gut microbiome and mental health: advances in research and emerging priorities Mol. Psychiatry 2022 27 1908 1919 10.1038/s41380-022-01479-w 35236957
Shoubridge, A. P. et al. The gut microbiome and mental health: advances in research and emerging priorities. Mol. Psychiatry 27, 1908–1919 (2022).35236957
552. Liu L Shah K The potential of the gut microbiome to reshape the cancer therapy paradigm: a review JAMA Oncol. 2022 8 1059 10.1001/jamaoncol.2022.0494 35482355
Liu, L. & Shah, K. The potential of the gut microbiome to reshape the cancer therapy paradigm: a review. JAMA Oncol. 8, 1059 (2022).35482355
553. Park EM Targeting the gut and tumor microbiota in cancer Nat. Med. 2022 28 690 703 10.1038/s41591-022-01779-2 35440726
Park, E. M. et al. Targeting the gut and tumor microbiota in cancer. Nat. Med. 28, 690–703 (2022).35440726
554. Sepich-Poore GD The microbiome and human cancer Science 2021 371 eabc4552 10.1126/science.abc4552 33766858
Sepich-Poore, G. D. et al. The microbiome and human cancer. Science 371, eabc4552 (2021).33766858
555. Gowen R Gamal A Di Martino L McCormick TS Ghannoum MA Modulating the microbiome for Crohn’s disease treatment Gastroenterology 2023 164 828 840 10.1053/j.gastro.2023.01.017 36702360
Gowen, R., Gamal, A., Di Martino, L., McCormick, T. S. & Ghannoum, M. A. Modulating the microbiome for Crohn’s disease treatment. Gastroenterology 164, 828–840 (2023).36702360
556. Motta J-P Wallace JL Buret AG Deraison C Vergnolle N Gastrointestinal biofilms in health and disease Nat. Rev. Gastroenterol. Hepatol. 2021 18 314 334 10.1038/s41575-020-00397-y 33510461
Motta, J.-P., Wallace, J. L., Buret, A. G., Deraison, C. & Vergnolle, N. Gastrointestinal biofilms in health and disease. Nat. Rev. Gastroenterol. Hepatol. 18, 314–334 (2021).33510461
557. Arumugam M Enterotypes of the human gut microbiome Nature 2011 473 174 180 10.1038/nature09944 21508958
Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).21508958
558. Costea PI Enterotypes in the landscape of gut microbial community composition Nat. Microbiol. 2018 3 8 16 10.1038/s41564-017-0072-8 29255284
Costea, P. I. et al. Enterotypes in the landscape of gut microbial community composition. Nat. Microbiol. 3, 8–16 (2018).29255284
559. Zhong H Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children Microbiome 2019 7 2 10.1186/s40168-018-0608-z 30609941
Zhong, H. et al. Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children. Microbiome 7, 2 (2019).30609941
560. Knights D Rethinking “Enterotypes” Cell Host Microbe 2014 16 433 437 10.1016/j.chom.2014.09.013 25299329
Knights, D. et al. Rethinking “Enterotypes”. Cell Host Microbe 16, 433–437 (2014).25299329
561. Lai S Enterotypes of the human gut mycobiome Microbiome 2023 11 179 10.1186/s40168-023-01586-y 37563687
Lai, S. et al. Enterotypes of the human gut mycobiome. Microbiome 11, 179 (2023).37563687
562. Bourdeau RW Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts Nature 2018 553 86 90 10.1038/nature25021 29300010
Bourdeau, R. W. et al. Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts. Nature 553, 86–90 (2018).29300010
563. Willis JR Citizen science charts two major “stomatotypes” in the oral microbiome of adolescents and reveals links with habits and drinking water composition Microbiome 2018 6 218 10.1186/s40168-018-0592-3 30522523
Willis, J. R. et al. Citizen science charts two major “stomatotypes” in the oral microbiome of adolescents and reveals links with habits and drinking water composition. Microbiome 6, 218 (2018).30522523
564. Gajer, P. et al. Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4 (2012).
565. Adolph EF Early concepts of physiological regulations Physiol. Rev. 1961 41 737 770 10.1152/physrev.1961.41.4.737 13859463
Adolph, E. F. Early concepts of physiological regulations. Physiol. Rev. 41, 737–770 (1961).13859463
566. Cannon WB Organization for physiological homeostasis Physiol. Rev. 1929 9 399 431 10.1152/physrev.1929.9.3.399
Cannon, W. B. Organization for physiological homeostasis. Physiol. Rev. 9, 399–431 (1929).
567. Baptista V Starting physiology: understanding homeostasis Adv. Physiol. Educ. 2006 30 263 264 10.1152/advan.00075.2006 17108259
Baptista, V. Starting physiology: understanding homeostasis. Adv. Physiol. Educ. 30, 263–264 (2006).17108259
568. Kotas ME Medzhitov R Homeostasis, inflammation, and disease susceptibility Cell 2015 160 816 827 10.1016/j.cell.2015.02.010 25723161
Kotas, M. E. & Medzhitov, R. Homeostasis, inflammation, and disease susceptibility. Cell 160, 816–827 (2015).25723161
569. Davies KJA Adaptive homeostasis Mol. Asp. Med. 2016 49 1 7 10.1016/j.mam.2016.04.007
Davies, K. J. A. Adaptive homeostasis. Mol. Asp. Med. 49, 1–7 (2016).
570. Khakisahneh S Zhang X-Y Nouri Z Wang D-H Gut microbiota and host thermoregulation in response to ambient temperature fluctuations mSystems 2020 5 e00514 e00520 10.1128/mSystems.00514-20 33082280
Khakisahneh, S., Zhang, X.-Y., Nouri, Z. & Wang, D.-H. Gut microbiota and host thermoregulation in response to ambient temperature fluctuations. mSystems 5, e00514–e00520 (2020).33082280
571. Bongers, K. S. et al. The gut microbiome modulates body temperature both in sepsis and health. Am. J. Respir. Crit. Care Med. 207,1030–1041 (2022).
572. Li B Microbiota depletion impairs thermogenesis of brown adipose tissue and browning of white adipose tissue Cell Rep. 2019 26 2720 2737.e5 10.1016/j.celrep.2019.02.015 30840893
Li, B. et al. Microbiota depletion impairs thermogenesis of brown adipose tissue and browning of white adipose tissue. Cell Rep. 26, 2720–2737.e5 (2019).30840893
573. Gurven M Rapidly declining body temperature in a tropical human population Sci. Adv. 2020 6 eabc6599 10.1126/sciadv.abc6599 33115745
Gurven, M. et al. Rapidly declining body temperature in a tropical human population. Sci. Adv. 6, eabc6599 (2020).33115745
574. Protsiv M Ley C Lankester J Hastie T Parsonnet J Decreasing human body temperature in the United States since the Industrial Revolution eLife 2020 9 e49555 10.7554/eLife.49555 31908267
Protsiv, M., Ley, C., Lankester, J., Hastie, T. & Parsonnet, J. Decreasing human body temperature in the United States since the Industrial Revolution. eLife 9, e49555 (2020).31908267
575. Liu Y A widely distributed gene cluster compensates for uricase loss in hominids Cell 2023 186 3400 3413.e20 10.1016/j.cell.2023.06.010 37541197
Liu, Y. et al. A widely distributed gene cluster compensates for uricase loss in hominids. Cell 186, 3400–3413.e20 (2023).37541197
576. Kasahara K Gut bacterial metabolism contributes to host global purine homeostasis Cell Host Microbe 2023 31 1038 1053.e10 10.1016/j.chom.2023.05.011 37279756
Kasahara, K. et al. Gut bacterial metabolism contributes to host global purine homeostasis. Cell Host Microbe 31, 1038–1053.e10 (2023).37279756
577. Johnson RJ Do thrifty genes exist? Revisiting uricase Obesity 2022 30 1917 1926 10.1002/oby.23540 36150210
Johnson, R. J. et al. Do thrifty genes exist? Revisiting uricase. Obesity 30, 1917–1926 (2022).36150210
578. Chang BSW Ancient insights into uric acid metabolism in primates Proc. Natl Acad. Sci. 2014 111 3657 3658 10.1073/pnas.1401037111 24556992
Chang, B. S. W. Ancient insights into uric acid metabolism in primates. Proc. Natl Acad. Sci. 111, 3657–3658 (2014).24556992
579. Muller PA Microbiota-modulated CART + enteric neurons autonomously regulate blood glucose Science 2020 370 314 321 10.1126/science.abd6176 32855216
Muller, P. A. et al. Microbiota-modulated CART + enteric neurons autonomously regulate blood glucose. Science 370, 314–321 (2020).32855216
580. Suez J Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance Cell 2022 185 3307 3328.e19 10.1016/j.cell.2022.07.016 35987213
Suez, J. et al. Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell 185, 3307–3328.e19 (2022).35987213
581. Chen B-Y Characteristics and correlations of the oral and gut fungal microbiome with hypertension Microbiol. Spectr. 2023 11 e01956 22 36475759
Chen, B.-Y. et al. Characteristics and correlations of the oral and gut fungal microbiome with hypertension. Microbiol. Spectr. 11, e01956–22 (2023).36475759
582. O’Donnell JA Zheng T Meric G Marques FZ The gut microbiome and hypertension Nat. Rev. Nephrol. 2023 19 153 167 10.1038/s41581-022-00654-0 36631562
O’Donnell, J. A., Zheng, T., Meric, G. & Marques, F. Z. The gut microbiome and hypertension. Nat. Rev. Nephrol. 19, 153–167 (2023).36631562
583. Bushyhead D Quigley EMM Small intestinal bacterial overgrowth—pathophysiology and its implications for definition and management Gastroenterology 2022 163 593 607 10.1053/j.gastro.2022.04.002 35398346
Bushyhead, D. & Quigley, E. M. M. Small intestinal bacterial overgrowth—pathophysiology and its implications for definition and management. Gastroenterology 163, 593–607 (2022).35398346
584. Hayase E Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease Cell 2022 185 3705 3719.e14 10.1016/j.cell.2022.09.007 36179667
Hayase, E. et al. Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease. Cell 185, 3705–3719.e14 (2022).36179667
585. Lu Q Stappenbeck TS Local barriers configure systemic communications between the host and microbiota Science 2022 376 950 955 10.1126/science.abo2366 35617395
Lu, Q. & Stappenbeck, T. S. Local barriers configure systemic communications between the host and microbiota. Science 376, 950–955 (2022).35617395
586. Anhê FF Barra NG Cavallari JF Henriksbo BD Schertzer JD Metabolic endotoxemia is dictated by the type of lipopolysaccharide Cell Rep. 2021 36 109691 10.1016/j.celrep.2021.109691 34525353
Anhê, F. F., Barra, N. G., Cavallari, J. F., Henriksbo, B. D. & Schertzer, J. D. Metabolic endotoxemia is dictated by the type of lipopolysaccharide. Cell Rep. 36, 109691 (2021).34525353
587. Marshall JC The microbiology of multiple organ failure: the proximal gastrointestinal tract as an occult reservoir of pathogens Arch. Surg. 1988 123 309 10.1001/archsurg.1988.01400270043006 3341911
Marshall, J. C. The microbiology of multiple organ failure: the proximal gastrointestinal tract as an occult reservoir of pathogens. Arch. Surg. 123, 309 (1988).3341911
588. Berg R Bacterial translocation from the gastrointestinal tract Trends Microbiol. 1995 3 149 154 10.1016/S0966-842X(00)88906-4 7613757
Berg, R. Bacterial translocation from the gastrointestinal tract. Trends Microbiol. 3, 149–154 (1995).7613757
589. Meisel M Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host Nature 2018 557 580 584 10.1038/s41586-018-0125-z 29769727
Meisel, M. et al. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557, 580–584 (2018).29769727
590. Peng S CRB1-associated retinal degeneration is dependent on bacterial translocation from the gut Cell 2024 187 1387 1401.e13 10.1016/j.cell.2024.01.040 38412859
Peng, S. et al. CRB1-associated retinal degeneration is dependent on bacterial translocation from the gut. Cell 187, 1387–1401.e13 (2024).38412859
591. Massier L Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes Gut 2020 69 1796 1806 10.1136/gutjnl-2019-320118 32317332
Massier, L. et al. Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes. Gut 69, 1796–1806 (2020).32317332
592. Anhê FF Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity Nat. Metab. 2020 2 233 242 10.1038/s42255-020-0178-9 32694777
Anhê, F. F. et al. Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity. Nat. Metab. 2, 233–242 (2020).32694777
593. Simpson BW Trent MS Pushing the envelope: LPS modifications and their consequences Nat. Rev. Microbiol. 2019 17 403 416 10.1038/s41579-019-0201-x 31142822
Simpson, B. W. & Trent, M. S. Pushing the envelope: LPS modifications and their consequences. Nat. Rev. Microbiol. 17, 403–416 (2019).31142822
594. Lasselin J Comparison of bacterial lipopolysaccharide-induced sickness behavior in rodents and humans: Relevance for symptoms of anxiety and depression Neurosci. Biobehav. Rev. 2020 115 15 24 10.1016/j.neubiorev.2020.05.001 32433924
Lasselin, J. et al. Comparison of bacterial lipopolysaccharide-induced sickness behavior in rodents and humans: Relevance for symptoms of anxiety and depression. Neurosci. Biobehav. Rev. 115, 15–24 (2020).32433924
595. Page MJ Kell DB Pretorius E The role of lipopolysaccharide-induced cell signalling in chronic inflammation Chronic Stress 2022 6 247054702210763 10.1177/24705470221076390
Page, M. J., Kell, D. B. & Pretorius, E. The role of lipopolysaccharide-induced cell signalling in chronic inflammation. Chronic Stress 6, 247054702210763 (2022).
596. Cani PD Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 2007 56 1761 1772 10.2337/db06-1491 17456850
Cani, P. D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772 (2007).17456850
597. Yang Y Within-host evolution of a gut pathobiont facilitates liver translocation Nature 2022 607 563 570 10.1038/s41586-022-04949-x 35831502
Yang, Y. et al. Within-host evolution of a gut pathobiont facilitates liver translocation. Nature 607, 563–570 (2022).35831502
598. Hoyles L Regulation of blood–brain barrier integrity by microbiome-associated methylamines and cognition by trimethylamine N-oxide Microbiome 2021 9 235 10.1186/s40168-021-01181-z 34836554
Hoyles, L. et al. Regulation of blood–brain barrier integrity by microbiome-associated methylamines and cognition by trimethylamine N-oxide. Microbiome 9, 235 (2021).34836554
599. Zhu W Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk Cell 2016 165 111 124 10.1016/j.cell.2016.02.011 26972052
Zhu, W. et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165, 111–124 (2016).26972052
600. Benson TW Gut microbiota–derived trimethylamine n-oxide contributes to abdominal aortic aneurysm through inflammatory and apoptotic mechanisms Circulation 2023 147 1079 1096 10.1161/CIRCULATIONAHA.122.060573 37011073
Benson, T. W. et al. Gut microbiota–derived trimethylamine n-oxide contributes to abdominal aortic aneurysm through inflammatory and apoptotic mechanisms. Circulation 147, 1079–1096 (2023).37011073
601. Wang Z Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease Nature 2011 472 57 63 10.1038/nature09922 21475195
Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57–63 (2011).21475195
602. Wang H The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer Cell Metab. 2022 34 581 594.e8 10.1016/j.cmet.2022.02.010 35278352
Wang, H. et al. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer. Cell Metab. 34, 581–594.e8 (2022).35278352
603. Mirji G The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer Sci. Immunol. 2022 7 eabn0704 10.1126/sciimmunol.abn0704 36083892
Mirji, G. et al. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer. Sci. Immunol. 7, eabn0704 (2022).36083892
604. Needham BD A gut-derived metabolite alters brain activity and anxiety behaviour in mice Nature 2022 602 647 653 10.1038/s41586-022-04396-8 35165440
Needham, B. D. et al. A gut-derived metabolite alters brain activity and anxiety behaviour in mice. Nature 602, 647–653 (2022).35165440
605. Qi X Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome Nat. Med. 2019 25 1225 1233 10.1038/s41591-019-0509-0 31332392
Qi, X. et al. Gut microbiota–bile acid–interleukin-22 axis orchestrates polycystic ovary syndrome. Nat. Med. 25, 1225–1233 (2019).31332392
606. Yun C The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice Nat. Metab. 2024 6 947 962 10.1038/s42255-024-01041-8 38769396
Yun, C. et al. The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice. Nat. Metab. 6, 947–962 (2024).38769396
607. Trabelsi M-S Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells Nat. Commun. 2015 6 7629 10.1038/ncomms8629 26134028
Trabelsi, M.-S. et al. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat. Commun. 6, 7629 (2015).26134028
608. Koh A Microbially produced imidazole propionate impairs insulin signaling through mTORC1 Cell 2018 175 947 961.e17 10.1016/j.cell.2018.09.055 30401435
Koh, A. et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell 175, 947–961.e17 (2018).30401435
609. Molinaro A Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology Nat. Commun. 2020 11 5881 10.1038/s41467-020-19589-w 33208748
Molinaro, A. et al. Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology. Nat. Commun. 11, 5881 (2020).33208748
610. White PJ Newgard CB Branched-chain amino acids in disease Science 2019 363 582 583 10.1126/science.aav0558 30733403
White, P. J. & Newgard, C. B. Branched-chain amino acids in disease. Science 363, 582–583 (2019).30733403
611. Nemet I A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors Cell 2020 180 862 877.e22 10.1016/j.cell.2020.02.016 32142679
Nemet, I. et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell 180, 862–877.e22 (2020).32142679
612. Tennoune N Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide α-MSH, at the origin of eating disorders Transl. Psychiatry 2014 4 e458 e458 10.1038/tp.2014.98 25290265
Tennoune, N. et al. Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide α-MSH, at the origin of eating disorders. Transl. Psychiatry 4, e458–e458 (2014).25290265
613. Gil-Cruz C Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy Science 2019 366 881 886 10.1126/science.aav3487 31727837
Gil-Cruz, C. et al. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Science 366, 881–886 (2019).31727837
614. Wang K Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target Science 2023 381 eadd5787 10.1126/science.add5787 37535747
Wang, K. et al. Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target. Science 381, eadd5787 (2023).37535747
615. Granton E Biofilm exopolysaccharides alter sensory-neuron-mediated sickness during lung infection Cell 2024 187 1874 1888.e14 10.1016/j.cell.2024.03.001 38518773
Granton, E. et al. Biofilm exopolysaccharides alter sensory-neuron-mediated sickness during lung infection. Cell 187, 1874–1888.e14 (2024).38518773
616. Valles-Colomer M The person-to-person transmission landscape of the gut and oral microbiomes Nature 2023 614 125 135 10.1038/s41586-022-05620-1 36653448
Valles-Colomer, M. et al. The person-to-person transmission landscape of the gut and oral microbiomes. Nature 614, 125–135 (2023).36653448
617. Finlay BB CIFAR Humans, & the Microbiome. Are noncommunicable diseases communicable? Science 2020 367 250 251 10.1126/science.aaz3834 31949069
Finlay, B. B. CIFAR Humans, & the Microbiome. Are noncommunicable diseases communicable? Science 367, 250–251 (2020).31949069
618. Sarkar A Microbial transmission in the social microbiome and host health and disease Cell 2024 187 17 43 10.1016/j.cell.2023.12.014 38181740
Sarkar, A. et al. Microbial transmission in the social microbiome and host health and disease. Cell 187, 17–43 (2024).38181740
619. Chong B Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019 eClinicalMedicine 2023 57 101850 10.1016/j.eclinm.2023.101850 36864983
Chong, B. et al. Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019. eClinicalMedicine 57, 101850 (2023).36864983
620. Lindstrom M Global burden of cardiovascular diseases and risks collaboration, 1990–2021 J. Am. Coll. Cardiol. 2022 80 2372 2425 10.1016/j.jacc.2022.11.001 36517116
Lindstrom, M. et al. Global burden of cardiovascular diseases and risks collaboration, 1990–2021. J. Am. Coll. Cardiol. 80, 2372–2425 (2022).36517116
621. Wang, Y. et al. Global burden of digestive diseases: a systematic analysis of the global burden of diseases study, 1990–2019. Gastroenterology 165, 773–783.e15 (2023).
622. Ong, K. L. et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 402, 203–234 (2023).
623. Tran KB The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 Lancet 2022 400 563 591 10.1016/S0140-6736(22)01438-6 35988567
Tran, K. B. et al. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 400, 563–591 (2022).35988567
624. Fink G Tediosi F Felder S Burden of Covid-19 restrictions: National, regional and global estimates eClinicalMedicine 2022 45 101305 10.1016/j.eclinm.2022.101305 35224471
Fink, G., Tediosi, F. & Felder, S. Burden of Covid-19 restrictions: National, regional and global estimates. eClinicalMedicine 45, 101305 (2022).35224471
625. Bello MGD Knight R Gilbert JA Blaser MJ Preserving microbial diversity Science 2018 362 33 34 10.1126/science.aau8816 30287652
Bello, M. G. D., Knight, R., Gilbert, J. A. & Blaser, M. J. Preserving microbial diversity. Science 362, 33–34 (2018).30287652
626. Allsup CM George I Lankau RA Shifting microbial communities can enhance tree tolerance to changing climates Science 2023 380 835 840 10.1126/science.adf2027 37228219
Allsup, C. M., George, I. & Lankau, R. A. Shifting microbial communities can enhance tree tolerance to changing climates. Science 380, 835–840 (2023).37228219
627. Raaijmakers JM Kiers ET Rewilding plant microbiomes Science 2022 378 599 600 10.1126/science.abn6350 36356130
Raaijmakers, J. M. & Kiers, E. T. Rewilding plant microbiomes. Science 378, 599–600 (2022).36356130
628. Reardon S Faecal transplants could help preserve vulnerable species Nature 2018 558 173 174 10.1038/d41586-018-05352-1 29895922
Reardon, S. Faecal transplants could help preserve vulnerable species. Nature 558, 173–174 (2018).29895922
629. Cahan E As superbugs flourish, bacteriophage therapy recaptures researchers’ interest JAMA 2023 329 781 10.1001/jama.2022.17756 36811929
Cahan, E. As superbugs flourish, bacteriophage therapy recaptures researchers’ interest. JAMA 329, 781 (2023).36811929
630. Strathdee SA Hatfull GF Mutalik VK Schooley RT Phage therapy: from biological mechanisms to future directions Cell 2023 186 17 31 10.1016/j.cell.2022.11.017 36608652
Strathdee, S. A., Hatfull, G. F., Mutalik, V. K. & Schooley, R. T. Phage therapy: from biological mechanisms to future directions. Cell 186, 17–31 (2023).36608652
631. Bayfield OW Structural atlas of a human gut crassvirus Nature 2023 617 409 416 10.1038/s41586-023-06019-2 37138077
Bayfield, O. W. et al. Structural atlas of a human gut crassvirus. Nature 617, 409–416 (2023).37138077
632. Benler S Thousands of previously unknown phages discovered in whole-community human gut metagenomes Microbiome 2021 9 78 10.1186/s40168-021-01017-w 33781338
Benler, S. et al. Thousands of previously unknown phages discovered in whole-community human gut metagenomes. Microbiome 9, 78 (2021).33781338
633. Nayfach S Metagenomic compendium of 189,680 DNA viruses from the human gut microbiome Nat. Microbiol. 2021 6 960 970 10.1038/s41564-021-00928-6 34168315
Nayfach, S. et al. Metagenomic compendium of 189,680 DNA viruses from the human gut microbiome. Nat. Microbiol. 6, 960–970 (2021).34168315
634. Camarillo-Guerrero LF Almeida A Rangel-Pineros G Finn RD Lawley TD Massive expansion of human gut bacteriophage diversity Cell 2021 184 1098 1109.e9 10.1016/j.cell.2021.01.029 33606979
Camarillo-Guerrero, L. F., Almeida, A., Rangel-Pineros, G., Finn, R. D. & Lawley, T. D. Massive expansion of human gut bacteriophage diversity. Cell 184, 1098–1109.e9 (2021).33606979
635. Shkoporov AN Hill C Bacteriophages of the human gut: the “known unknown” of the microbiome Cell Host Microbe 2019 25 195 209 10.1016/j.chom.2019.01.017 30763534
Shkoporov, A. N. & Hill, C. Bacteriophages of the human gut: the “known unknown” of the microbiome. Cell Host Microbe 25, 195–209 (2019).30763534
636. Yutin N Discovery of an expansive bacteriophage family that includes the most abundant viruses from the human gut Nat. Microbiol. 2017 3 38 46 10.1038/s41564-017-0053-y 29133882
Yutin, N. et al. Discovery of an expansive bacteriophage family that includes the most abundant viruses from the human gut. Nat. Microbiol. 3, 38–46 (2017).29133882
637. Zhang F Aschenbrenner D Yoo JY Zuo T The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly Lancet Microbe 2022 3 e969 e983 10.1016/S2666-5247(22)00203-8 36182668
Zhang, F., Aschenbrenner, D., Yoo, J. Y. & Zuo, T. The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly. Lancet Microbe 3, e969–e983 (2022).36182668
638. Kong HH Segre JA Cultivating fungal research Science 2020 368 365 366 10.1126/science.aaz8086 32327584
Kong, H. H. & Segre, J. A. Cultivating fungal research. Science 368, 365–366 (2020).32327584
639. Thomas CM Desmond-Le Quéméner E Gribaldo S Borrel G Factors shaping the abundance and diversity of the gut archaeome across the animal kingdom Nat. Commun. 2022 13 3358 10.1038/s41467-022-31038-4 35688919
Thomas, C. M., Desmond-Le Quéméner, E., Gribaldo, S. & Borrel, G. Factors shaping the abundance and diversity of the gut archaeome across the animal kingdom. Nat. Commun. 13, 3358 (2022).35688919
640. Hoegenauer C Hammer HF Mahnert A Moissl-Eichinger C Methanogenic archaea in the human gastrointestinal tract Nat. Rev. Gastroenterol. Hepatol. 2022 19 805 813 10.1038/s41575-022-00673-z 36050385
Hoegenauer, C., Hammer, H. F., Mahnert, A. & Moissl-Eichinger, C. Methanogenic archaea in the human gastrointestinal tract. Nat. Rev. Gastroenterol. Hepatol. 19, 805–813 (2022).36050385
641. Pennisi E Survey of archaea in the body reveals other microbial guests Science 2017 358 983 983 10.1126/science.358.6366.983 29170214
Pennisi, E. Survey of archaea in the body reveals other microbial guests. Science 358, 983–983 (2017).29170214
642. Borrel G Brugère J-F Gribaldo S Schmitz RA Moissl-Eichinger C The host-associated archaeome Nat. Rev. Microbiol. 2020 18 622 636 10.1038/s41579-020-0407-y 32690877
Borrel, G., Brugère, J.-F., Gribaldo, S., Schmitz, R. A. & Moissl-Eichinger, C. The host-associated archaeome. Nat. Rev. Microbiol. 18, 622–636 (2020).32690877
643. Yang L Li A Wang Y Zhang Y Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy Signal Transduct. Target. Ther. 2023 8 35 10.1038/s41392-022-01304-4 36646684
Yang, L., Li, A., Wang, Y. & Zhang, Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduct. Target. Ther. 8, 35 (2023).36646684
644. Bullman S The intratumoral microbiota: from microniches to single cells Cell 2023 186 1532 1534 10.1016/j.cell.2023.03.012 37059062
Bullman, S. The intratumoral microbiota: from microniches to single cells. Cell 186, 1532–1534 (2023).37059062
645. Swanton C Embracing cancer complexity: Hallmarks of systemic disease Cell 2024 187 1589 1616 10.1016/j.cell.2024.02.009 38552609
Swanton, C. et al. Embracing cancer complexity: Hallmarks of systemic disease. Cell 187, 1589–1616 (2024).38552609
646. Cao Y Intratumoural microbiota: a new frontier in cancer development and therapy Signal Transduct. Target. Ther. 2024 9 15 10.1038/s41392-023-01693-0 38195689
Cao, Y. et al. Intratumoural microbiota: a new frontier in cancer development and therapy. Signal Transduct. Target. Ther. 9, 15 (2024).38195689
647. Blake SJ Wolf Y Boursi B Lynn DJ Role of the microbiota in response to and recovery from cancer therapy Nat. Rev. Immunol. 2024 24 308 325 10.1038/s41577-023-00951-0 37932511
Blake, S. J., Wolf, Y., Boursi, B. & Lynn, D. J. Role of the microbiota in response to and recovery from cancer therapy. Nat. Rev. Immunol. 24, 308–325 (2024).37932511
648. Bai X Engineering the gut microbiome Nat. Rev. Bioeng. 2023 1 665 679 10.1038/s44222-023-00072-2
Bai, X. et al. Engineering the gut microbiome. Nat. Rev. Bioeng. 1, 665–679 (2023).
649. Kurtz CB An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans Sci. Transl. Med. 2019 11 eaau7975 10.1126/scitranslmed.aau7975 30651324
Kurtz, C. B. et al. An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci. Transl. Med. 11, eaau7975 (2019).30651324
650. Durmusoglu D In situ biomanufacturing of small molecules in the mammalian gut by probiotic Saccharomyces boulardii ACS Synth. Biol. 2021 10 1039 1052 10.1021/acssynbio.0c00562 33843197
Durmusoglu, D. et al. In situ biomanufacturing of small molecules in the mammalian gut by probiotic Saccharomyces boulardii. ACS Synth. Biol. 10, 1039–1052 (2021).33843197
651. Selle K In vivo targeting of clostridioides difficile using phage-delivered CRISPR-Cas3 antimicrobials mBio 2020 11 e00019 e00020 10.1128/mBio.00019-20 32156803
Selle, K. et al. In vivo targeting of clostridioides difficile using phage-delivered CRISPR-Cas3 antimicrobials. mBio 11, e00019–e00020 (2020).32156803
652. Lam KN Phage-delivered CRISPR-Cas9 for strain-specific depletion and genomic deletions in the gut microbiome Cell Rep. 2021 37 109930 10.1016/j.celrep.2021.109930 34731631
Lam, K. N. et al. Phage-delivered CRISPR-Cas9 for strain-specific depletion and genomic deletions in the gut microbiome. Cell Rep. 37, 109930 (2021).34731631
653. Patel JR Oh J Wang S Crawford JM Isaacs FJ Cross-kingdom expression of synthetic genetic elements promotes discovery of metabolites in the human microbiome Cell 2022 185 1487 1505.e14 10.1016/j.cell.2022.03.008 35366417
Patel, J. R., Oh, J., Wang, S., Crawford, J. M. & Isaacs, F. J. Cross-kingdom expression of synthetic genetic elements promotes discovery of metabolites in the human microbiome. Cell 185, 1487–1505.e14 (2022).35366417
654. Wang L Engineering consortia by polymeric microbial swarmbots Nat. Commun. 2022 13 3879 10.1038/s41467-022-31467-1 35790722
Wang, L. et al. Engineering consortia by polymeric microbial swarmbots. Nat. Commun. 13, 3879 (2022).35790722
655. Robinson JM Twenty important research questions in microbial exposure and social equity mSystems 2022 7 e01240 21 10.1128/msystems.01240-21 35089060
Robinson, J. M. et al. Twenty important research questions in microbial exposure and social equity. mSystems 7, e01240–21 (2022).35089060
656. Oduaran, O. H. et al. Microbiome research in Africa must be based on equitable partnerships. Nat. Med. 10.1038/s41591-024-03026-2 (2024).
657. Hou K Microbiota in health and diseases Signal Transduct. Target. Ther. 2022 7 135 10.1038/s41392-022-00974-4 35461318
Hou, K. et al. Microbiota in health and diseases. Signal Transduct. Target. Ther. 7, 135 (2022).35461318
658. Sender R Fuchs S Milo R Are We really vastly outnumbered? revisiting the ratio of bacterial to host cells in humans Cell 2016 164 337 340 10.1016/j.cell.2016.01.013 26824647
Sender, R., Fuchs, S. & Milo, R. Are We really vastly outnumbered? revisiting the ratio of bacterial to host cells in humans. Cell 164, 337–340 (2016).26824647
659. Sender R Fuchs S Milo R Revised estimates for the number of human and bacteria cells in the body PLoS Biol. 2016 14 e1002533 10.1371/journal.pbio.1002533 27541692
Sender, R., Fuchs, S. & Milo, R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 14, e1002533 (2016).27541692
660. Porcari S Key determinants of success in fecal microbiota transplantation: from microbiome to clinic Cell Host Microbe 2023 31 712 733 10.1016/j.chom.2023.03.020 37167953
Porcari, S. et al. Key determinants of success in fecal microbiota transplantation: from microbiome to clinic. Cell Host Microbe 31, 712–733 (2023).37167953
661. Ng, R. W. et al. Revisiting the donor screening protocol of faecal microbiota transplantation (FMT): a systematic review. Gut 73,1029–1031 (2023).
662. Gulati AS Nicholson MR Khoruts A Kahn SA Fecal microbiota transplantation across the lifespan: balancing efficacy, safety, and innovation Am. J. Gastroenterol. 2023 118 435 439 10.14309/ajg.0000000000002167 36580630
Gulati, A. S., Nicholson, M. R., Khoruts, A. & Kahn, S. A. Fecal microbiota transplantation across the lifespan: balancing efficacy, safety, and innovation. Am. J. Gastroenterol. 118, 435–439 (2023).36580630
663. Allegretti JR Mullish BH Kelly C Fischer M The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications Lancet 2019 394 420 431 10.1016/S0140-6736(19)31266-8 31379333
Allegretti, J. R., Mullish, B. H., Kelly, C. & Fischer, M. The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. Lancet 394, 420–431 (2019).31379333
664. Schmidt TSB Drivers and determinants of strain dynamics following fecal microbiota transplantation Nat. Med. 2022 28 1902 1912 10.1038/s41591-022-01913-0 36109636
Schmidt, T. S. B. et al. Drivers and determinants of strain dynamics following fecal microbiota transplantation. Nat. Med. 28, 1902–1912 (2022).36109636
665. Shen NT Timely use of probiotics in hospitalized adults prevents clostridium difficile infection: a systematic review with meta-regression analysis Gastroenterology 2017 152 1889 1900.e9 10.1053/j.gastro.2017.02.003 28192108
Shen, N. T. et al. Timely use of probiotics in hospitalized adults prevents clostridium difficile infection: a systematic review with meta-regression analysis. Gastroenterology 152, 1889–1900.e9 (2017).28192108
666. Cohen CR Randomized trial of lactin-V to prevent recurrence of bacterial vaginosis N. Engl. J. Med. 2020 382 1906 1915 10.1056/NEJMoa1915254 32402161
Cohen, C. R. et al. Randomized trial of lactin-V to prevent recurrence of bacterial vaginosis. N. Engl. J. Med. 382, 1906–1915 (2020).32402161
667. Goldenberg JZ Mertz D Johnston BC Probiotics to prevent Clostridium difficile infection in patients receiving antibiotics JAMA 2018 320 499 10.1001/jama.2018.9064 30027207
Goldenberg, J. Z., Mertz, D. & Johnston, B. C. Probiotics to prevent Clostridium difficile infection in patients receiving antibiotics. JAMA 320, 499 (2018).30027207
668. Suez J Zmora N Segal E Elinav E The pros, cons, and many unknowns of probiotics Nat. Med. 2019 25 716 729 10.1038/s41591-019-0439-x 31061539
Suez, J., Zmora, N., Segal, E. & Elinav, E. The pros, cons, and many unknowns of probiotics. Nat. Med. 25, 716–729 (2019).31061539
669. Piewngam P Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: a phase 2, double-blind, randomised, placebo-controlled trial Lancet Microbe 2023 4 e75 e83 10.1016/S2666-5247(22)00322-6 36646104
Piewngam, P. et al. Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand: a phase 2, double-blind, randomised, placebo-controlled trial. Lancet Microbe 4, e75–e83 (2023).36646104
670. Sanders ME Merenstein DJ Reid G Gibson GR Rastall RA Probiotics and prebiotics in intestinal health and disease: from biology to the clinic Nat. Rev. Gastroenterol. Hepatol. 2019 16 605 616 10.1038/s41575-019-0173-3 31296969
Sanders, M. E., Merenstein, D. J., Reid, G., Gibson, G. R. & Rastall, R. A. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat. Rev. Gastroenterol. Hepatol. 16, 605–616 (2019).31296969
671. Fagnant HS Orally ingested probiotic, prebiotic, and synbiotic interventions as countermeasures for gastrointestinal tract infections in nonelderly adults: a systematic review and meta-analysis Adv. Nutr. 2023 14 539 554 10.1016/j.advnut.2023.02.002 36822240
Fagnant, H. S. et al. Orally ingested probiotic, prebiotic, and synbiotic interventions as countermeasures for gastrointestinal tract infections in nonelderly adults: a systematic review and meta-analysis. Adv. Nutr. 14, 539–554 (2023).36822240
672. Swanson KS The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics Nat. Rev. Gastroenterol. Hepatol. 2020 17 687 701 10.1038/s41575-020-0344-2 32826966
Swanson, K. S. et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat. Rev. Gastroenterol. Hepatol. 17, 687–701 (2020).32826966
673. Salminen S Author Correction: The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics Nat. Rev. Gastroenterol. Hepatol. 2022 19 551 551 10.1038/s41575-022-00628-4 35538163
Salminen, S. et al. Author Correction: The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat. Rev. Gastroenterol. Hepatol. 19, 551–551 (2022).35538163
674. Wargo JA Modulating gut microbes Science 2020 369 1302 1303 10.1126/science.abc3965 32913089
Wargo, J. A. Modulating gut microbes. Science 369, 1302–1303 (2020).32913089
675. Raffatellu M Learning from bacterial competition in the host to develop antimicrobials Nat. Med. 2018 24 1097 1103 10.1038/s41591-018-0145-0 30082869
Raffatellu, M. Learning from bacterial competition in the host to develop antimicrobials. Nat. Med. 24, 1097–1103 (2018).30082869
676. Sorbara MT Pamer EG Microbiome-based therapeutics Nat. Rev. Microbiol. 2022 20 365 380 10.1038/s41579-021-00667-9 34992261
Sorbara, M. T. & Pamer, E. G. Microbiome-based therapeutics. Nat. Rev. Microbiol. 20, 365–380 (2022).34992261
677. Renz H Skevaki C Early life microbial exposures and allergy risks: opportunities for prevention Nat. Rev. Immunol. 2021 21 177 191 10.1038/s41577-020-00420-y 32918062
Renz, H. & Skevaki, C. Early life microbial exposures and allergy risks: opportunities for prevention. Nat. Rev. Immunol. 21, 177–191 (2021).32918062
678. Vatanen T The human gut microbiome in early-onset type 1 diabetes from the TEDDY study Nature 2018 562 589 594 10.1038/s41586-018-0620-2 30356183
Vatanen, T. et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 562, 589–594 (2018).30356183
679. Dong D Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment Gut Microbes 2023 15 2192478 10.1080/19490976.2023.2192478 36951545
Dong, D. et al. Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment. Gut Microbes 15, 2192478 (2023).36951545
680. Yadegar A Beneficial effects of fecal microbiota transplantation in recurrent Clostridioides difficile infection Cell Host Microbe 2023 31 695 711 10.1016/j.chom.2023.03.019 37167952
Yadegar, A. et al. Beneficial effects of fecal microbiota transplantation in recurrent Clostridioides difficile infection. Cell Host Microbe 31, 695–711 (2023).37167952
681. Cohen SH Extended follow-up of microbiome therapeutic SER-109 through 24 weeks for recurrent Clostridioides difficile infection in a randomized clinical trial JAMA 2022 328 2062 10.1001/jama.2022.16476 36260754
Cohen, S. H. et al. Extended follow-up of microbiome therapeutic SER-109 through 24 weeks for recurrent Clostridioides difficile infection in a randomized clinical trial. JAMA 328, 2062 (2022).36260754
682. Walter J Shanahan F Fecal microbiota-based treatment for recurrent Clostridioides difficile infection Cell 2023 186 1087 10.1016/j.cell.2023.02.034 36931236
Walter, J. & Shanahan, F. Fecal microbiota-based treatment for recurrent Clostridioides difficile infection. Cell 186, 1087 (2023).36931236
683. Sims MD Safety and tolerability of SER-109 as an investigational microbiome therapeutic in adults with recurrent Clostridioides difficile infection: a phase 3, open-label, single-arm trial JAMA Netw. Open 2023 6 e2255758 10.1001/jamanetworkopen.2022.55758 36780159
Sims, M. D. et al. Safety and tolerability of SER-109 as an investigational microbiome therapeutic in adults with recurrent Clostridioides difficile infection: a phase 3, open-label, single-arm trial. JAMA Netw. Open 6, e2255758 (2023).36780159
684. Sehgal K Cifu AS Khanna S Treatment of Clostridioides difficile Infection JAMA 2022 328 881 10.1001/jama.2022.12251 35939317
Sehgal, K., Cifu, A. S. & Khanna, S. Treatment of Clostridioides difficile Infection. JAMA 328, 881 (2022).35939317
685. Louie T VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial JAMA 2023 329 1356 10.1001/jama.2023.4314 37060545
Louie, T. et al. VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial. JAMA 329, 1356 (2023).37060545
686. Garey KW Assessment of quality of life among patients with recurrent clostridioides difficile infection treated with investigational oral microbiome therapeutic SER-109: secondary analysis of a randomized clinical trial JAMA Netw. Open 2023 6 e2253570 10.1001/jamanetworkopen.2022.53570 36716031
Garey, K. W. et al. Assessment of quality of life among patients with recurrent clostridioides difficile infection treated with investigational oral microbiome therapeutic SER-109: secondary analysis of a randomized clinical trial. JAMA Netw. Open 6, e2253570 (2023).36716031
687. Khoruts A Staley C Sadowsky MJ Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology Nat. Rev. Gastroenterol. Hepatol. 2021 18 67 80 10.1038/s41575-020-0350-4 32843743
Khoruts, A., Staley, C. & Sadowsky, M. J. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat. Rev. Gastroenterol. Hepatol. 18, 67–80 (2021).32843743
688. Wu, R., Xiong, R., Li, Y., Chen, J. & Yan, R. Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation. J. Autoimmun. 141, 103062 (2023).
689. Paramsothy S Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial Lancet 2017 389 1218 1228 10.1016/S0140-6736(17)30182-4 28214091
Paramsothy, S. et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389, 1218–1228 (2017).28214091
690. Baumgart DC Le Berre CNewer Biologic and small-molecule therapies for inflammatory bowel disease N. Engl. J. Med. 2021 385 1302 1315 10.1056/NEJMra1907607 34587387
Baumgart, D. C. & Le Berre, C. Newer Biologic and small-molecule therapies for inflammatory bowel disease. N. Engl. J. Med. 385, 1302–1315 (2021).34587387
691. Chang JT Pathophysiology of inflammatory bowel diseases N. Engl. J. Med. 2020 383 2652 2664 10.1056/NEJMra2002697 33382932
Chang, J. T. Pathophysiology of inflammatory bowel diseases. N. Engl. J. Med. 383, 2652–2664 (2020).33382932
692. Caruso R Lo BC Núñez G Host–microbiota interactions in inflammatory bowel disease Nat. Rev. Immunol. 2020 20 411 426 10.1038/s41577-019-0268-7 32005980
Caruso, R., Lo, B. C. & Núñez, G. Host–microbiota interactions in inflammatory bowel disease. Nat. Rev. Immunol. 20, 411–426 (2020).32005980
693. Schirmer M Garner A Vlamakis H Xavier RJ Microbial genes and pathways in inflammatory bowel disease Nat. Rev. Microbiol. 2019 17 497 511 10.1038/s41579-019-0213-6 31249397
Schirmer, M., Garner, A., Vlamakis, H. & Xavier, R. J. Microbial genes and pathways in inflammatory bowel disease. Nat. Rev. Microbiol. 17, 497–511 (2019).31249397
694. Lavelle A Sokol H Gut microbiota-derived metabolites as key actors in inflammatory bowel disease Nat. Rev. Gastroenterol. Hepatol. 2020 17 223 237 10.1038/s41575-019-0258-z 32076145
Lavelle, A. & Sokol, H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 17, 223–237 (2020).32076145
695. Lopetuso, L. R. et al. The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease. Gut 72, 1642–1650 (2023).
696. Xin, Y. et al. Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial. J. Autoimmun. 141, 103058 (2023).
697. Yang, R., Chen, Z. & Cai, J. Fecal microbiota transplantation: Emerging applications in autoimmune diseases. J. Autoimmun. 141, 103038 (2023).
698. Palmer JD Foster KR Bacterial species rarely work together Science 2022 376 581 582 10.1126/science.abn5093 35511986
Palmer, J. D. & Foster, K. R. Bacterial species rarely work together. Science 376, 581–582 (2022).35511986
699. Smith AB Enterococci enhance Clostridioides difficile pathogenesis Nature 2022 611 780 786 10.1038/s41586-022-05438-x 36385534
Smith, A. B. et al. Enterococci enhance Clostridioides difficile pathogenesis. Nature 611, 780–786 (2022).36385534
700. Santus W Mycobiota and diet-derived fungal xenosiderophores promote Salmonella gastrointestinal colonization Nat. Microbiol. 2022 7 2025 2038 10.1038/s41564-022-01267-w 36411353
Santus, W. et al. Mycobiota and diet-derived fungal xenosiderophores promote Salmonella gastrointestinal colonization. Nat. Microbiol. 7, 2025–2038 (2022).36411353
701. Neumann PE Neumann EE General histological woes: definition and classification of tissues Clin. Anat. 2021 34 794 801 10.1002/ca.23741 33909319
Neumann, P. E. & Neumann, E. E. General histological woes: definition and classification of tissues. Clin. Anat. 34, 794–801 (2021).33909319
702. Terminology, F. I. C. on A. Terminologia Histologica: International Terms for Human Cytology and Histology (Lippincott Raven, 2008).
703. Aggarwal, N. et al. Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies. Chem. Rev. 123, 31–72 (2022).
704. Javan GT Human thanatomicrobiome succession and time since death Sci. Rep. 2016 6 29598 10.1038/srep29598 27412051
Javan, G. T. et al. Human thanatomicrobiome succession and time since death. Sci. Rep. 6, 29598 (2016).27412051
705. Hasan N Yang H Factors affecting the composition of the gut microbiota, and its modulation PeerJ 2019 7 e7502 10.7717/peerj.7502 31440436
Hasan, N. & Yang, H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ 7, e7502 (2019).31440436
706. Dimitriu PA New insights into the intrinsic and extrinsic factors that shape the human skin microbiome mBio 2019 10 e00839 19 10.1128/mBio.00839-19 31266865
Dimitriu, P. A. et al. New insights into the intrinsic and extrinsic factors that shape the human skin microbiome. mBio 10, e00839–19 (2019).31266865
707. Flandroy L The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems Sci. Total Environ. 2018 627 1018 1038 10.1016/j.scitotenv.2018.01.288 29426121
Flandroy, L. et al. The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems. Sci. Total Environ. 627, 1018–1038 (2018).29426121
